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The aim of this study was to determine management regimens and level of 
knowledge of diabetes and its‟ ocular complications among private patients in a 
sample of the population of the Western Cape region of South Africa. A population-
based cross-sectional study design, using purposive accidental random sampling, 
was used. Questionnaires completed by diabetic patients who fund their condition 
privately outside of the South African Public Health sector were used. One hundred 
and twenty-two subjects participated in the research, 66 (54%) males and 56 (46%) 
females. There were 73 rural and 49 urban participants. The overall sample mean 
BMI was 30.7, average fasting plasma glucose (FPG) 8.1 mmol/l and the majority of 
respondents did not perform a daily FPG test or know the significance of the HbA1c 
test. The majority of participants were unaware of the serious ocular consequences 
of prolonged hyperglycaemia. Sixty-seven percent of respondents considered that 
they knew enough about diabetes to manage their own condition. From the data it is 
apparent that private patients‟ knowledge of the systemic and ocular complications 
of diabetes is sub-optimal. Whilst the majority considered annual eye examinations 
as important, less than one-third of respondents actually undertook them. 
Optometrists should be offered programmes to enhance their skills and co-manage 
and educate diabetic patients with other health care practitioners on a formal basis. 
Health insurance institutions should take cognisance of the value of patient 
education and preventative diabetic management and incentivize patients and health 
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PATIENTS’ KNOWLEDGE OF DIABETES, ITS OCULAR 
COMPLICATIONS AND MANAGEMENT IN PRIVATE PRACTICE 
POPULATION IN THE WESTERN CAPE 
CHAPTER 1 
BACKGROUND AND ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION 
The World Health Organisation (WHO) (2005: 200) has claimed that chronic diseases 
caused 35 million of the 58 million annual deaths worldwide in 2005. Whereas 
previously those suffering from hypertension, diabetes or obesity were deemed to be 
upper or middle class white suburbanites, now the picture appears vastly different: a 
total of 80% of these deaths occurred in lower and middle-income countries with a 
consequent major impact on local economies. Alexander et al. (2008: 2088) argue 
that Diabetes Mellitus (DM) is common, costly and increasingly prevalent, 
maintaining that more expensive and complex therapies are being applied to an 
ever-increasing diabetic population. The Society for Endocrinology, Metabolism and 
Diabetes of South Africa (SEMDSA) (2007) estimates that almost 29% of the 
population of the Western Cape who are over 65 years old have diabetes. This 
alarming statistic probably represents only a portion of the true number of diabetics 
as many South Africans do not have adequate access to health care (Castro-Leal et 
al. 2000) and, it could be surmised that, if more people could be screened in the 
public sector, more diagnoses would be made. The disease appears to cross all 
boundaries; it has no respect for income, gender, race or socio-economic conditions 
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and is linked to obesity (Rippey, 1994:305). However, the specific health risks 
associated with obesity may differ according to gender, race and socio-economic 
condition (Paeratakul et al. 2002: 1205). Many higher income earners who over-
indulge become sedentary, obese, and become victims of the Metabolic Syndrome 
with their lifestyle choices and habits determining their path into hypertension, 
hypercholesterolemia and diabetes (Paeratakul et al. 2002: 1205). Psaty et al. 
(2006: 177) state that clinicians should be treating individual risk factors which make 
up the metabolic syndrome by promoting diet, weight loss and exercise. In the 
words of Cheta (2006: 176) “all the components of the metabolic syndrome…can be 
discovered in the picture of obesity”. Sparks et al. (2005: 1926) describe how 
obesity and type 2 diabetes have been associated with a high fat diet. Those from 
lower income groups often do not have access to good nutrition and rely on fatty 
diets to supplement their energy levels, which lead to obesity and the lifestyle 
diseases mentioned above (Drewnowski and Darmon, 2005: 265). These patients 
are often, though not always, rural, sub-optimally educated and seldom have access 
to information pertaining to their condition other than the periodic contact they have 
with various health workers in the public health system. In support of these factors, 
Motala et al. (2008: 1783) maintains that there is an epidemic of glucose 
intolerance, which is a known risk factor for diabetes, in the South African rural 
population. 
Genetically, some diabetics may also have risk factors which may predispose them to 
becoming diabetic. The angiotensin I converting enzyme gene was suspected of 
causing diabetic kidney disease (Dorin et al. 1994: 690) although this appears to be 
disputed in a 1998 study by Kimura et al. (1998: 1659). Although approximately 
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50% of genetic based diabetes is connected to the HLA genetic region (Steck et al. 
2005: 2482), Concannon et al. (2009: 1018) found that five non-HLA chromosome 
regions showed some evidence of linkage to Type 1 diabetes; whilst Wang et al. 
(2009: 1401) suspect that the liver pyruvate kinase gene is the most likely gene 
responsible in Type 2 diabetes. Whatever the causative gene, however, it is not 
disputed that there is a definite genetic base in many instances of diabetes mellitus.  
 
Table 1.1:  Summary of Type 2 diabetes in different South African   
  population groups (SEMDSA) (2007) 
Population Region (number 





African Cape Town, urban            
8% 
30+ Diabet Care 
1993;16:601 
African Qwa Qwa, rural             
4.8% 
25+ S Afr Med J 
1995;85:90 
African  Durban, urban                 
6% 
15+ S Afr Med J 
1993;83:641 
Mixed (Coloured) Cape Town                  
28.7% 
65+ S Afr Med J 1997;87 
(suppl 3):364 
Mixed (Coloured) Cape Town, peri-urban 
10.8% 
15 - 86 Diabet Med 
1999;16:946 
European Durban, urban                 
3% 
15 - 69 S Afr Med J 
1994;84:257 
Indian Durban, urban               
13% 





In terms of the prevalence of diabetes in South Africa, Cape Town has the largest 
rate where 28.7% of the Coloured population over the age of 65 is diabetic. This is 
illustrated in Table 1.1.  A further study by Motala et al. (2006: 79) states that there 
is a global epidemic of Type 2 diabetes which will most affect the developing world. 
This is confirmed by statistics in the Diabetes Atlas published by the International 
Diabetes Federation (cf. Table 1.2), where it can be seen that the International 
Diabetes Federation estimates that currently there are some 194 million people with 
diagnosed diabetes and by 2025 there will be 333 million diabetes patients 
worldwide.  
 
Table 1.2:  International diabetic statistics (Diabetes Atlas)    
  (International Diabetes Federation, 2006) 
All diabetes and Impaired glucose tolerance (IGT) 2003 2025 
Total world population (billions) 6.3 8.0 
Adult population (billions) (20-79 years) 3.8 5.3 
Number of people with diabetes (millions)(20-79 years) 194 333 
World diabetes prevalence % (20-79 years) 5.1 6.3 
Number of people with IGT (millions) (20-79 years) 314 472 
IGT Prevalence % (20-79 years) 8.2 9.0 
 
1.1.1 Types of Diabetes and its Ocular Complications  
According to Sukha and Rubin (2007: 120), diabetes can be classified into three 
main types: Type 1 (or insulin-dependent diabetes), Type 2 (or non-insulin 
22 
 
dependent diabetes) and gestational diabetes occurring only in pregnancy and a 
major risk factor to progress to Type 2 diabetes after the pregnancy (Buchanan and 
Xiang 2005: 485). Type 1 is divided into idiopathic or autoimmune diabetes mellitus 
both resulting in insulin dependence and loss of pancreatic beta cells, while Type 2 
diabetes is largely a lifestyle disease, resulting from poor diet, sedentary living and 
lack of exercise, causing insulin resistance to glucose metabolism. Gestational 
diabetes is a state of carbohydrate intolerance often caused by hormonal changes 
during pregnancy affecting 2.5% of all pregnant women (Xiong 2003: 223). The 
World Health Organisation (WHO) has classified the diagnostic fasting plasma 
(blood) glucose value for the diagnosis of all diabetes to be 7.0 mmol/l (Alberti and 
Zimmert 1998: 539 – 553).  
 
As far as the ocular complications and associations of diabetes are concerned, these 
include cranial nerve palsies, decreased corneal sensitivity and healing, open and 
closed angle glaucoma, pupil abnormalities, cataract, retinal ischaemic and 
hemorrhagic disorders and refractive changes (Sukha and Rubin 2007: 120 and 
Records 1970: 709). 
 
1.1.2 Financial implications of diabetes 
Kowjala et al. (2007: 917) examined the costs of diabetes treatment and care in 
Pakistan, concluding that these costs are high. In the United States the estimated 
$132 billion cost for diabetes treatment in 2003 probably underestimates the true 
burden of diabetes (American Diabetes Association 2003: 917) as there are certain 
aspects that cannot be measured like pain and suffering. Furthermore, the cost of 
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care given by unpaid caregivers and volunteers is not factored into the calculations 
as well as the incalculable cost to society and those suffering from the disease and 
their families. Motala et al. (2006: 79) indicated that treatment involves both direct 
(medication) and indirect (diet and lifestyle changes) interventions and developing 
countries can ill-afford the burden to the fiscus. They therefore recommended that 
more cost-effective programmes be introduced to reduce the financial burden on the 
State.  
 
It can be argued that, by understanding the problems associated with diabetes and 
the possible consequences of the disease, compliance and management can be 
better achieved. Research conducted by Clarke-Farr et al. (2006: 134), which 
focused mainly on the public health sector, established the levels of knowledge of 
diabetic patients about their condition. Diabetes appears to be as much a problem in 
the private sector and it follows that a study needs to be conducted on the degree of 
knowledge that private sector diabetics have of their condition. Anecdotal evidence 
shows that, possibly due to the higher levels of education, there is a greater 
understanding of the condition per se, but knowledge of the consequences of the 
condition, especially ocular complications, remains somewhat vague. Private patients 
may also be able to spend more time with their physicians than would be the case at 
a public health care facility and thereby are perhaps able to gain a better 
understanding and insight into their condition and be better placed to manage their 




This study, therefore, aims to examine the knowledge of diabetes and its 
consequences in diabetic patients in the private sector. In addition, comparisons can 
later be made between the studies involving the public sector by Clarke-Farr et al. 
(2006: 134) and Mashige et al. (2008: 95) to see if there are indeed differences in 
this knowledge and, if so, what these differences are and why they occur. As a result 
of this, planned strategies and interventions may be implemented to reduce the 
ocular complications in diabetic patients where better patient co-operation and 
compliance could improve the effectiveness in the treatment of diabetes. Improved 
knowledge of the condition and its dangers could reinforce information already 
received but, perhaps, long-forgotten or poorly understood. Furthermore the role 
and value of the optometrist in managing these patients may be expanded. 
 
1.2 STATEMENT OF THE PROBLEM 
Previous studies by Clarke-Farr et al. (2006: 134) and Mashige et al. (2008: 95) 
have concentrated primarily on the public sector patient knowledge of diabetes 
mellitus and its ocular complications. This does not complete the picture as there are 
many thousands, possibly millions, of diabetic patients in the private sector who 
either self-fund their medical needs or are members of medical schemes. These 
patients also need to comply with their treatment regimen and be regularly screened 
for the consequences of diabetes. This raises the question: what is the current level 
of knowledge of diabetic patients about their disease in the private sector and how 




Anecdotal evidence from patients in private optometric practice suggests that once 
diagnosed with diabetes private patients are given a diet sheet by their general 
practitioner and a prescription for medication and are told to return for a follow-up 
visit within a specified period. The majority of diagnoses are made by General 
Practitioners and referrals are made to specialist physicians only if diabetes control 
proves to be troublesome. This study therefore aimed to ascertain the depth of 
knowledge and understanding of the ocular complications of diabetes of privately 
treated diabetic patients with the further benefit of informing policy and 
recommendations for general practitioners and allied health care workers, optometry 
included.  
 
1.3 THE AIM, GOAL AND OBJECTIVES OF THE STUDY 
The aim of this study was to determine the management regimens and level of 
knowledge of diabetes and its‟ ocular complications among private patients in a 
cross-section of the population of the Western Cape region of South Africa. The 
overall goal of the study was to enhance the role of the Primary Care Practitioner, 
including optometrists, in performing a constructive supporting service in the overall 
management and care of the diabetic patient in private practice. 
 
In order to achieve the stated aims and goals, the following objectives were 
developed: 
 
1. To determine the level of knowledge of diabetic patients in the private sector 
 about diabetes 
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2. To determine the level of knowledge of diabetic patients in the private sector 
about the ocular complications of diabetes 
3. To determine the level of knowledge of diabetic patients in the private sector 
about the management and treatment protocols of diabetes 
4. To determine how diabetic patients manage their own condition 
5. Determine possible differences in rural and urban respondents regarding 
knowledge and management of diabetes 
 
1.4 SCOPE OF THE STUDY 
 
The scope of the study was primarily based in the field of optometry and primary 
healthcare but also crossed the fields of general medical practice, ophthalmology 
and nursing as each of these health care providers participate in the management 
and treatment of the diabetic patient. 
 
Due to the fact that one of the key complications of uncontrolled diabetes is 
blindness, optometrists see many of these patients routinely in their daily practice, 
often on referral from general practitioners. This provides an ideal interface for the 






1.5 SIGNIFICANCE AND VALUE OF THE STUDY 
 
The increasing prevalence of diabetes, especially Type 2 diabetes, locally and 
worldwide, makes this disease one of the greatest health challenges of our time. 
Adequate blood glucose control is essential in keeping the consequences of diabetes 
at bay and knowledge of the consequences should assist patient compliance with 
their treatment regimens. This holds equally true for both those patients in the 
public sector and in the private sector.  
A study of this type will compliment other studies which concentrated on the Public 
Health Sector and raise the profile of the private optometric practitioner as a primary 
healthcare provider. The optometrist would use their valuable knowledge and 
significant skills to play an important supportive role in the co-management of the 
diabetic patient. Information obtained from this and similar studies can be 
incorporated in training modules aimed specifically at the diabetic optometric 
patient, enabling practitioners to make even more informed decisions regarding 
referral, monitoring and counseling. 
1.6 DESIGN OF THE STUDY AND METHODS OF INVESTIGATION 
 
1.6.1 Research design 
A population-based cross-sectional study, using purposive accidental random 
sampling, was used for this research. The study consisted of questionnaires 
completed by diabetic patients who fund their condition privately, that is outside of 
the South African Public Health sector. The patients were from mixed socio-
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economic backgrounds. The quantitative aspect of the study involved the analysis 
and synthesis of the data collected and a thorough literature review together with 
the statistical analysis of the overall responses obtained from the questionnaire.  The 
qualitative aspect utilised certain questions within the questionnaire which allowed 
for an assessment of the patients‟ own perceptions of his or her diabetes and 
general health status. Bowling (2002:187) describes the purposive sampling design 
as one which aims to sample a group of people with a particular characteristic and in 
this case all have diabetes. The questionnaire was developed after reviewing 
previous studies (Clarke-Farr et al. 2006: 134 and Mashige et al. 2008: 95), and the 
questions derived focussed on issues relating to the private sector patient.  
1.6.2 Methods of investigation 
 A comprehensive literature study regarding the nature of the various types of 
diabetes and the various issues revolving around diabetes and its ocular 
complications was undertaken. These issues included the metabolic syndrome, 
obesity, the genetic basis of diabetes, stress-induced diabetes, depression and 
anxiety as a cause and as a result of diabetes as well as studies regarding the 
ethnic prevalence of the condition. General and ocular complications and the 
knowledge and lack of knowledge of diabetes were also researched. In addition, 
access to services was included in the questionnaire.  
 
 A pilot study was conducted with the questionnaire prior to the commencement 




 The questionnaire provided quantitative data derived from the question coding in 
the Likert Scale, while qualitative analysis was achieved through the analysis of 
the open-ended answers.   
 
 A detailed questionnaire was used to determine patients‟ knowledge of their own 
diabetic status, treatment and other issues pertaining to their knowledge of the 
potential complications of diabetes. The questionnaire also contained biographical 
data for statistical analysis. 
 
The questionnaire was developed using Microsoft Excel in order to assess the 
knowledge of the private patient regarding his or her diabetes. The first group of 
questions contained biographical details, including the patients‟ height and weight in 
order to establish their Body Mass Index (BMI), thereafter the questions elicited 
information regarding the patients‟ knowledge of diabetes, the ocular complications 
of diabetes, their management and treatment regimens and possible barriers for 
access to treatment. The questionnaire contained sections in a Likert scale format. 
There were various options for the patient to choose from for example “agree”, 
“disagree” and “unsure” or “very important”, “important” or “slightly important” as 
well as “never”, “usually” or “always”. 
1.6.3 Sample Selection 
1.6.3.1 Target population 
The target population for the study was diabetic patients who are members of 
medical schemes, or who privately fund their treatment and do not make use of 
public health facilities, within the selected private practices in the region of the 
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Western Cape Province of South Africa. Convenience sampling will be employed for 
patient selection. 
1.6.3.2 Sample size 
To obtain a 95% confidence level at a confidence interval of 3, the minimum sample 
needed for all nine provinces of South Africa needed to be 1077 (Creative Research 
Systems, 2009). Calculations based on Creative Research Systems (2009), for the 
same level in the Western Cape determined the minimum sample to be 0.101 X 
1077 = 108. The sample size consisted of 122 [n sample = 122] accidental purposively 
selected patients examined in the private optometric practices.  
1.6.3.3 Description of the sample 
The geographical area of the study is located in the Western Cape region of South 
Africa. Private diabetic patients attending selected private optometric practices in the 
region were asked to complete an anonymous questionnaire containing information 
relevant to the study. The private optometric practices were selected in order to 
represent one urban and one rural population sample. One practice was in the near 
West Coast (Milnerton) and one in Malmesbury.  
1.6.4 Data analysis 
Once the questionnaires were completed the data was captured using Microsoft 
Excel 2007. The data from the captured questionnaires was then statistically 
analyzed according to frequency, mean, median, mode, range and standard 
deviation where appropriate. The results were summarized quantitatively and 
qualitative inferences were also described. 
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1.6.5 Reliability, validity and trustworthiness 
When establishing reliability in research, an instrument is considered reliable if it 
consistently gives the same results. Polgar et al. (2000: 137) define reliability as “the 
reproducibility of results”. Bowling (2002: 147) refers to the reproducibility and 
consistency of the instrument, where it is free from random error and is 
homogenous. Therefore, in order to facilitate the reliability of the data gathering 
instrument, patients completed the same questions in the questionnaire at different 
times.  
 
“Validity is an assessment of whether an instrument measures what it aims to 
measure” (Bowling 2002: 147). To evaluate the validity of the instrument, a pilot 
study was undertaken by the researcher to reinforce the internal validity. The size of 
the research population was aimed to give the study external validity, whereby the 
findings could be generalised to the wider population of interest, also known as 
population validity (Polgar and Thomas 2000: 41). In addition, the size of the sample 
also aimed to lend ecological validity, whereby the situation in which an investigation 
is carried out is generalisable to other situations.  
 
Triangulation was achieved in this study by using data from the questionnaire, a 
literature review and from similar studies in the public health sector. This 
triangulation lends trustworthiness, or credibility, to the research and, according to 
Cohen and Crabtree (2008: 331), qualitative research should “use such techniques 
as triangulation ... to promote attainment of truth or validity through the process of 
verifying findings.” Green (2005: 66), citing Smaling (1992: 319), says that the aim 
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of triangulation is to perform the research study in at least two different ways either 
by using two or more kinds of data sources or, more appropriately in this study, 
using two or more research methods or approaches including working with other 
researchers. 
 
1.6.6 Ethical considerations 
All human research studies require ethical approval and prior ethical approval for this 
study was obtained from the UKZN Biomedical Research and Ethics Committee. 
Furthermore, the study was undertaken in full conformity with the Ethical Rules of 
the Health Professionals Council of South Africa governing, in particular, the rights of 
patients and patient confidentiality. It follows that data obtained from the 
questionnaires would be kept confidential and all participants voluntarily completed 
the questionnaires with prior informed consent. Patients were also assured of 
anonymity at all times with a further understanding that any participant was free to 
withdraw from the study at any time without penalisation. 
1.6.6.1 Inclusion and exclusion criteria 
Inclusion criteria:  All diagnosed diabetic patients on a medical scheme, dependent 
or privately-funded.  
Exclusion criteria: Non-diabetic patients or diabetic patients being treated in the 





1.7 DEFINING THE TERMINOLOGY 
 Diabetes mellitus 
The Oxford Handbook of Clinical Medicine (1997: 528) defines diabetes mellitus as a 
syndrome caused by the lack of or diminished effectiveness of insulin, which is 
characterised by hyperglycaemia and “deranged metabolism”.  
 Ocular complications 
Ocular complications refer to pathological conditions of the eye which are directly 
attributable to the condition of diabetes. These include refractive changes, cataracts, 
neovascular complications, retinal changes, secondary glaucoma, ocular 
hypertension, nerve palsies and other neuro-ocular disorders and diabetic 
retinopathy. 
 Diabetic retinopathy 
Diabetic retinopathy results from changes in the blood vessels of the retina due to 
diabetes and is a major potential complication of the disease (Sopharak et al. 2008: 
720-727). The symptoms can seriously affect the patient‟s vision and are a major 
cause of blindness. Macular oedema, exudates and haemmorhages are the primary 
signs of diabetic retinopathy (Antonetti et al. 2006: 2407).  
 Metabolic syndrome 
Grundy et al. (2004: 433-438) have defined the metabolic syndrome as having six 
components. These are abdominal obesity, atherogenic dyslipidaemia, hypertension 
or elevated blood pressure, insulin resistance or glucose intolerance, 
proinflammatory state (recognized clinically by elevations of C-reactive protein) and 





For the purposes of this study, patients are defined as individuals attending an 
optometric practice for the purposes of having their eyes examined and being 
refracted with the view of providing spectacles or contact lenses. Diabetic patients 
are those individuals attending the private optometric practices who have been 
diagnosed with diabetes mellitus. 
 Primary health care 
The WHO refers to primary health care as providing a place to which people can 
bring a wide range of health problems. It is further described as “a hub from which 
patients are guided through the health system” (WHO 2008 :xvii) and, as such, 
primary care can be seen as a starting point for those with health problems from 




In this chapter a broad overview of the study has been given with emphasis on the 
global problem of diabetes and its attendant factors such as obesity and the 
metabolic syndrome. Further attention has been given to the cost implications of 
treatment, both to the individual and the State. The significance of the study was 
described as well as the research methodology, including the sample description, 
sample size and sampling techniques and the statistical methods employed in order 
to derive the results. Finally, a list of important terms used in the study is provided. 
In Chapter Two a comprehensive literature study is presented whereby diabetes and 
the aspects incorporated in the questionnaire are described in order to give them 
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relevance and context. Studies are reviewed concerning the prevalence, risk factors, 
general complications and ocular complications of diabetes as well as the benefits of 





















2.1 DIABETES MELLITUS 
 
This chapter will examine the literature pertinent to this study. It will include, inter 
alia, the mechanism of diabetes mellitus (DM) and its actions, its aetiology, 
prevalence, risk factors and the general complications consequent to the condition. 
Furthermore, literature concerning the ocular effects and complications of DM as 
well as the knowledge and lack of knowledge of the condition and how these two 
concepts impact on the treatment of DM is reviewed.  
Rippey (1994:303) describes diabetes mellitus as a chronic disorder of metabolism 
where insulin is either absent or fails to act as it should. Fowler (2008:77) explains 
diabetes as a group of chronic diseases characterised by one main criteria, 
hyperglycaemia. Evidence of changes in glucose concentrations, insulin resistance 
(or insensitivity) and insulin secretion has been shown as much as three to six years 
before diagnosis of diabetes. This is a concept sometimes referred to as pre-diabetes 
and is reported by Tabak et al. (2009: 2215 – 2221). Pre-diabetes consists of 
Impaired Fasting Glucose (IFG) and/or impaired glucose tolerance and is a major 
risk factor for the development of true diabetes with micro- and macrovascular 
complications (Aroda and Ratner, 2008: 3259). Interestingly, this so-called pre-
diabetes is reversible according to Perreault et al. (2009: 1346) and normal glucose 
regulation can often be attained through weight loss and lifestyle modification. In 
terms of primary health care, this reversibility should be a major target for treatment 
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and counselling. In the overall battle against this disease, education about the risks 
and potential complications of DM and the promotion of lifestyle modification will 
reap great benefits for at-risk individuals in the future. Joshi and Joshi (2008: 22) 
emphasise that development of Type 2 diabetes from pre-diabetes can be prevented 
by diet changes, moderate weight loss and exercise. In a 10-year study by 
Mozaffarian et al. (2009: 798) lifestyle risk factors were examined in accordance 
with their risk factors for diabetes. Low-risk groups were defined as those who 
included: moderate physical activity (walking), dietary score (higher fibre, lower 
saturated and trans fats), never smoked or former smoker more than 20 years ago, 
Body Mass Index (BMI) < 25 and female waste circumference of 88cm and 92 cm 
for men. These researchers found that the rate of incident diabetes was 35% lower 
for those who had a positive lifestyle combination than those who did not. In Sri 
Lanka, Katulanda et al. (2008: 1062) noted that those with diabetes and pre-
diabetes were older, physically inactive, frequently lived in urban areas and had a 
family history of diabetes. Furthermore, they had a higher BMI, greater waist 
circumference and waist-hip ratio, higher blood pressure, higher LDL cholesterol and 
higher triglycerides. 
De Fronzo (2009: 773) maintains that the core pathophysiological defects in diabetes 
are insulin resistance in liver and muscle, and beta cell failure. Furthermore, beta cell 
failure occurs much earlier than previously understood and those who are in the 
upper levels of glucose intolerance have lost up to 80% of their beta cell function. 
Moreover, the fat cell, with accelerated lipolysis, the gastro-intestinal tract with 
incretin, a hormone which increases insulin secretion, deficiency or resistance and 
the brain with insulin resistance are all important facets in the development of 
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glucose intolerance in Type 2 diabetes (De Fronzo, 2009: 773). In clinical diabetes, 
however, there is evidence of impaired carbohydrate metabolism and the primary 
diagnostic feature is raised blood glucose or hyperglycaemia. The importance of 
protecting the body against hyperglycaemia cannot be overstated, stresses Fowler 
(2008: 77), adding that the effects of hyperglycaemia are macrovascular and 
microvascular. Macrovascular effects include coronary artery disease, peripheral 
artery disease and stroke while microvascular complications include nephropathy, 
neuropathy and retinopathy. In terms of hyperglycaemia, the World Health 
Organisation (WHO) has classified the diagnostic fasting plasma (blood) glucose 
(FPG) value for the diagnosis of all diabetes to be 7.0mmol/l (Alberti and Zimmert, 
1998: 539). The HbA1c test, which measures the glycosylated haemoglobin in the 
blood, used in combination with the FPG is also cited by Sato et al. (2009:644) as a 
valuable predictor of Type 2 diabetes. Inoue et al. (2008: 1157) studied the 
combination of the FPG and HbA1c tests as a predictor of diabetes and, using the 
definition of diabetes as >7.0 mmol/l, found the cumulative incidence was 24.8% 
compared with those with normal fasting glucose and conclude that the combination 
of these tests identifies those individuals who are at risk of progression to Type 2 
diabetes. Elley et al. (2008: 1295) found, however, that the HbA1c test as a stand-
alone was an equally valuable predictor of risk for cardiovascular disease (CVD) and 
for each 1% increase of HbA1c there was a 1.08 increase in risk for a CVD event – 
the so-called hazard ratio. 
The action or presence of insulin is critical for the normal functioning of the human 
body. In contrast, the inaction or absence of insulin gives rise to glucose not being 
metabolised as it should. The most important action of insulin is to facilitate the 
39 
 
transfer of glucose into cells while also maintaining the plasma glucose level 
between 3 and 5mmol/l (Rippey, 1994: 303). It is this lack of glucose control in 
diabetes which needs to be tackled aggressively according to Gale (2008: 9) with the 
central objective of therapy being to reduce vascular risk “by any means available.” 
Clinically, what physicians are attempting with treatment is to improve the quality of 
life and in this context Collins et al. (2009: 603) feel that the diabetic patients‟ 
quality of life is definitely enhanced when care is provided at a primary care setting, 
provided the primary care provider renders good quality care. This research is an 
attempt to deal with this principle. It aims further to provide primary care 
practitioners, including optometrists, with insights regarding the lack of information 
regarding diabetes by those who have the disease. By knowing of a deficiency in the 
system, practitioners can act accordingly and provide better information to their 
patients in order to supplement and enhance current treatment regimens. 
2.2 PREVALENCE OF DIABETES 
 
Wild et al. (2004: 1047), report on the global “diabetes epidemic”. They maintain 
that the increase in obesity worldwide will result in any projections being an 
underestimate. The figures quoted in this study indicate the prevalence of diabetes 
worldwide to be 2.8% of the global population in 2000, rising to 4.4% in 2030; this 
represents 171 million people in 2000, some 11% higher than previous estimates  
increasing to 366 million in 2030 (Wild et al. 2004: 1051) (cf. Figure 2.1). In sub-
Saharan Africa the estimate was 7.146 million people in 2000 rising to 18.645 million 
in 2030, representing a 161% increase. The global percentage increase to the year 
2030 is 114%. By far the greatest area of prevalence is in the age group 46 – 64 
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and it is in this group that the projected increase will escalate from 80 million in 
2000 to 141 million by 2030.  
 
 
Figure 2.1 Worldwide prevalence of diabetes (Hossain et al. 2007:213 – 215) 
Prevalence rates for those under 40 years will double by 2030 while those over 65 
will rise from approximately 55 million to 130 million (Wild et al. 2004: 1050). The 
global prevalence is slightly higher in men younger than 60 but higher in older 
women, possibly due to women living longer; there is an overall higher prevalence in 
men, although there are more women with diabetes (Wild et al. 2004: 1050). 
In developed countries the prevalence is also a matter for concern. Harris et al. 
(1998: 518) reported on the prevalence of diabetes in the United States between 
1988 and 1994 and concluded that the prevalence of diagnosed diabetes for that 
period was 5.1% of adults ≥20 years of age, while the estimate of undiagnosed 
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diabetes was 2.9%. Those with Impaired Fasting Glucose (IFG) were reported to be 
6.9% or 13.4 million people. Table 2.1 lists the countries with the highest numbers 
of diabetes from 2000 and projected to 2030. 
TABLE 2.1  List of countries with the highest numbers of estimated cases of  
  diabetes for 2000 and 2030 (Wild 2004:1049) 
Country and ranking People with diabetes 
2000 (millions) 
Country and ranking People with diabetes 
2030 (millions) 
1. India 31.7 1. India 79.4 
2. China 20.8 2. China 42.3 
3. U.S.  17.7 3. U.S. 30.3 
4. Indonesia 8.4 4. Indonesia 21.3 
5. Japan 6.5 5. Pakistan 13.9 
6. Pakistan      5.2      6. Brazil    11.3 
7. Russian Fed 4.6 7. Bangladesh 11.1 
8. Brazil 4.6 8. Japan 8.9 
9. Italy 4.3 9. Philippines 7.8 
10. Bangladesh 3.2 10. Egypt 6.7 
 
 
Cowie et al. (2008: 287) examined the prevalence of diagnosed diabetes, 
undiagnosed diabetes and pre-diabetes in the United States during 2005 – 2006 and 
found the prevalence of diabetes in people ≥20 years of age to be 12.9%. Forty per 
cent of individuals had diabetes or pre-diabetes and almost a third of the elderly had 
diabetes. Of the elderly, 75% had diabetes or pre-diabetes. In their study diabetes 
prevalence was approximately twice as high in non-Hispanic black citizens and 
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Mexican-Americans. According to their results the crude prevalence of diagnosed 
diabetes rose from 5.1% in 1988 – 1994 to 7.7% in 2005 – 2006 and they conclude 
by stating that over 40% of persons ≥20 years of age have hyperglycaemia, with a 
higher prevalence in minorities. In New York City, Thorpe et al. (2009: 57) reported 
that the prevalence of diabetes was 12.5%, with 3.8% of those being undiagnosed. 
In this study Asians had the highest prevalence of impaired glucose metabolism but 
were significantly less likely to be obese. In Germany, Heidemann et al. (2009: 655) 
reported a prevalence of 5.34% between 2002 – 2005, while in Australia Catanzariti 
et al. (2009: 596) state that the incidence of Type 1 diabetes among 0 – 14 year-
olds is very high compared to many other countries, citing the mean adjusted 
incidence rate for Type 1 diabetes in Australia between 2000 – 2006 as 21.6 per 100 
000 person years. A Swedish study by Ringborg et al. (2008: 1178) found that 
prevalence of diabetes increased from 2.2% to 3.5% between 1996 and 2003, citing 
relatively stable incidence and declining mortality as perhaps the reason for the 
slight increase. On the Asian sub-continent, Katulanda et al. (2008: 1062) report 
that one in 5 adults in Sri Lanka has either diabetes or pre-diabetes and that 33% of 
those with diabetes are undiagnosed. In Africa, Motala et al. (2008: 1783) 
conducted a study in rural areas of South Africa and found the prevalence of 
diabetes to be 3.9% but IFG was higher in men (4%) than women (0.8%). They 
concluded that there was a moderate prevalence of diabetes in the rural areas but a 
higher prevalence of total disorders of glycaemia which indicated to them that rural 
communities in South Africa may well be into an “epidemic” of glucose intolerance. 
In terms of South African diabetes prevalence, Rheeder (2006: 20) estimates that 
Type 2 diabetes prevalence in South Africa varies between 3% and 28.7%, with the 
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greatest prevalence in the South African Indian population (13%) and the elderly 
Cape Coloured community (28.7%) (cf. Figure 2.2). 
Figure 2.2:  Estimated prevalence of diabetes by age and gender, South Africa  
  2000.  (Bradshaw et al. 2007: 702) 
 
The South African prevalence of diabetes in terms of age and gender is illustrated in 
Figure 2.2. It can be seen that females in the age group 60 – 69 and 80 years and 
over are most affected. Figure 2.3 illustrates, however, how the urban male is 
highest affected and that males overall appear to be most susceptible to becoming 
diabetic. Table 2.4 indicates the prevalence of diabetes by population group, age 
and sex, illustrating that the urban black African between 60 and 80 years has 
10.8% prevalence, almost equal to that of the white population. This, however pales 
in comparison to the Coloured population group who, between the ages of 70 – 80 
have a prevalence of 26.9% and the Asian/Indian population group, a quarter of 
whom are diabetic by the age of 45, rising to a third between 60 – 80 years. 
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Bradshaw et al. (2007: 700) found that, of South Africans over the age of 30, 5.5% 
had diabetes, a figure that increased with age. These authors found that 14% of 
ischaemic heart disease, 10% of stroke, 12% of hypertensive disease and 12% of 
renal disease in adults were attributable to diabetes. They also estimate that 22 412 
deaths in South Africa in the year 2000 were caused by diabetes (cf. Table 2.2). 
These figures are further summarised in Table 2.5.  
Figure 2.3:  Prevalence of diabetes in rural and urban South Africa   








Table 2.2:  Prevalence percentage of diabetes by population group, age   
  and gender, South Africa 2000. (Bradshaw et al. 2007:703) 
Population Group 





Urban Black African 30-44 2.2 1.5 
  
45-59 9.2 13 
  
60-69 10.8 16.7 
  
70-79 10.8 16.7 
  
80+ 10.8 16.7 
  
30+ 5.4 7.3 
     Non-urban Black African 30-44 1.1 0.8 
  
45-59 4.6 6.5 
  
60-69 5.4 8.4 
  
70-79 5.4 8.4 
  
80+ 5.4 8.4 
  
30+ 2.7 3.7 
     Coloured 30-44 0.8 0.4 
  
45-59 8.4 8.7 
  
60-69 12.5 33.3 
  
70-79 26.9 19.4 
  
80+ 26.9 19.4 
  
30+ 5.1 7.3 
     White 30-44 0.5 0.8 
  
45-59 7.3 8.2 
  
60-69 10 13.9 
  
70-79 10.8 16.7 
  
80+ 10.8 16.7 
  
30+ 5.1 7.3 
     Asian/Indian 30-44 9.6 9.8 
  
45-59 25.2 18.4 
  
60-69 30 30 
  
70-79 30 30 
  
80+ 30 30 
  
30+ 18 16.4 
     South Africa 30-44 1.6 1.3 
  
45-59 7.7 9.7 
  
60-69 9.6 15.1 
  
70-79 10.7 14.7 
  
80+ 11.2 15 
  




Table 2.3:  Prevalence of diabetes in South Africa (SEMDSA) 
Population Region (number of 
participants) 
Prevalence (%) Age range 
(years) 
Reference 
African Cape Town, urban 
(729) 
8 30 + Diabet Care 
1993;16:601 
African QwaQwa, rural 
(853) 





African Durban, urban 
(479) 
5.3 15 + S Afr Med J 
1993;83:641 
Mixed Cape Town, urban 
(200) 




Mixed Cape Town, peri-
urban (974) 
10.8 15 - 86 Diabet Med 
1999;16:946 
European Durban, urban 
(396) 
3 15 - 69 S Afr Med J 
1994;84:257 
Indian Durban, urban 
(2479) 
13 15 + Diabet Care 
1994;17:70 
 
Table 2.4:  Diabetes prevalence (percentage) in South Africa by Province 2003. 
  (RSA DoH Demographic and Health Survey: 2003) 
Province Females Males 
Western Cape 6.6 3.7 
Eastern Cape 3.8 2.7 
Northern Cape 3 3 
Free State 4 1.8 
KZN 4 2.5 
North West 1.8 1.5 
Gauteng 3.5 2.6 
Mpumalanga 2.1 2.5 
Limpopo 3.5 2.4 
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Table 2.4 indicates the provincial prevalence of diabetes in South Africa, with the 
Western Cape having the highest prevalence of diabetes amongst both females and 
males.  
2.3 TYPES OF DIABETES 
 
Diabetes can be classified into three main types (Sukha and Rubin, 2007: 120): Type 
1, or insulin dependent diabetes (IDDM); Type 2, or non-insulin dependent diabetes 
(NIDDM) and gestational diabetes, occurring only in pregnancy. Type 1 is divided 
into idiopathic and autoimmune diabetes mellitus (DM) both resulting in insulin 
dependence and loss of pancreatic beta cells, while Type 2 diabetes is largely a 
lifestyle disease, resulting from poor diet, sedentary living and lack of exercise, 
causing insulin resistance to glucose metabolism. Gestational diabetes is a state of 
carbohydrate intolerance often caused by hormonal changes during pregnancy 
affecting 2.5% of all pregnant women (Xiong 2003: 223). 
In Type 1, which largely affects younger individuals, low insulin levels result from 
the destruction of Beta cells in the pancreas due to infiltration of the Islets of 
Langerhans by lymphocytes with fibrosis and atrophy following later (Rippey 1994: 
305). It is further suggested that there is perhaps a genetic basis for the contracting 
of Type 1 diabetes. The angiotensin I converting enzyme gene was suspected of 
causing diabetic kidney disease (Dorin et al.1994: 690) although this appears to be 
disputed in a 1998 study by Kimura et al. (1998: 1659). Concannon et al. 
(2009:1018) found that five non-HLA chromosome regions showed some evidence of 
linkage to Type 1 diabetes; whilst Wang et al. (2009: 461) suspect that the liver 
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pyruvate kinase gene is the most likely gene responsible in Type 2 diabetes. Rippey 
(1994: 305) suggests that the gene responsible may be triggered by exposure to a 
virus and proposes further that the responsible viruses include the Coxsackie B and 
Rubella. Whatever the causative gene, however, it is not disputed that there is a 
definite genetic base in many instances of diabetes mellitus. Abhary et al. (2009: 
2137) are also of the opinion that variations within the AKR1B1 gene are associated 
with diabetic retinopathy. 
In Type 1 diabetes there is often severe hyperglycaemia due to glucose not entering 
the cells. This glucose level then exceeds the kidney threshold and spills over into 
the urine, a condition known as glycosuria. The glycosuria results in an osmotic 
diuresis causing polyuria (excessive urine production), dehydration and then 
excessive thirst (polydipsia) (Rippey, 1994: 305). Therefore the presenting 
symptoms for Type 1 diabetes are often initially excessive thirst and excessive 
urination. 
Weight loss in Type 1 diabetes is a common occurrence. Rippey (1994: 305) 
describes this phenomenon as happening due to glucose not being able to be 
utilised in energy production with the result that fat is broken down and free fatty 
acids are released. These combine with acetylcoenzyme A in the liver but, without 
insulin, acetylcoenzyme A cannot enter the mitochondria and partake in the Krebs 
cycle to form ATP and is converted into ketone bodies, a large portion of which is 
acetone. These ketone bodies also cannot be used in muscle tissues and accumulate 
causing ketosis and metabolic acidosis (ketoacidosis). Neu et al. (2009: 1647) argue 
that ketoacidosis occurring at diabetes onset is still a major problem. The classic 
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smell of acetone on the breath of diabetic patients entering into ketoacidosis is 
indicative of a Type 1 diabetic in severe distress, often resulting in diabetic coma and 
possible death. Goldberg (2009: 3171) mentions certain biomarkers which are 
evidence of islet damage resulting from cytokines in autoimmune activation in Type 
1 diabetes. 
Type 2 diabetes is by far the most commonly found type of diabetes accounting for 
80 – 90% of all cases (Rippey, 1994: 305), who suggests further that obesity is 
associated with the development of insulin resistance. Rheeder (2006: 20) notes that 
the increase in diabetes worldwide is directly linked to the increase in obesity and 
that Type 2 diabetes is often associated with obesity and in older persons with a 
familial history of the disease. Zeitler (2009: 2215), however, has noted that over 
the last two decades non-autoimmune mediated Type 2 diabetes has increased 
markedly amongst adolescents and he suggests a unique pathophysiology in this 
group. Nadeau et al. (2009: 3687) insists that the incidence of paediatric Type 2 
diabetes is increasing and found that adolescents with Type 2 diabetes had 
significantly lower VO2 peak (ability to effectively utilise oxygen intake, or a 
reduction in oxygen uptake, for ATP production) and decreased insulin sensitivity, 
amongst other factors, than their leaner counterparts. All these factors indicate 
decreased cardiopulmonary fitness and are signs of potentially life-threatening 
challenges. 
Omar and Motala (1994: 46) report that there appears to be a definite high familial 
aggregation of Type 2 diabetes in the South African Indian population making it 
apparent that genetic factors play an important role it its pathogenesis. This is 
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supported by the fact that as many as seventeen genetic loci have been convincingly 
associated with Type 2 diabetes (Florez 2008: 4633). Chung et al. (2009: 552) 
determined the effect of the common adiponectin gene polymorphisms on changes 
in adiponectin levels due to diet and certain insulin resistance indices. These authors 
concluded that the genetic variants identified have an effect on insulin resistance 
and adiponectin levels in those individuals recently diagnosed with impaired fasting 
glucose or Type 2 diabetes. Further in the genetic field, Swedish researchers 
Jonsson et al. (2009: 2409) have found that a common variant in the KCNQ1 gene is 
associated with increased risk of future Type 2 diabetes in Scandinavians. However 
Brito et al. (2009: 1411), in their study of 16003 Swedish adults, have suggested 
that a genetic predisposition to hyperglycaemia is somewhat dependent on personal 
lifestyle factors. This perhaps indicates a role for both mechanisms in the 
development of Type 2 diabetes. 
In contrast to Type 1 diabetes, Type 2 diabetic beta cells are largely intact and 
preserved in the pancreatic Islets of Langerhans and insulin is present albeit in a 
lower quantity than is normally the case. However, the tissues develop a resistance 
to the action of insulin and there are indeed fewer insulin receptors (Rippey, 1994: 
305). This combination has the effect of negating the glucose–insulin relationship 
and, as a consequence, the same effects of Type 1 diabetes occur with polydipsia 
and polyuria manifesting as signs and symptoms of the condition.  
A third type of diabetes, known as gestational diabetes, occurs during pregnancy 
and along with obesity is a common metabolic abnormality during this time 
(Catalano et al. 2003: 1674). This form of diabetes is a major risk factor to progress 
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to Type 2 diabetes after the pregnancy (Buchanan and Xiang 2005: 485). According 
to these researchers the pathophysiological mechanisms involved are increased 
insulin resistance and an inadequate insulin response, which affects insulin regulated 
carbohydrate, lipid and protein metabolism. Reece et al. (2009: 1789) state that 
gestational diabetes is a substantial and growing health concern with certain 
populations due to environmental, genetic and social factors. Gestational diabetes 
carries a very high risk of progression to development of postpartum Type 2 
diabetes and both intensive lifestyle interventions and hypoglycaemic treatment are 
effective in delaying or preventing the development of diabetes (Ratner et al. 2008: 
4774). Gestational diabetes has serious long-term consequences for both baby and 
mother and Reece et al. (2009: 1789) remark on a predisposition of children to 
obesity, the metabolic syndrome and diabetes. In order to counteract this, Bellamy 
et al. (2009: 1773) recommend increased awareness of the risk factors involved and 
that clinicians make use of dietary, lifestyle and pharmaceutical methods to try and 
delay the onset of Type 2 diabetes. Oganowski et al. (2009:3 34) have noted that 
obesity and a higher BMI are strong predictors for gestational diabetes requiring 
insulin treatment. 
Joshi and Joshi (2008: 29) report on other types of diabetes and mention pancreatic 
disease as a cause of hyperglycaemia together with hormonal disease, drug or 





2.4 RISK FACTORS FOR DIABETES 
 
Risk factors can broadly be seen as modifiable and non-modifiable. Currently, 
genetic-based diabetes is considered to be caused by non-modifiable factors, while 
obesity and a sedentary lifestyle are considered modifiable factors which may lead to 
diabetes. In the case of modifiable factors, lifestyle changes can lead to the 
prevention of diabetes development. Gudbjörnsdottir et al. (2009: 53) examined 
various risk factors in Type 2 diabetic and coronary heart disease (CHD) patients. 
They found a high prevalence of adverse lifestyle characteristics including being 
overweight, obese, smoking and having a large waist circumference. Pierce et al. 
(2009: 679) researched undiagnosed diabetes data in the United Kingdom and found 
that a quarter of diabetes cases in the United Kingdom were undiagnosed. They 
found that male sex, high BMI, increased waist circumference, higher systolic blood 
pressure and high triglycerides were significant risk factors for undiagnosed 
diabetes. It is evident that risk factors for Type 2 DM are centred on certain largely 
modifiable elements which are described below. 
2.4.1 Body Mass Index (BMI) 
The concept of BMI as a measure of fatness or obesity has been in use for many 
years and has superseded the using of weight alone as an indication of obesity (Cole 
et al. 1990: 25). In the United Kingdom the National Health Service (NHS) uses BMI 
as a measure of adiposity because it is “an easy, cheap and non-invasive means of 
assessing excess body fat” (National Obesity Observatory, 2009: 5). It has been 
mentioned previously that a significant risk factor for Type 2 diabetes is waist 
circumference; BMI is a valuable description of body shape and mass as the 
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following examples illustrate. Rolland-Cachera et al. (1991: 13) describes the 
measurement of BMI as weight (kg)/height (metres)2. Thus a 1.8 metres tall person 
weighing 70kg would have a BMI of 70/1.82 = 21.60 and would be described as 
relatively slim. If an individual of 1.55 metres weighed 70kg he or she would have a 
BMI of 29.14, an indication that he or she is shorter and less slim and this would be 
classified as an „at risk‟ BMI. Therefore it can be seen that the higher the BMI the 
higher the indication of obesity. 
2.4.2 Obesity 
Joshi and Joshi (2008: 29) note that, although Type 2 diabetes is typically seen in 
people aged 40 and older, there appear to be recent trends for the condition to 
manifest earlier. This, say the authors, is particularly due to increasing obesity and 
lack of regular exercise. The disease burden associated with obesity is substantial, 
according to Paeratakul et al. (2002: 1205). These authors suggest that the risk of 
having diabetes, hypertension, heart disease and high cholesterol increase with 
increased body weight. Gardner and Gabbay (2009: 328) argue that obesity is a 
challenge for every ophthalmologist while Pierce et al. (2009: 679) identified BMI 
and waist circumference, amongst others, as major risk factors for Type 2 diabetes. 
Rheeder (2006: 20) is of a similar opinion and a study by Kramer et al. (2009: 851) 
further concluded that increased abdominal obesity and increased BMI are 
associated with albuminuria, the presence of albumin in the urine, in overweight and 
obese adults with Type 2 diabetes. Measures of central and overall adiposity were 
used by Mackay et al. (2009: 956) to predict Type 2 diabetes in all patients with the 
exception of African Americans where central measures were more effective. All of 
these facts lead to the unavoidable conclusion that obesity is a serious indicator of 
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potential, even manifest, poor health leading inexorably to poor quality of life, if not 
to diabetes. This is not limited to adults and Kaufman et al. (2009: 953) have 
identified that children in the sixth grade are exhibiting increased BMI and potential 
risk factors for the development of Type 2 diabetes. This was especially evident in 
minority populations, where Hispanic youths had a greater degree of increased BMI 
and blood glucose levels than blacks and whites. This has further implications for 
Type 1 diabetes where Viner et al. (2008: 1056) found that a higher childhood BMI 
was an independent risk factor for the development of Type 1 diabetes and supports 
suggestions that obesity is the link between Type 1 and Type 2 diabetes. Those at 
risk for type 2 diabetes show systematic activation of proinflammatory and 
procoagulant pathways due to obesity and insulin resistance (Goldberg 2009: 3171). 
To further compound decrease in quality of life with obesity, obese diabetic patients 
measured by BMI and waist circumference were found by Foster et al. (2009: 1017) 
to have high degrees of obstructive sleep apnoea and recommend that physicians be 
aware of the potential dangers inherent with this condition. Furthermore, among 
overweight and obese women with Type 2 diabetes urinary incontinence is highly 
prevalent and reportedly far exceeds all other complications related to diabetes 
(Phelan et al. 2009: 1391). 
It is therefore a well-established concept that obesity is a strong risk factor for Type 
2 diabetes and Liese et al. (2009: 1434) have researched the so-called DASH diet 
(Dietary Approaches to Stop Hypertension) and conclude that adherence to this 
eating pattern involving fruit, vegetables and low fat dairy products may potentially 
prevent Type 2 diabetes. Nettleton et al. (2009: 688), however, have suggested that 
55 
 
the daily intake of diet soda drinks, while not an indication of causality, is associated 
with significantly greater risks of metabolic syndrome and Type 2 diabetes. Japanese 
researchers Kodama et al. (2009: 959) have concluded that replacing fat with 
carbohydrates appears to make insulin resistance worse and that if patients want to 
participate in a Low Fat High Carbohydrate (LFHC) diet they should balance their 
energy intake to levels sufficient for optimum weight reduction. Too high an intake 
of carbohydrates is clearly as bad as too much fat, especially if the carbohydrates 
are not being utilised for energy production. Kuizer et al. (2009: 791) have shown 
that following a diabetes prevention program aimed at lifestyle modification, patients 
exhibited significant modification of lifestyle factors that are normally associated with 
elevated diabetes risk. Vegans, according to Tonstad et al. (2009: 791), appear to 
have the lowest mean BMI (23.6 kg/m2) and conclude that the five-unit difference 
between vegetarians and non-vegetarians indicates a strong potential for 
vegetarianism to protect against obesity and consequent Type 2 diabetes. Danish 
researchers de Fine et al. (2008: 933) studied how the 10 years of weight change 
preceding diabetes diagnosis varied with weight at age 20 and found that women 
gained more weight than men and the lower the weight at age twenty the greater 
the weight gain. Interestingly, the average weight gain in the 10 years preceding 
diabetes diagnosis was only 1 kg and decreased markedly with age. They contend, 
however, that it is important to advise young patients in particular and especially 
females who have gained considerable weight to be attentive to this in order to 
prevent the development of diabetes.  
It is thus apparent that the first steps toward reversal of risk factors associated with 
obesity are to be found in a healthy diet. The benefits of exercise in terms of a 
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weight loss programme are clear but importantly are also apposite in terms of 
reduction of arterial stiffness which has a direct impact on cardiovascular mortality 
(Madden et al. 2009:1531). Furthermore, exercise capacity, or the ability to perform 
exercise, has been shown by Kokkinos et al. (2009: 623) to be a strong predictor of 
all-purpose mortality in, especially, men with Type 2 diabetes. Physical activity has 
been shown by Thomas et al. (2008: 9) to be positively related to both glucose 
tolerance and resting energy expenditure. This implies that moderate exercise could 
be a force for prevention of diabetes in adolescents by promoting glucose disposal 
efficiently and by increasing “energy expenditure”. This would ensure that 
carbohydrates which would normally remain unused for energy and be stored as fat 
are indeed used as energy. The importance of moderate exercise such as brisk 
walking to improve insulin sensitivity and other metabolic risk factors is highlighted 
by Ekelund et al. (2009: 1081), who found that low levels of physical activity were 
associated with insulin resistance. Ferland et al. (2009: 589) discovered that blood 
glucose is lower in Type 2 diabetic patients when exercise is done after a meal. The 
importance and beneficial effect of low-Glycaemic Index (GI) food on exercise-
induced hypoglycaemia is emphasised in this study. 
2.4.3 The Metabolic Syndrome 
The term metabolic syndrome refers to a group of, specifically cardiovascular, risk 
factors whose pathophysiology is related to insulin resistance (Kahn et al. 2005: 
2289).  The prevalence of the metabolic syndrome is significantly higher in Type 2 
diabetes than in Type 1 according to Hawa et al. (2008: 160). Reaven (2006: 1237) 




The patient must have one of the following: 
 Diabetes mellitus: FPG ≥7 mmol/l or 2 hour postprandial ≥11.1 mmol/l 
 Impaired Glucose Tolerance (IGT): FPG <7 mmol/l or 2 hour postprandial ≥7.8 
mmol/l but <11.1 mmol/l 
 Impaired Fasting Glucose (IFG): ≥6.1 mmol/l but <7 mmol/l and postprandial 
<7.8 mmol/l 
Plus any two of: 
 Waist to hip ratio >0.9 in men and >0.85 in women or BMI >30 or both 
 Triglycerides ≥1.7 mmol/l; HDL cholesterol <0.9 mmol/l in men or < 1.0 mmol/l 
in women or both 
 Blood pressure ≥140/90 mmHg 
 Microalbuminuria: excretion rate ≥20µg/min 
From the above it can be seen that the metabolic syndrome and its‟ components 
appear to be very close to that of clinical diabetes with upper limits of FPG close to 
that of diabetes, the presence of obesity, increased BMI and risk factors of 
hypertension, cholesterol and triglycerides. Thorn et al. (2009:950) concluded that 
the metabolic syndrome is a 2.1 times risk factor for cardiovascular mortality. This 
becomes even greater in Type 1 diabetes-related mortality when nephropathy 
becomes a particular challenge, where a risk factor of 2.5 was reported. This is a 
conclusion in agreement with Bianchi et al. (2008: 1412) who maintain there is a 
close and independent association between the metabolic syndrome and kidney 
disease and nephropathy prevalence increases with the number of metabolic 
syndrome components present in patients. Luk et al. (2008: 2357), in a Hong Kong 
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study, have shown that the presence of the metabolic syndrome is an independent 
predictor of chronic kidney disease in patients with Type 2 diabetes. 
2.4.4 Ethnicity 
Numerous studies have associated diabetes with ethnicity, a non-modifiable risk 
factor in diabetes. In Hawaii, Maskarinec et al. (2009: 2563) studied diabetes 
incidence between Caucasians, Japanese Americans and native Hawaiians and found 
native Hawaiians (14.4 per 1000 person years) to have the highest incidence, 
followed by Japanese Americans (12.4) and Caucasians (6.5). They found that BMI 
was positively associated with incidence and that education was inversely associated 
with BMI. This high interaction between ethnicity, education and BMI suggests to 
these authors that significant ethnic differences in diabetes aetiology exist. Herman 
et al. (2009: 1689) found glycolated haemoglobin, using the HbA1c test, to be 
higher in Hispanics, Asians and Africans than in Caucasians although they mention 
that, because of inherent biological variations, this higher HbA1c level may not 
always hold true. Lisabeth et al. (2008: 778) concluded that Mexican-American 
women had an increased risk of stroke at younger ages compared to non-Hispanic 
white women suggesting that the increased prevalence of hypertension and diabetes 
could be the reason. In New Zealand, Kenealy et al. (2008: 1302) found that in the 
Maori population diabetics were 30% more likely to have cardiovascular events 
compared to other groups. Motala et al. (2003: 23) established that South African 
Indians had a particularly high incidence of Type 2 diabetes, a fact borne out by a 
study done by Oza-Frank et al. (2009: 1644) who concluded that Asian Indian 
ethnicity was strongly associated with diabetes. This is confirmed in a previous study 
by Davis (2008:52) who studied the ethnic diversity in Type 2 diabetes in the United 
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Kingdom. He found that Indian Asian patients were younger at onset of diabetes 
than Afro-Caribbean and Caucasian patients even though they had the lowest 
prevalence of hypertension and current smoking. Afro-Caribbean patients had the 
poorest glycaemic control yet they had the best lipid profile and had a 70% lower 
risk of fatal myocardial infarction than Caucasians and Indian Asian patients had the 
highest risk for nephropathy. Davis (2008: 52) concludes by stating that there are 
sustained ethnic differences in the nature of diabetes. A previous South African 
study by Omar and Motala (1996: 45) found the prevalence amongst South African 
Indians was as high as 13%. Wang et al. (2009: 461) estimated the prevalence of 
diabetes in rural China to be 21.1 million persons aged 30+ with 9.2 million people 
having diabetic retinopathy. It would appear that, from the evidence of the studies 
mentioned, ethnicity, in particular Asian ethnicity, is a major non-modifiable risk 
factor in contracting Type 2 diabetes.  
2.4.5 Age and gender 
Other non-modifiable risk factors for diabetes are age and gender. The use of the 
terms „Juvenile Onset‟ and „Adult Onset‟ when describing Type 1 and Type 2 diabetes 
respectively appear to be losing favour in the light of the increasing numbers of 
adolescents developing Type 2 diabetes coupled with childhood obesity. Hillier and 
Peduta (2003: 2999) argue that the earlier onset of Type 2 diabetes results in a 
more aggressive form of the disease especially from a cardiovascular perspective. 
These authors state further that although CVD rates are higher in adults with 
diabetes, young adults with early-onset Type 2 diabetes have a much higher risk of 
CVD compared to those non-diabetics of a similar age. This was true with 
microalbuminuria as well. In terms of treatment progression, earlier-onset Type 2 
60 
 
diabetes is associated with earlier onset of insulin therapy than those with usual or 
later onset diabetes. Although Type 1 diabetes continues to be largely a disease of 
juvenile onset, Felthower et al. (2003: 437) report that in Yorkshire the mean age of 
onset of Type 1 diabetes has dropped from 9.2 to 8.4 years for children aged 0–14 
and from 16.0 to 14.6 for individuals 0–29 over the period 1991–1999. This research 
agrees with a Finnish study by Karvonen et al. (1999: 1066) who found that the 
greatest incidence in Type 1 diabetes occurred in children under five years of age.  
Whilst Choi and Shi (2001:1221) claim that the prevalence of diabetes increases with 
age and body mass index and increases inversely with energy expenditure in both 
males and females, the age-adjusted global prevalence of diabetes was 12.7% for 
males and 8.4% for females (Ohmura et al. 1993: 1198). These authors found the 
impaired glucose tolerance (IGT) between genders to be almost equal (males 
19.6%, females 18.4%), yet Omar et al. (1993: 641), during the same period, found 
a marked difference between Zulu men and women with 5.5% of males having IGT 
compared to 11.5% of females. Conversely, the prevalence of diabetes in Zulu 
adults was 5.2% for females and 2.3% in males. In the United States of America, 
Narayan et al. (2003: 1884) found the risk of developing diabetes was 32.8% for 
males and 38.5% for females and, to add emphasis to the risk of mortality of 
diabetes, these authors have estimated that men will lose 11.6 life-years while 
women will lose 14.3 life-years. In terms of quality of life (QOL), however, the 
authors suggest that men will lose 18.6 QOL-years as opposed to 22.0 for women. 
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2.4.6 Genetics and family 
The association between parental history of Type 2 diabetes, the presence of the 
metabolic syndrome and diabetic complications in patients with Type 1 diabetes was 
studied by Thorn et al. (2008: 63). They found that Type 1 diabetic patients who 
had a positive parental history of Type 2 diabetes had a higher prevalence of the 
metabolic syndrome, higher BMI, larger waist circumference, higher triglycerides and 
higher HbA1c as well as larger insulin doses. Type 2 diabetes parental history was 
also associated with a later onset of Type 1 diabetes. A policy of communicating 
familial risk increased personal control over prevention of diabetes, according to Pijl 
et al. (2009: 597). This positive intervention did not result in fatalism but some 
evidence exists that it increased healthy behaviour. 
2.4.7 Depression 
Depression is a common phenomenon amongst patients with chronic illnesses 
(Ciechanowski, 2000: 3278). In assessing the relationships between depression 
scores and diabetes, glucose and insulin, Holt et al. (2009: 641), using the Hospital 
Anxiety and Depression Scale (HADS), found that men with undiagnosed diabetes 
had significantly higher HADS scores. This supported their hypothesis that 
depression was a significant risk factor for diabetes and that clinicians should screen 
all depressive individuals for diabetes. It has been shown by Knol et al. (2006: 837) 
that depressed adults have a 37% increased risk of developing Type 2 diabetes; it is 
not yet known, however, whether treatment of depression can prevent or reduce 
this incidence. Other research carried out by Mezuk et al. (2008: 2383) claim this 
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risk figure to be as high as 60%, while Aikens et al. (2008: 1324) have found the 
incidence of depression is higher amongst insulin users.  
2.4.8 Hypertension 
Because of the association between lifestyle disease and diabetes, hypertension is 
frequently found in conjunction with diabetes. There is some debate as to whether 
hypertension is a direct risk factor for diabetes or whether diabetes is a risk factor 
for hypertension. That the two conditions are often found together is not in dispute. 
Repeti et al. (1994: 511) studied the link between arterial hypertension and 
diabetes. They found a 50% increase in the incidence of arterial hypertension in 
diabetic subjects compared with non-diabetic individuals. Furthermore, retinopathy 
occurred twice as often in hypertensive diabetic females than non-hypertensive. Izzo 
et al. (2009: 567) suggest that Type 2 diabetes might be associated with pre-
existing hypertension and after their study of 1754 patients they conclude that 
uncontrolled hypertension is associated with a twofold increased risk of incident 
diabetes which was independent of BMI or age and FPG. Gress et al. (2000: 905) 
mention that prescribing beta-blockers for hypertensive therapy appears to increase 
the risk of diabetes but show that angiotensin converting enzyme inhibitors (ACE 
inhibitors) and thiazide diuretics pose no threat in this regard. 
2.4.9 Other 
Chronic insomnia rather than poor sleep has been associated with higher risk for 
diabetes (Vgontzas et al. 2009: 1980), who found the highest risk was for persons 




2.5 SYSTEMIC COMPLICATIONS OF DIABETES 
2.5.1 Kidney disease (nephropathy) 
Fowler (2008: 77) states that diabetic nephropathy is the leading cause of kidney 
failure in the United States. Nephropathy is defined as proteinuria of >500mg in 24 
hours in diabetic patients which is usually preceded by lower degrees of proteinuria 
called microalbuminuria, where microalbumin is excreted. In untreated diabetics 
microalbuminuria rapidly progresses to proteinuria followed by nephropathy (Fowler, 
2008: 77). Diabetic retinopathy is a major predictor of nephropathy and is stronger 
for Type 1 diabetics than Type 2 (El-Asrar et al. 2001: 1), especially where there is 
evidence of proliferative retinopathy. Goldberg (2009: 3171) notes recent 
developments indicating that an inflammatory cascade results in beta cell damage, 
insulin resistance and vascular complications in diabetes which are associated with 
nephropathy. As mentioned in 2.4.1 above, Type 1 diabetic patients with 
nephropathy and the metabolic syndrome have a 2.5 increased mortality risk factor 
than those without any of the metabolic syndrome factors (Thorn et al. 2009: 950). 
2.5.2 Diabetic neuropathy 
Amongst the general complications of diabetes is the often painful occurrence of 
diabetic neuropathy. The American Diabetes Association, in Fowler (2008: 77), 
defines diabetic neuropathy as “the presence of symptoms and/or signs of peripheral 
nerve dysfunction in people with diabetes after the exclusion of other causes.” Vinik 
et al. (2003: 365) state that diabetic autoimmune neuropathy is the most common 
and troublesome complication of diabetes mellitus. Symptoms may be diffuse or 
confined to a single source i.e. an organ or organ system. These researchers found 
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the pathogenesis of these autoimmune diabetic complications to include altered 
metabolism, vascular insufficiency and loss of growth factor trophism, causing 
atrophy, and autoimmune destruction of nerves. In a longitudinal study of diabetic 
neuropathy, Dyck et al. (1993: 817) found that 66% of Type 1 diabetics and 59% of 
Type 2 diabetics had some form of neuropathy. Approximately half of neuropathies 
reported were polyneuropathies and significant evidence of carpal tunnel syndrome 
and visceral autonomic neuropathy was also seen. Diabetic neuropathy, along with 
vasculopathy, is a major contributor to diabetic foot ulcer with impaired cutaneous 
oxygenation being the strongest risk factor (McNeely et al. 1995: 216). Argoff et al. 
(2006: 3) state that half of diabetic patients suffer from some form of diabetic 
neuropathy and diabetic peripheral neuropathy (DPN) is the leading cause of foot 
ulcers which are, in turn, a major cause of amputation in the United States.  
Other afflictions associated with DPN include chronic pain, insomnia and depression 
(Wiggin et al. 2009: 1634). The link between risk factors for diabetes, manifest 
diabetes and DPN appear to be elevated triglycerides correlated with myelinated 
fibre density loss. This appears to support the theory that hyperlipidaemia is 
instrumental in the progression of diabetic neuropathy in diabetes. Anti-depressant 
medication is often prescribed to combat the discomfort associated with this 
condition (Max et al. 1992: 1250). Treatment of diabetic neuropathy pain is further 
examined by Ziegler (2008: 255) who states that increased alcohol consumption, 
hypertension, smoking and cholesterol all play a role in the development and 
progression of this condition. Cardiovascular autonomic neuropathy (CAN) is a 
common form of autoimmune diabetic neuropathy causing anomalies of heart rate 
control and central and peripheral vasculopathies (Maser and Lenhard, 2005: 5896). 
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Its clinical manifestations include exercise intolerance, orthostatic hypotension and, 
sometimes, painless myocardial ischaemia leading to death. Barr et al. (2006: 1114) 
demonstrate that individuals with diabetic neuropathy are nearly four times more 
likely to have retinopathy and twice as likely to have albuminuria, concluding that 
neuropathy is associated with other microvascular complications associated with 
diabetes. 
2.5.3 Cardiovascular disease (CVD) 
The central pathological mechanism in microvascular disease is atherosclerosis, 
which, says Fowler (2008: 77), is thought to occur from chronic inflammation and 
injury to the arterial wall in the peripheral or coronary vascular system. Endothelial 
injury causes oxidised lipids from Low Density Lipoprotein (LDL) cholesterol to 
penetrate the arterial wall eventually causing an atherosclerotic lesion with a fibrous 
cap. Gatti et al. (2009: 1550) researched whether the association between poor 
glycaemic control and lower HDL (high density lipoprotein) cholesterol in Type 2 
diabetes was dependent on obesity or a high level of triglycerides. They concluded 
that poor glycaemic control was an independent risk factor for lower HDL 
cholesterol, the so-called “good” cholesterol. Japanese researchers Hayashi et al. 
(2009: 1221) have found that lower HDL cholesterol is an important risk factor for 
both ischaemic heart disease as well as CVD especially in the diabetic elderly. 
Diabetes has been shown by Giorda et al. (2008: 2154) to be a strong predictor of 
recurrent CVD events, indicating that approximately 6% of diabetics develop a 
recurrent major CVD event annually, especially myocardial infarction, and those with 
long-standing previous CVD show a higher incidence of recurrence. Church et al. 
(2009: 1289) concluded that CVD mortality was three times higher in diabetic 
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compared to non-diabetic males; indeed the presence of both diabetes and the 
metabolic syndrome substantially increased the mortality risk of CVD. Williams 
(2008: 13) states that hypertension is established as a major risk factor for 
premature CVD and death in people with Type 2 diabetes and all modern guidelines 
now recommend the routine treatment of hypertension in Type 2 diabetes. This 
study of hypertension in diabetes revealed that hypertension was most common in 
people with Type 2 diabetes and that the treatment of this hypertension was 
dramatically beneficial in reducing the risk of major macro- and microvascular 
complications. 
In a study of 106 Type 2 diabetic youths aged 10 – 22, West et al. (2008: 175) 
found that youths with Type 2 diabetes had a higher degree of elevated blood 
pressure, obesity, larger waste circumference, low HDL cholesterol and high 
triglycerides. This study concluded that children and young adults with Type 2 
diabetes had a much less favourable CVD risk profile than their non-diabetic 
counterparts. In terms of cholesterol as a risk factor for CVD, the use of statins, the 
term for HMG Co-A reductase inhibitors, which are used in the treatment of 
hypercholesterolaemia, have been associated by Yee et al. (2004: 962) with a 
significant delay in the starting of insulin therapy as an adjunct to oral anti-diabetic 
medications in Type 2 diabetics. 
Blood pressure control in diabetes is often difficult to achieve, according to McLean 
et al. (2008: 2355) and often have better results when treated by a team including 
pharmacists and nursing staff. Wong et al. (2009: 34) report that in their study less 
than one-third of patients with diabetes and hypertension achieved the desired blood 
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pressure levels and fewer than half were aware of the correct or desired level for 
their condition. Gudbjörnsdottir et al. (2009: 53) found that patients with diabetes 
and hypertension used an increasing amount of lipid-lowering drugs over time which 
improved their blood lipid profiles but that their hypertension targets were not being 
met. Conversely, it has been shown by Wu et al. (2008: 69) that diabetic patients 
suffer more from orthostatic hypotension, rapid drop in blood pressure when 
standing up from a sitting or supine position, than non-diabetics. In a long-term 
follow-up study of hypertensive diabetics, Holman et al. (2008: 1565) concluded that 
good blood pressure control was essential in order to ensure that the benefits of this 
control in diabetic treatment was to be maintained. 
2.5.4 Other 
2.5.4.1 Sexual dysfunction 
The conclusion of a study by Enzlin et al. (2009: 780) was that depression is the 
major predictor of sexual dysfunction in women with Type 1 diabetes. Amongst Type 
1 diabetic women of any age who were still sexually active, up to 35% reported 
female sexual dysfunction (FSD). Slightly more than half of these subjects reported 
that loss of libido and problems with orgasm were problematic, while 47% reported 
a lack of adequate lubrication and more than a third reported lack of arousal. In 
men, Romeo et al. (2000: 788) have stated that the data obtained in their study of 
sexual function indicates that there is a strong association between glycaemic 
control and erectile dysfunction (ED) and Jackson (2004: 358) observed that ED is 
three times more common in men with diabetes. He suspects further that ED most 
commonly reflects endothelial dysfunction and autonomic neuropathy and might be 
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a marker for silent occlusive arterial disease but, with sexual dysfunction having 
multifactoral aetiology, psychological issues appear to predominate. Penson and 
Wessells (2004: 225) add that ED is one of the most common complications in 
diabetes and one of the most under-diagnosed, stressing a knowledge of the 
pathophysiology of the condition in order to successfully address it. Increasing 
duration of diabetes was positively associated with ED for men over 50, according to 
Bacon et al. (2002: 1458). 
2.5.4.2 Thyroidopathy 
The use of metformin as Type 2 diabetes therapy appears to influence thyroid 
stimulating hormone (TSH) with a drop in TSH being observed in patients with 
hypothyroidism (Cappelli et al. 2009: 1589) and Type 2 diabetics under treatment 
for hypothyroidism should be re-evaluated after 6 – 12 months of treatment. 
Endothelial function is also affected by long-term hyperglycaemia in Type 1 diabetes 
according to Ceriello et al. (2009: 2751). They maintain that this has implications not 
only for the thyroid gland but for all areas of the body with an endothelial layer, not 
least important of which is the cornea. This loss of function or dysfunction is only 
addressed by normalisation of glucose and oxidative stress. 
2.5.4.3 Deafness 
Type 2 diabetes has been associated with a prevalent, but not incident, hearing loss 
in the older population (Mitchell et al. 2009: 483). These researchers report that 
accelerated hearing loss progression over 5 years was more than twice as likely in 
persons diagnosed with diabetes than in non-diabetic individuals. 
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2.5.4.4 Mental health complications 
Ciechanowski, (2000: 3278) explored the impact of depression on primary care 
diabetic patients in terms of their self-care, compliance with treatment, functioning 
and health care costs. Unsurprisingly, those in the group with medium to high 
depression scores were significantly less adherent to dietary guidelines. Those in the 
highest sector of depression also had the highest percentage of oral medication non-
adherence, poorer physical and mental functioning and a greater probability of 
incurring emergency, primary or specialist care and inpatient or mental health costs. 
Depressed diabetics had total health costs 86% higher than non-depressed 
diabetics. A further conclusion was that depressive severity was associated with 
poorer diet and medication compliance, functional incapacity and higher healthcare 
costs.  Ali et al. (2006: 1165) found raised rates of depression in patients with Type 
2 diabetes although Mezuk et al. (2008: 2383) concluded that Type 2 diabetes is 
associated with only a modest rise in risk of depression. An association, albeit weak, 
between depression and glycaemic control was found mainly amongst users of 
insulin (Aikens et al. 2008: 1324), where those Type 2 diabetics who made use of 
insulin might be particularly susceptible; however Makine et al. (2009: 28), from 
their meta-analysis, found depression was associated with poor glycaemic control in 
Type 2 diabetes and, in poorly controlled Type 2 diabetes, insulin progression is 
often postponed due to negative beliefs. Egede and Ellis (2008: 213) studied 
indigent Type 2 diabetic patients and concluded that those patients who were 
depressed had poorer diabetes self-care and felt less in control of their disease. In a 
study by Fisher et al. (2008: 1096), 506 Type 2 diabetic patients were assessed over 
18 months. It was found that diabetics displayed high rates of affective and anxiety 
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disorders over time relative to community adults, showing 60% higher for Major 
Depressive Disorder, 123% for General Anxiety Disorder and 85% for Panic disorder. 
The prevalence of depressive affect and distress was 60 – 73% higher than affective 
and anxiety disorders. Younger age, female gender and high co-morbidities were 
related to persistence of all conditions and HbA1c was positively related to 
depressive effect. This high prevalence of comorbid disorders and the persistence of 
the depressive effect and distress led these researchers to believe that continued or 
repeated mental health assessments of diabetic patients should form part of each 
patient contact.  Collins et al. (2009: 153) found high levels of anxiety and 
depression in patients with diabetes with 32% exceeding the „mild to severe‟ anxiety 
scale and 22.4% having „mild to severe‟ depression. Risk factors for severity of 
depression and anxiety were identified as diabetes complications, smoking, being an 
ex-drinker or heavy drinker and uncertainty about glycaemic controls. Females and 
those with poor glycaemic control were found to have higher anxiety scores, while 
those with a higher socio-economic status and older age were found to exhibit the 
lowest anxiety and depressive signs and symptoms. They concluded that the 
prevalence of anxiety and depression in diabetics is far higher than in the general 
population. Canadian researchers Lysy et al. (2008: 1133) found that inactive 
diabetics were 1.75 times more likely to be depressed than those more active. The 
depressed were almost twice as likely to be more inactive than the non-depressed. 
Their conclusion was that there is a strong association between depressed mood and 
physical inactivity in Type 2 diabetics and that this depression may well be modified 
positively with depression-specific management and exercise encouragement. A 
study to examine the impact of the diagnosis of Type 2 diabetes on psychological 
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well-being of Dutch patients was conducted by Adriaanse et al. (2004: 992) who 
concluded that the diagnosis of Type 2 diabetes had no psychological effect, adverse 
or positive. It was found by Gonzalez et al. (2008: 1102), though, that patients with 
higher levels of depression and depressive symptoms reported significantly lower 
adherence to general diet recommendations, less exercise and poorer foot care. 
Moreover, each one-point increase in the depressive score was associated with a 
108 fold increase in the chances of non-adherence to prescribed medication, which 
indicated to them that depressive symptoms predict subsequent non-compliance 
with important aspects of diabetes self-care in Type 2 diabetic patients.  
2.5.4.5 Stress 
Dungan et al. (2009: 1798) researched stress hyperglycaemia, raised blood sugar 
resulting from increased stress levels, and concluded that even those diabetics on 
tight blood glucose control were susceptible to stress induced hyperglycaemia and 
that these patients were at greater risk of adverse consequences as were non-
diabetic patients with stress hyperglycaemia.  
The condition of Diabetes Distress (DD) is raised by Fisher et al. (2009: 622) who 
describe it as distinct from depression and related to diabetes outcomes. The 
potential for being distressed included female gender, having had a previous major 
depressive disorder and having poor diet and low exercise. It was found that 
negative life-events increased the negative effects of higher HbA1c levels. 
2.5.4.6 Cognitive function 
Diabetes is associated with cognitive decline and dementia according to Launer et al. 
(2009: 221). These researchers discovered a significant association between HbA1c 
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levels and cognitive testing scores and concluded that higher HbA1c levels are 
associated with lower cognitive scores. Similarly, Ruis et al. (2009: 1261) noted that 
Type 2 diabetes is known to be associated with decrements in memory, executive 
functions and information processing speed. In studying early Type 2 diabetic 
patients to assess whether cognitive ability had been affected at early stages of the 
disease, they found that modest cognitive function decrease was already present at 
early stages of Type 2 diabetes. A history of microvascular disease and smoking 
exacerbated this state. Researchers van Duinkerken et al. (2009: 2335) have 
ascertained that chronic hyperglycaemia is one of the major factors affecting brain 
functioning negatively as functional connectivity becomes affected. This occurs even 
before macrovascular complications are evident. They postulated that 
hyperglycaemia may underlie cerebral function changes in Type 1 diabetes, as 
measured by magnetic field fluctuations at the scalp. In their study Type 1 diabetic 
patients performed worst on general cognitive ability, information processing speed 
and motor speed. Those Type 1 diabetic patients with diabetic retinopathy had the 
poorest functional connectivity compared to Type 1 diabetics without microvascular 
complications. Kim et al. (2008: 1440) maintain that poor glycaemic control, central 
obesity and hypertension all influence cognitive functions like attention and 
psychomotor speed. Waist circumference was associated with poor performance 
overall with the problem being most apparent in older Type 2 diabetic patients. 
Interestingly, studies by Deyore et al. (2009: 635) have found that a diet higher in 
polyunsaturated fats relative to saturated and trans fats has the potential of 
reducing cognitive decline in, especially older, Type 2 diabetic patients.  
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It would appear that throughout the literature there exists a common thread 
regarding the promotion of a healthier lifestyle to prevent and manage diabetes. Due 
to their primary health role, the optometrist is ideally suited to assist in the 
education and promotion of lifestyle changes to facilitate blood glucose control. 
2.6 OCULAR COMPLICATIONS OF DIABETES 
 
Anecdotal evidence suggests that individuals with diabetes are largely unaware of 
the possible adverse consequences the disease may bring in terms of their ocular 
health. Indeed, this is the thrust of this study. There are often vague references to 
the fact that diabetes „can affect the eyes‟ but usually no more than that. Zhang et 
al. (2008: 1421) studied the prevalence of visual impairment among adults in the 
United States both with and without diabetes and found that approximately 11% of 
these adults with diabetes had some form of visual impairment. Furthermore, those 
with diabetes were more likely to have uncorrectable visual impairment which led 
them to the conclusion that vision loss is more common in people with diabetes than 
without. 
The most common ocular complications associated with diabetes are: cataracts, 
refractive changes, diabetic retinopathy, secondary glaucoma and ocular 
neuropathy. 
2.6.1 Cataract 
The metabolic and intricate biochemical processes involved in growth of the 
crystalline lens cells is a self-regulating one (Lang, 2000: 167). This metabolic 
activity is essential for the lens function and the maintenance of clarity. Any 
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disturbance of this will influence its‟ optical performance negatively. The lens 
epithelium maintains equilibrium and transportation of nutrients, minerals and water 
into and out of the lens. Lang (2000: 167) describes this as a “pump-leak system”, 
which allows active transfer of sodium, potassium, calcium and amino acids from the 
aqueous humour into the lens. This homeostasis maintenance is closely related to 
the water balance of the lens, which loses water with age reducing the diluted 
component of protein within its matrix resulting in insoluble protein accumulation. As 
a consequence, the lens become harder, less elastic and less transparent with the 
central portion of the lens (nucleus) becoming sclerosed and yellowish with age 
(Lang, 2000: 167). 
In 1984 Perkins (1984:293) wrote that the diabetic patient required cataract surgery 
earlier than non-diabetics and, in 1985, Klein et al. (1985: 1191) said that persons 
with diabetes have been found to be at increased risk of developing cataracts 
compared to non-diabetics. Furthermore, it appeared to these authors that female 
diabetics had higher rates of cataracts than males. In their study they also found 
that prevalence of cataract significantly increased in younger persons with longer 
duration of diabetes, older age at examination, increased severity of retinopathy, use 
of diuretics and higher HbA1c. In older individuals retinopathy severity, higher 
HbA1c and diuretic usage, smoking and lower intra-ocular pressure (IOP) were 
significantly associated with cataract. In 1993, Bron et al. (1993: 260) wrote about 
the changes occurring in the human lens with diabetes, noting inter alia refractive 
changes, cataract, age-related thickening, auto-fluorescence and yellowing. The lens 
swelling and cataract was ascribed to an accumulation of sorbitol in the cortical 
fibres of the lens, especially so in adult diabetics whose cataracts resemble those of 
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older persons with age-related non-diabetic cataracts. Interestingly, these authors 
note further that the occurrence of cataract is a predictor of mortality in the diabetic.  
The typical diabetic cataract is rare in younger diabetic patients says Lang (2000: 
179). He describes the process as transient metabolic decompensation which causes 
a radial “snowflake” pattern of cortical cataract and observes that the progress of a 
diabetic cataract is rapid, occurring two to three years earlier than normal age-
related cataracts. Weimer et al. (2008: 2017) investigated the effect of diabetes on 
the internal structure of the crystalline lens and found that the nucleus and different 
cortical layers of the lens were substantially thicker in Type 1 diabetics than the 
control group. Furthermore, a significant association was found between the 
duration of diabetes and the thickening of the lens structures. Importantly, no 
significant change in thickness was found in the lenses of Type 2 diabetes patients, 
leading the researchers to conclude that Type 1 diabetes has a significant effect on 
the internal structures of the lens. This change is probably due to swelling which 
affects all the components while Weimer et al. (2008: 2017) suggest Type 2 diabetic 
cataract appears to have a different pathogenesis in this regard. In Brazil, Esteves et 
al. (2008: 324) found that there was a high prevalence of cataracts in Brazilian Type 
1 diabetics and suggest that the more severe the disease the greater the risk of 
cataract. Dal Pizzol et al. (2008: 564) concluded that the prevalence of cataracts in 
Type 1 diabetic patients in Brazil was almost 20%, and significantly associated with 
retinopathy. The influence of diabetes and CVD on cataract formation was 
researched in the Blue Mountains Eye Study where Tan et al. (2008: 317) confirmed 
that diabetes was a risk factor for age-related cataract and IFG was a possible risk 
factor for cortical cataract. These authors concluded that a cluster of abnormalities 
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related to insulin resistance was responsible for cataract formation rather than CVD. 
In a study on older diabetic patients, Tumosa (2008: 515) found that elderly diabetic 
persons were 1.5 times more likely to develop vision loss and blindness than non-
diabetics of a similar age. The vision loss is due to ocular and periocular conditions 
including dry eye, cataracts, maculopathy and glaucoma. 
Modern treatment for cataract is extra-capsular cataract extraction (ECCE) with 
phacoemulsification and concurrent intra-ocular lens implants. An Australian study 
by Hong et al. (2009: 1510) concluded that diabetic retinopathy progression was 
found to be more frequent in patients undergoing phacoemulsification than non-
diabetics, although this was still lower than those having either extracapsular or 
intracapsular procedures. 
2.6.2 Refractive changes 
Optometric practitioners should be well aware of the refractive changes inherent 
with prolonged hyperglycaemia. In 1982, Eva et al. (1982: 500) wrote that sudden 
myopic increases in refraction were always associated with elevated blood glucose. 
But a review of patient records had persuaded the researchers that the changes 
were not toward myopia rather toward hyperopia. Fledelius (2009: 1987) was 
equally surprised to observe a hyperopic shift in hyperglycaemia, despite previous 
teachings that myopic change was the primary refractive manifestation of 
uncontrolled diabetes. Grosvenor (1996: 141), in contrast, speaks of a bilateral 
hyperopic change, or increase in hyperopia, due to a decrease in blood sugar. This 
implies that hyperglycaemia causes a bilateral increase in myopia, termed a myopic 
shift. Naidoo (1999: 427) comments that several refractions may be needed in order 
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to obtain the true correction in poorly controlled diabetics and that there may be an 
earlier onset of Presbyopia with a decrease in accommodative ability.  
Jacobsen et al. (2007:510) saw that the prevalence of myopia in diabetic patients 
was considerably higher than in the background Danish population. They suggest 
that poor blood glucose control is a significant risk factor for myopia and that 
hyperglycaemia may be a complicating factor in myopia progression. Ebeigbe and 
Osaiyuwo (2009: 28) considered the influence of sorbitol within the crystalline lens 
possibly affecting the refractive index and thereby altering the refraction status. 
2.6.3 Diabetic Retinopathy 
Diabetic Retinopathy (DR) may be the most common microvascular complication of 
diabetes notes Fowler (2008: 77), who adds that the risk of retinopathy increases 
with duration and severity of the disease. He observes that retinopathy may develop 
as early as 7 years before the diagnosis of Type 2 diabetes. Furthermore, Kanski 
(2003: 439) determined that the prevalence of DR is higher in Type 1 diabetes than 
in Type 2 and is the most common cause of blindness in the United Kingdom 
between the ages of 20 and 65. He mentions that duration of diabetes is considered 
the greatest risk factor of all for DR followed by inadequate blood glucose control. 
Klein et al. (1984: 520) observed that, after ten years of diabetes, males had greater 
risk of diabetic retinopathy than females and that retinopathy severity was related to 
longer duration of the disease. Further risk factors included uncontrolled high blood 
glucose levels, the presence of proteinuria and hypertension.   
Whilst good blood glucose control serves mainly to delay the onset of DR, Kanski 
(2003: 439) is of the opinion that the incidence of DR after 10 years is 50% yet very 
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rare within 5 years. These statistics are supported by Lang (2000: 314), who 
maintains that 90% of diabetics will exhibit DR after 20 years and will occur despite 
optimum therapy. Klein et al. (1984: 520), in the Wisconsin Study of Diabetic 
Retinopathy, found the prevalence of DR varied from 17% in less than five years to 
97.5% in persons with diabetes for 15 or more years. Other risk factors for DR are 
pregnancy, which is occasionally associated with rapid onset proliferative DR; poorly 
controlled hypertension which is associated with proliferative DR development and 
kidney disease which is also associated with worsening of DR, although corrective 
treatment of kidney disease is associated with DR recovery and improvement. Lang 
(2000: 314) is clear that despite symptoms of keratoconjunctivitis sicca, 
xanthelasma, infections, refraction changes (often transient), cataract and 
glaucoma, 90% of all visual impairments are from diabetic retinopathy.  
In order to reduce DR there is evidence from Dodson (2009: 997) that would 
suggest that lipid-modifying therapy with Fenofibrate showing the most beneficial 
effects reducing the need for laser therapy and progression of pre-existing DR. 
Treatment for (proliferative) DR is by laser photocoagulation and, if serious enough, 
by pan-retinal photocoagulation (PRP). Lim et al. (2009: 857) have found that in 
diabetes, those eyes that have been treated by PRP have a far thinner nasal and 
inferior Retinal Nerve Fibre Layer (RNFL) than in non-diabetic eyes. Other studies, 
including that of Raymond et al. (2009: 410), have found that patients of south 
Asian ethnicity have a significantly higher prevalence of diabetic retinopathy and 
maculopathy. Interestingly, they have found that these same patients have 
significantly higher blood pressure, HbA1c and total cholesterol readings and are far 
younger at diagnosis than others in the study. 
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2.6.3.1 Causes of diabetic retinopathy 
The pathophysiology and pathogenesis of DR is explained by Kanski (2003: 439) as 
microangiopathy affecting the retinal precapillary arterioles,  capillaries and venules, 
although larger vessels may also become involved. Features of DR are microvascular 
occlusion and vascular leakage. Kanski (2003: 439) further describes the 
pathogenesis as a three-part phenomenon beginning with capillary changes where 
the basement membrane thickens, endothelial cell damage occurs and proliferation 
takes place. Secondly, red blood cells become deformed affecting the transport of 
oxygen negatively and finally platelets become increasingly sticky and aggregate. All 
of these steps lead to retinal capillary non-perfusion and result in ischaemia causing 
retinal hypoxia. The conclusion of this physiological cascade of events is 
arteriovenous shunts, where capillaries running between venules and arterioles 
become occluded and, ultimately, neovascularisation. Neovascularisation is thought 
to occur due to a vascular endothelial growth factor (VEG-F) which is released in a 
hypoxic state in order to revascularise an area of infarction. 
Microvascular leakage is thought to occur because the capillary walls lose their mural 
cells, or pericytes, making them weaker, causing them to distend and become prone 
to leakage (Kanski 2003: 439 – 440). This distension is also the reason for the 
presence of microaneurisms, known to be one of the first manifestations of DR. The 
consequence of this vascular leakage is oedema which can be diffuse from extensive 
leakage or localised from focal leakage. Chronic leakage results in hard exudates 
being deposited at the junction of normal and oedematous tissue. These exudates 
consist of lipoprotein and lipid-filled macrophages and typically manifest in a circular 
pattern around the site of leakage (Kanski, 2003: 442). 
80 
 
2.6.3.1 Classification of diabetic retinopathy 
Kanski (2003: 439) classifies diabetic retinopathy as: 
  Background retinopathy (BDR) which manifests as small round dot 
microaneurisms located at the inner nuclear layer of the retina, intraretinal 
haemorrhages originating from the venous end of the capillaries in a „dot and 
blot‟ form and usually found deeper in the retinal layers and superficial flame-
shaped haemorrhages which follow the course of the retinal nerve fibre layer 
(RNFL). There are also hard exudates located between the outer plexiform, or 
Henle‟s layer, and inner nuclear layers of the retina, usually arranged in clumps 
or in a circular pattern around areas of oedema. Finally retinal oedema is often 
visible also situated between the inner plexiform and RNFL. Further accumulation 
of fluid gives the fovea a cystoid, or swollen, appearance. 
 Diabetic maculopathy, which is the most common cause of visual complaint 
amongst diabetic patients. Indeed, say Yilmaz et al. (2009: 902), diabetic macula 
oedema is the leading cause of visual loss in diabetic retinopathy. This occurs 
when oedema is present in the macular region and is accompanied by exudates 
surrounding the macular area. There can also be diffuse maculopathy where 
there is generalised leakage from the capillaries, which is best diagnosed by 
fluoroscein angiography. Ischaemic maculopathy causes reduction in acuity with 
a relatively normal macular appearance, although exudates and haemorrhages 
may be seen elsewhere. This condition may also be manifest as mixed 
maculopathy where elements of oedema and ischaemia are both present. Finally, 
Clinically Significant Macular Oedema (CSMO) is defined as the presence of: 
81 
 
retinal oedema or hard exudates within 500µm of the macula and retinal oedema 
one disc area (approximately 5000µm) from the macula, any part of which is one 
disc diameter from the macula (Kanski, 2003: 445). 
 Preproliferative DR where vascular „beading‟, looping or segmentation is seen. 
All the clinical lesions are caused by ischaemic conditions and include cotton wool 
spots which occur from occlusion of capillaries in the RNFL and axon waste, 
which is responsible for the white appearance. Darker blot haemorrhages 
representing haemorrhagic infarcts and intraretinal microvascular abnormalities 
(IRMA) which are often seen next to areas of capillary closure are also evident. 
IRMA, however, do not exhibit great leakage with fluoroscein angiography 
(Kanski, 2003:443). 
 Proliferative Diabetic Retinopathy (PDR), the hallmark of which is 
neovascularisation. Klein et al. (1984:520), in the Wisconsin Epidemiologic Study 
of Diabetic Retinopathy, found that PDR varied from 1.2% with diabetes for less 
than ten years to 67% in persons having diabetes for 35 or more years. New 
vessels may proliferate at the optic disc (NVD) or elsewhere (NVE) along the 
course of the major temporal arcades. Non-perfusion of at least one quarter of 
the retina must be established before NVD is said to develop. The severity of 
neovascularisation is determined by the area covered by the new vessels as well 
as their location. Kanski (2003: 447) states that a retina with NVE is less likely to 
bleed than one with NVD. Fibrotic changes also occur in PDR and this usually 
happens in conjunction with the neovascularisation and is especially important as 
it is the cause of tractional retinal detachment which in itself plays an important 
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part in PDR progression (Kanski, 2003: 453). The fibrous tissue attaches to the 
posterior interface of the vitreous and contracts pulling the vitreous and 
detaching it and leaking plasma into the vitreous itself. This traction continues 
and the detached vitreous is pulled into the vitreous cavity until bleeding occurs 
in which case symptoms become apparent (Kanski, 2003: 453). Sometimes 
haemorrhage can occur within the vitreous gel but more often bleeding occurs in 
the retrohyaloid space, known as a preretinal haemorrhage, manifesting in a 
crescent shape which is the demarcation of the vitreous detachment. 
Lang (2000: 315), in Table 2.4, classifies DR into Nonproliferative and Proliferative 
and a distinction is made between Nonproliferative stages as mild, moderate and 
severe. A further distinction is made between proliferative stages as being non-high 
risk and high risk. 
The study by Hong et al. (2009: 1510) as mentioned in 2.6.1 is relevant when 
considering the progression of DR after cataract surgery, which was found to be 
higher after such procedures. Also relevant in terms of posterior vitreous 
detachment (PVD) is the research by Kawahara et al. (2008: 2784) regarding the 
use of statins injected into the vitreous to prevent PVD. Statins appear to counter 
the presence of transforming growth factor (TGF) which is present in higher 
concentrations in patients with PVD. Interestingly, Shiba et al. (2009: 1017) studied 
the effects of sleep apnoea, or sleep-disordered breathing (SDB), in diabetic patients 
and found that 29% of those with NPDR and 48% of PDR patients had SDB and 
conclude that the oxygen stress induced by sleep breathing disorders may promote 
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the production of vascular endothelial growth factors and promote the development 
of PDR. Table 2.7 shows a classification of diabetic retinopathy by Lang (2000: 315). 
Table 2.7:  Nonproliferative and proliferative Diabetic Retinopathy (Lang  






 Microaneurisms  
 intraretinal haemorrhages  
 hard exudates 
  retinal oedema 
  venous beading 
  excessive haemorrhages 
  cotton wool spots 





 Pre-retinal neovascularisation 
 Vitreous haemorrhage 
 Tractional retinal detachment (due to traction of 
vitreous scarring) 
 Rubeoisis irides  
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2.6.4 Secondary glaucoma 
Neovascular glaucoma is one of the serious consequences of PDR and is often a 
result of rubeosis irides which in itself is a regular sequela of PDR. Kanski (1999: 
477) says that rubeosis is especially common in eyes with severe retinal ischaemia 
or persistent retinal detachment. In rubeosis irides the new vessels block the 
anterior angle of the eye, drawing the angle together in a zip-like fashion (Lang 
2000: 271), causing acute angle closure with a poor prognosis. 
2.6.5 Ocular neuropathies 
Eshbaugh et al. (1995: 219) established that cranial mononeuropathies are a 
common occurrence in diabetes, being first reported in 1886 and include facial and 
ophthalmoplegic neuropathies. In terms of ophthalmic conditions, these researchers 
cite a Tokyo study which reported a 0.97% incidence of cranial nerve 3rd, 4th, 6th or 
7th palsies in the diabetic population over a 25-year period. They report further on a 
Mayo clinic study of over 4000 diabetic patients which concluded that abducens (VI) 
nerve palsy was by far the most common (44%), followed by oculomotor (III) nerve 
(28%) and trochlear (IV) nerve (15%). Diabetes and hypertension are regularly 
associated with ischaemic VI nerve palsy, according to Patel et al. (2005:760) who 
saw the combination of diabetes and hypertension was evident in 18.4% of cases, 
while in diabetes alone the frequency was 23.7%. These researchers concluded that 
there is a six-fold risk of having diabetes in cases of VI nerve palsy and an eight-fold 
risk with co-existing diabetes and hypertension. In their discussion, Eshbaugh et al. 
(1995: 219) found that lesions in diabetic cranial neuropathy can occur anywhere 
from the brainstem to the orbit. Jacobsen et al. (1994: 961) also identified diabetes 
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as an accepted risk factor for ischaemic III nerve palsy, alongside left ventricular 
hypertrophy and elevated hematocrit (red blood cell count in the blood). A 
commonly observed sequela in diabetes-associated III nerve palsy is pupil 
involvement which is observed as anisocoria (unequal pupil sizes) (Jacobsen, 1998: 
723) with the larger pupil being in the involved eye. The degree of anisocoria might 
only be slight but pupil involvement in this condition occurs more often than was 
previously recognised. Trochlear nerve lesions are less common than those of the III 
or VI nerves. Burger et al. (1970: 567) reported common risk factors for ocular 
neuropathies which include diabetes amongst many others. 
2.7 PATIENT EDUCATION AND KNOWLEDGE OF DIABETES 
 
Please (2007: 90) reports “knowledge of possible complications associated with 
disease is generally viewed as a precursor to positive health behaviours.” To 
paraphrase Joshi and Joshi (2008: 29), unless diabetic patients take ownership of 
the responsibility for their condition they are going to find it difficult to implement 
the lifestyle interventions necessary to combat the disease. In 1985, researchers 
Assal et al. (1985: 602) stated that it had taken more than 50 years for the 
beneficial effects of patient education to have been unequivocally proven. They 
mention further that the widespread failure to acknowledge the impact of patient 
education is the primary reason for the poor quality of diabetes care. 
2.7.1 Benefits of patient knowledge of diabetes 
Greenfield et al. (1988: 448) developed a programme designed to increase patient 
involvement in their medical decision making, contending that patients need to 
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participate actively in their own medical care in order to maximise the control of 
their condition. They discovered that prior to the intervention programme the mean 
HbA1c levels were 10.6mmol/l and after the intervention these levels had dropped to 
9.1mmol/l. Further analysis showed that those patients in the trial group were far 
more likely to ask pertinent questions regarding their treatment than the non-trial 
group and reported fewer functional limitations. This lead the authors to conclude 
that these interventions were positively affecting patient behaviour, improved blood 
sugar control and decreased functional limitations. In Sri Lanka, Fernando (1993: 
18) found similar results in a study of diabetic patients where he noted that it was 
widely accepted that patient education was essential in the treatment of diabetic 
patients. The conclusion of the study was that diabetes education improved patient 
knowledge and, most importantly, diabetes control. An Irish study by Coates and 
Boore (1996: 99), however, contested this finding and found no relationship 
between knowledge and glycaemic control. This supports an earlier study by 
Bloomgarden et al. (1987: 263) which concluded that patient education was not 
necessarily an efficacious intervention in insulin administered diabetes therapy. This 
premise, however, was effectively refuted by the results obtained by Srinivas et al. 
(2005: 264) who state categorically that an inverse linear relationship exists between 
performance on a diabetes knowledge test and HbA1c values. It would appear 
though that literacy levels are significant in obtaining positive results as shown by 
Hawthorne (2001: 373) who studied British Pakistani diabetic women and found that 
glycaemic control improved in women receiving culturally-appropriate health 
education but noted that illiterate women did not do as well as their literate peers in 
the knowledge skills test and also had a lower glycaemic improvement. This would 
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seem logical and supports the notion of education levels and diabetic management 
being linked. 
Khan et al. (2008: 1108) studied the prevalence and reasons why Bangladeshi 
patients were reticent to commence insulin therapy in Type 2 diabetes, apparently a 
frequent problem in their community. Reasons for insulin refusal included 
perceptions of disease severity increase, insulin leading to premature death, loss of 
control and the fear of hypoglycaemia. Weight gain, loss of independence and fear 
of needles was also reported to be influential. The Freemantle diabetes study done 
by Bruce et al. (2003: 82) also found that barriers to diabetes education confronted 
older people, minority groups and those with language or literacy difficulties. This 
aspect was already recognised in 1989 when Gilden et al. (1989: 1023) enrolled 
spouses of diabetic patients in a six-week diabetes education programme. It was 
found that reduction in stress was proportional to their increase in knowledge which 
was maintained six months after completion of the programme. They suggested that 
spousal participation and education was an effective intervention and adjunct to 
conventional therapy. More recent research by Phylis-Tsimikas et al. (2004: 110) 
found that after a one-year period of participation in a programme to improve 
patients‟ clinical diabetes care, knowledge and treatment satisfaction the study 
group had significant improvements in HbA1c levels (12% to 8.3%), total cholesterol 
and blood pressure. This nurse-driven or primary care programme, in order to be 




Research by Heisler et al. (2005: 816) examined the frequency and correlates of 
knowing one‟s latest HbA1c result and whether this is associated with a more 
accurate assessment of diabetes control and self-care and behaviour modification 
related to diabetes control. Surprisingly, 66% of respondents reported that they did 
not know their HbA1c results and only a quarter accurately reported them. This led 
the researchers to conclude that those who knew their HbA1c scores reported better 
diabetes understanding and assessment of their glycaemic control than those who 
did not. Unfortunately this knowledge alone was not sufficient to improve self-care 
of diabetes and glycaemic control, which needed other behavioural strategies to 
improve diabetic self-management.  
The use of electronic communication with healthcare providers by diabetic patients 
was studied by Harris et al. (2009: 1182), who wanted to see whether use of the 
communication facility improved HbA1c, blood pressure and LDL cholesterol in the 
group. They found that use of the communication facility resulted in a drop of HbA1c 
to <7%, although it was also associated with higher frequency of outpatient visits. 
Their conclusion, however, was that frequent use of the electronic messaging and 
communication facility improved glycaemic control. In terms of patient 
communication, Skinner et al. (2008: 1117) recommend that educators in diabetic 
self-management programmes talk less and promote a more facilitative and less 
didactic approach to achieve optimum results, while Cox et al. (2008: 1527) have 
used the internet as an effective tool for interactive blood glucose awareness 
training. When examining the communication skills of healthcare professionals in the 
paediatric diabetes services, Hambly et al. (2009: 502) observed that an important 
component of consultations was addressing psycho-social issues. These researchers 
89 
 
concluded that this represented a key training need within the communication skills 
framework for healthcare professionals. 
2.7.2 Lack of patient knowledge of diabetes 
Overall patient education in diabetes is poor according to Moran et al. (2005: 267) 
and there is an urgent need to plan and implement educational programmes to 
facilitate the treatment of diabetic patients. As long ago as 1978 Miller et al. (1978: 
275) were concerned with returning war veterans‟ ability to self-medicate, finding 
that 35% of these patients lacked any form of formal training in this regard. Of this 
group 17 patients had been placed on insulin without any instructions on the use 
thereof. Those who had a form of training were almost equally inept and could not 
demonstrate adequately the basic skills needed for self-care which included insulin 
administration, foot care, urine or blood testing and management of hypo- and 
hyperglycaemia.  In 1983 Eastman et al. (1983: 229) studied 50 Type 1 diabetic 
patients and their parents‟ ability to detect hypo- and hyperglycaemia. They 
concluded that rigorous interventions were required in order to improve the ability of 
both patients and their parents to self-manage. In a similar study, Williams et al. 
(1998: 166) studied patients both with diabetes and hypertension and concluded 
that inadequate functional health literacy levels were a serious impediment to 
educating patients with chronic diseases like hypertension and diabetes. This was a 
comparable conclusion to that of Hawthorne (2001: 373) in 2.7.1 above. Of the 
patients with adequate literacy levels, 92% knew that 160/100 constituted higher 
than normal blood pressure compared to 55% with inadequate literacy skills. A 
similar picture emerged with diabetics and their knowledge of hypoglycaemia. 
Literary skills aside, as mentioned in 2.4.7 above, Wong et al. (2009: 34) found that 
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less than half of hypertensive diabetics were aware of the importance of blood 
pressure control. In terms of the ocular complications of diabetes, Muñoz et al. 
(2008: 968) found the knowledge of ocular complications in Hispanics to be low and 
emphasised the use of culturally specific education protocols to address the problem. 
2.8 SOCIO-ECONOMIC IMPACT OF DIABETES 
 
Canadian diabetic patients were found to be twice as likely to be unemployed than 
non-diabetic individuals (Kraut et al. 2001: 64). Interestingly, these researchers 
found that diabetic patients without complications had incomes similar to those non-
diabetic counterparts. Those with complications received 72% of the income of the 
non-diabetic individuals and received 58% more income assistance from social 
support. In India, Bjorka et al. (2003: 61) confirmed that costs of treatment of 
diabetes amongst all socio-economic groups placed a great financial burden on both 
patients and state resources. Triomphe (1991: 300) observed that the costs to the 
French community for diabetic treatment were large. Furthermore, the allocation of 
resources for the diagnosis, treatment and prevention of diabetes was considerable 
and impacted indirectly on the economy in terms of loss of working days and 
deterioration in patient quality of life. The direct economic costs of diabetes were for 
medical treatment. Skyler (2000: 7) notes that the improvement of blood glucose 
reduces the costs associated with the treatment and long-term management of 
diabetes. Estimated costs ranged from $4000 to $5800 per patient for intensive 
glycaemic control, which was approximately three times the cost of conventional 
therapy (Skyler, 2000: 7). Valdmanis et al. (2001: 129) noted in their study that 
diabetic individuals were economically worse off on all disability measures, 
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concluding that they had fewer resources to deal with higher levels of disability and 
poorer health status. 
2.9 CONCLUSION 
 
In conclusion, this chapter has undertaken a review of the literature regarding 
characteristics of diabetes. The description of diabetes and the various types 
encountered have been highlighted. Furthermore, the global prevalence, causes and 
risk factors for diabetes have been described. These risk factors include obesity and 
the concept of BMI to grade obesity, the metabolic syndrome, lack of exercise and 
proper diet, stress and depression, hypertension and cardiovascular factors. The 
general complications of diabetes were examined which included nephropathy, 
diabetic neuropathy, cardiovascular disease, sexual dysfunction, thyroidopathy, 
depression and loss of cognitive function. Ocular complications of diabetes 
researched were cataract, refractive changes, diabetic retinopathy, its causes and its 
various classifications, secondary glaucoma and ocular neuropathies associated with 
diabetes. Finally, the importance and value of patient education and knowledge, or 
lack of knowledge of diabetes was examined, concluding that treatment and 
compliance is vastly improved with greater knowledge and awareness of the 
condition. The following chapter will describe the research methodology and 












In research hypotheses are developed which are tentative explanations accounting 
for a set of facts, according to Muijs (2004:1). These can be tested by further 
investigation which is the reason why hypothesis acceptance is always provisional. 
Upon further investigation the research may provide new and different data or 
circumstances may change. This chapter contains a rationale and theoretical basis 
for the research process, followed by an explanation of the research design and 
methodology used to obtain the data for this study. Reliability, validity and 
trustworthiness are explained and the chapter concludes with an overview of the 
ethical considerations for the research. 
 
3.2 THEORETICAL PERSPECTIVES ON THE RESEARCH STUDY 
3.2.1 Theoretical basis for the use of quantitative research 
Predominantly quantitative research approaches were used in this research. Muijs 
(2004: 1) describes the two main types of research methods as being quantitative 
and qualitative and uses the definition of quantitative research as given by Aliaga 
and Gunderson (2004) as “explaining phenomena by collecting numerical data that 
are analysed by mathematically based methods.” Thomas (2003: 2) is of the opinion 
that researchers using this technique seek explanations and predictions that can be 
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generalised to other persons and places. Polgar and Thomas (2000: 10) regard 
quantitative research as viewing our patients objectively, like natural objects, and 
then attempting to “identify and measure important variables which represent the 
causes and expressions of a clinical condition.” Certain questions in the research 
questionnaire had a qualitative element but these were summarized and analysed 
quantitatively. In quantitative research, phenomena that do not exist in a 
quantitative form can be converted into quantitative data by means of survey 
questionnaires. Attitudes, for example, can be quantitatively determined by using a 
grade, or Likert, scale format (Muijs, 2004: 1).  
 
Researchers use quantitative research designs in the following instances (Muijs, 
2004: 2): 
 When researchers want a quantitative answer or number to a question. For 
example: How many people…. 
 To examine numerical change: By what amount did student numbers increase 
over the period.… 
 When explaining phenomena: What factors are related to a change in… 
 When testing hypotheses: Is there a relationship between socio-economic 
background and low self-esteem? 
 
Furthermore, quantitative research involves collection of data in units. These units 
are known as variables and variable refers to the fact that data will differ between 
units (Muijs, 2004: 3).  
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There are certain problems that are endemic to quantitative research, according to 
Muijs (2004: 9). These include: 
 Exploration of a problem in depth where quantitative research will fail. 
Although a qualitative design gives a broad overview of information for any 
in-depth study, they are far superior where specific issues need to be 
examined. 
 Quantitative research cannot develop theories and hypotheses, only test 
them. 
 Complex issues are best examined by qualitative research where unexpected 
variables may emerge. Unexpected variables do not fit in well with a fixed 
variable quantitative study.  
 While quantitative studies are good for establishing cause and effect, or 
causality, meanings of events or circumstances need to be examined 
qualitatively. 
 
Muijs (2004: 9) refers to so-called mixed studies which involve both qualitative and 
quantitative elements which gives researchers both breadth and depth. In this 
instance, the use of questionnaires (quantitative) together with case studies 
(qualitative) would allow both methods to work concurrently. In mixed studies the 
qualitative and quantitative elements can have equal status or one can hold bias, 
depending on the research design. Thomas (2003: 6) contends that most modern 
researchers see the two methods as complimentary rather than antagonistic. This 
was noted by Jick (1978: 602) as early as 1978 where it was indicated that the two 
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methods should be regarded as complimentary, endorsing the use of both methods 
to negate the inherent weaknesses in each. 
 
There are two types of quantitative research: experimental design and non-
experimental design. The latter is most popular with survey research in the social 
sciences (Muijs, 2004: 9). Muijs (2004: 9) defines an experiment as “a test under 
controlled conditions.” The emphasis in experimental study designs is on “control” 
which is why they are usually conducted in laboratories. This is in contradistinction 
to non-experimental design research which is more varied. According to Muijs, 
(2004: 31) however, the most popular form of non-experimental research is the 
survey method. Furthermore, a cross-sectional study, where a group is surveyed 
only once, is often implemented as opposed to a longitudinal study where a group is 
surveyed over a number of years. 
 
In this research, the quantitative aspect involved the derivation of the data by 
means of the patient questionnaire. The qualitative research involved a 
comprehensive literature review and consultations with various colleagues and other 
experts in the field to check the accuracy, content and relevance of the data 
obtained. The qualitative aspect of a study involved the determination of what the 
patient thinks of his or her condition, something not possible in a statistical analysis 
but rather better suited to an interview research study. This would include his or her 
family setting and social circumstances (Polgar & Thomas 2000: 10). In the 
Demographic and Health Survey by the South African Department of Health 
(Makubalo et al.. 1998: 206-218), the authors found that those with a lower level of 
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education were most susceptible to so-called lifestyle diseases, like hypertension and 
diabetes. It was for this reason that, for this research, the questionnaire contained 
questions regarding respondents level of education as an important variable to be 
considered. Other qualitative aspects regarding comments by the participants were 
assessed, including how they perceived their diabetes and general health. 
 
In order to arrive at the truth or, as Polgar and Thomas (2000: 4) refer to it, 
“knowledge”, one can use various “methods of knowing”. These are authority, 
rationalism and intuition. In the first, knowledge is considered true because of 
tradition or because experienced researchers or clinicians have said it was true. This 
method has its problems, not the least of which is what happens if someone of equal 
academic stature states the exact opposite of what was traditionally believed or 
taught? Who is, indeed, correct? The scientific method utilised in this study removes 
all subjective influences and relies on an objective review of the data obtained. 
Indeed, quantitative analysis is predicated on objectivity where the researcher is 
encouraged not to become involved in case he or she “contaminates” the data 
collection process (Kleinbaum et al. 1982: 22). It is for this reason that, in this 
research, there was no attempt made to create an abnormal or unnatural setting 
while the patient completed the questionnaire like, for example, in an examination or 
test. 
 
Polgar and Thomas (2000: 4) argue that rationalism relies on logic and reason. Logic 
guarantees that the conclusion arrived at is true. However, if one of the logical steps 
proves to be empirically false then the logical “truth” arrived at is incorrect. Scientific 
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study relies on logic but it requires evidence to be collected to support the logical 
and mathematical routes taken in the search for the truth. 
 
Polgar & Thomas (2000: 4) refer to the “Eureka moment”, when intuition holds sway 
and truth is judged by the clearness of thought or of the experience, stating that 
“knowledge is sometimes acquired by sudden insights.” Sadly, many an intuitive 
diagnosis or decision is found wanting when faced with the empirical results. The 
19th century physician Ignaz Semmelweiss was ostracized and condemned by his 
fellow practitioners for daring to suggest that doctors themselves were potential 
carriers of disease which contradicted the intuitions of his colleagues and incurred 
their wrath (Polgar and Thomas 2000: 4). 
 
Scientific method is based on three elements (Durward and Baer, 1995: 436), 
namely skepticism, determinism and empiricism. Skepticism implies that all thought 
or statement is open to doubt and analysis. Determinism means that all events occur 
because of certain physical laws and causes and not because of luck, demons or evil 
spirits, while empiricism extols the notion that enquiry be conducted through 
observation and verified through experience. In this study these three concepts were 
utilised in the development of the research instrument. The various statements that 
respondents were asked about contained elements that they were unlikely to have 
knowledge of in order to ascertain their level of knowledge. The patients in the 
study were all diabetic as a result of physiological events and the observations 




An illustration of the scientific method, consistent with the methodology of 
„positivism‟ (Polgar and Thomas 2000: 5) is seen in figure 3.1 below: 
 




In the above figure, it appears that observations describes the precise, unbiased 
recording of observations, aspects of persons, objects and events which forms the 
empirical basis of all science These can be verbal descriptions or sets of 
measurements, both of which must be formulated so that they can be replicated and 
repeated by others. These observations may be used to develop scientific 
hypotheses which are “statements which specify the nature of the relationship 
between two or more sets of observations.” (Polgar and Thomas 2000: 5-6).  These 
hypotheses, according to these authors must have clear-cut, observable referents so 
that, when the hypotheses are confirmed by empirical means, they become laws. 
 
Furthermore, theories or, more precisely, scientific theories, are speculations 
representing current knowledge of the subject. These result from evidence derived 
from scientific research and from which hypotheses can be converted into theories, 
which are more general systems of explanation. (Polgar and Thomas 2000: 6). From 









which is verifiable from the data that, in turn, must be trustworthy, valid and 
reliable. These latter concepts will be dealt with in greater detail in section 3.8. 
 
3.2.1 Theoretical basis for the use of Health Research 
Research is defined by Polgar and Thomas (2000: 3) as being a systematic and 
principled way of providing evidence in order to solve health care problems, while 
Bowling (2002: 1) defines it as “the systematic and rigorous process of inquiry which 
aims to describe phenomena.”  Furthermore, research methods refers to the 
practices and techniques used to collect, process and analyse the data, the sample 
size and methods of sampling and how the data will be collected. It also refers to 
the choice of measurement instrument and how the data is to be processed and 
analysed (Bowling 2002: 143). 
 
In this study an attempt has been made to examine the state of diabetes knowledge 
of private patients. In order to do this a population based cross-sectional study 
design using purposive accidental random sampling was undertaken. Health research 
is closely linked to health systems research and often the line between the two is 
blurred. Firstly, Hunter and Long (in Bowling 2002: 3) explain health research as 
being in relation to health generally and playing an important role in the planning 
and operation of health services aiming to achieve health. Secondly, health systems 
research strives to improve the health of the community by enhancing the efficiency 
and effectiveness of the health system “as an integrated part of the overall process 
of socio-economic development” (Bowling 2002: 3). 
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In this research both concepts appear to be appropriate because, as Bowling (2002: 
3) indicates, the process for obtaining systematic knowledge and technology which 
can be used for the improvement of the health of individual groups is, effectively, 
health research. This, in turn, provides the basic information on the health and 
disease of a certain population, which is the essence of this study. The results 
obtained with this research are aimed at contributing to the improvement of the 
health of the community which then substantiates the two definitions previously 
described. 
 
The definitions of the two research types further emphasises the need for a 
multidisciplinary approach to health in general. According to Pope, in Bowling (2002: 
4), there are no boundaries in health research as it is all somehow interconnected 
and all health research is a place “within which disciplines can meet”. In this 
instance optometry proposes to play a more participative role in primary health care, 
which is traditionally the domain of the district health personnel and larger hospitals. 
This would be similar to Pharmacy which has also begun to play an increasing role in 
primary health care offering blood pressure monitoring as well as cholesterol and 
diabetes blood tests on their premises. 
 
Health research is essentially broader than health systems or health services 
research, which aims rather to target cost-effective and appropriate treatment for a 
specific condition or group of conditions that health research has uncovered 
(Bowling 2002:51). Broadly speaking, the aim of health research is to understand 
how people become ill, their perceptions and experiences in relation to (their) health 
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and the effects of the illness. It can also encompass the experience of healthcare, 
how society reacts to (their) illness and the functioning of health services in relation 
to their effects on people.  
 
This study, therefore, is a health research study utilising questionnaires. It utilises a 
descriptive research method involving the comparison of the characteristics of a 
variable with that of another variable. In this instance consideration is made 
between variables relating to, inter alia, demographics (patient age, race, gender, 
and education), clinical data and knowledge of diabetes, diabetes management and 
its general and ocular complications.  
 
3.2.2 Theoretical basis for population-based research 
Population-based research is defined by the Robert W Johnson Research Foundation 
(2005: 1) as another term for epidemiology or the study of disease in populations. 
Whilst this study is not an epidemiological study, it will compliment current 
understanding of the disease and patient management. The use of populations 
distinguishes epidemiological studies from clinical medicine and other biomedical 
research (Kleinbaum et al. 1982: 20). Epidemiology, in turn, focuses on combining 
results from many subjects which, according to Kleinbaum et al. (2004: 20), ties in 
with its primary and ultimate goal: the improvement of the health status of 
populations. Polgar and Thomas (2000: 295) refer to population-based research as 
“the study of the distribution and determinants of disease within a community.”  
 
Kleinbaum et al. (2004: 20) lists the aims of epidemiological research as: 
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 Describing the health status of the population 
 Explaining aetiologies 
 Predicting occurrences 
 Controlling distributions of diseases by preventing new occurrences, 
 eradication of existing occurrences, prolonging life with disease or 
 improving health status of the afflicted 
 
They mention further two different goals or levels at which epidemiological research 
is conducted, namely understanding and intervention. 
 
Understanding is concerned with observations and inferences leading to 
accumulation of knowledge about disease occurrence and aetiology, while 
intervention involves collecting information which can be used to make informed 
public health decisions. The objective of research at intervention level is to evaluate 
health practices, programs and policies to prevent disease and promote good health 
(Kleinbaum et al. 2004: 22). 
 
Study populations may be classified by racial, ethnic, age cohort or by geographic 
cohort. In this study the cohort is specifically the diabetic patient who privately funds 
his or her treatment. This is different to community-based research which is focused 
on all people in a defined geographic community. Although, that being said, this 
study is confined to the geographical area of the Western Cape Province and so one 
could possibly consider this study to be a combination of the two forms where the 
population base or epidemiology is concerned with a single geographical area. 
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Although this study is population-based it is not intended to be an epidemiological 
study. 
3.2.3 Theoretical basis for questionnaire based research 
Muijs (2004: 9) has referred to survey methods as the most popular form of 
quantitative research in the social sciences. Survey methods include the use of 
questionnaires which have both advantages and disadvantages. The advantages are 
listed as follows by Muijs (2004: 44): 
 They are easy to use and most people are familiar with them 
 Participants can sit and think about their answers 
 They are flexible and can contain a wide range of questions 
 It is easy to generalise findings to real world settings 
 Can gather large amounts of data at relatively low cost 
The disadvantages are: 
 Low response rates, with non-return rates often lower than 50% 
 Time-consuming follow up and data entry 
 
When considering response rate in questionnaire research, Babbie (1992: 267) 
considers a 50% return rate as “adequate”, while a 60% return is rated “good”. In 
order to increase the return rate and minimise the problems, Muijs (2004: 44) 
recommends the following steps: 
 Keep questionnaires short 
 Telephone/contact participants to arrange completion of the 
 questionnaires 
 Promise and provide feedback to respondents 
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 Provide a reward for completion of questionnaires 
 Follow up calls 
 Maintain credibility. This can be done by keeping promises made in 
 respect of, especially, confidentiality. 
In order to as far as possible align these principles in this research, respondents 
were assured of confidentiality and were promised feedback on the results once 
published. Respondents were invited to return to discuss any aspect of the study, 
including the results, at any time. 
 
3.3 REVIEW OF METHODS AND PROCEDURES  
3.3.1 Research design   
Research design refers to the overall structure or plan of the research. In this study, 
the research involved the collection of data from questionnaires which were 
completed by the patients at their attending optometric practice. This data was then 
captured, collated and statistically analysed. 
 
A population-based cross-sectional study design, using purposive accidental random 
sampling, was used for this research. The study consisted of questionnaires 
completed by diabetic patients who fund their condition privately, that is outside of 
the South African Public Health sector. The patients were from mixed socio-
economic backgrounds. The quantitative aspect of the study involved the analysis 
and synthesis of the data collected together with the statistical analysis of the overall 
responses obtained from the questionnaire.  The qualitative aspect utilised certain 
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questions within the questionnaire which allowed for an assessment of the patients 
own perceptions of his or her diabetes and general health status.  
3.3.2 Literature review 
The research process was initiated with an extensive literature review encompassing 
the field of diabetes, its clinical presentation and causes, prevalence, risk factors, 
general complications, ocular complications and patient knowledge of their condition 
(Chapter 2). The literature was obtained from text books, publications, journal 
articles and the internet. Further information for the study was also gained from 
personal correspondence with experts in the field.  
3.3.3 Research instrument – patient questionnaire 
From the literature review, it became evident that certain variables are significant in 
diabetes. Using the evidence from the literature review and previous studies in this 
field, notably Clarke-Farr et al. (2006: 134) and Mashige et al. (2008: 95), a 
questionnaire was designed to compile data for each patient. Such data included:  
 
Section A: Biographical details. There were 10 questions in this section including 
location (rural or urban), age, gender, ethnic group, language, occupation, education 
details, weight, height and a Body Mass Index calculation for each participant. 
Patient heights were measured on a wall-mounted tape measure and they were 
requested to indicate their weight on the questionnaire. 
 
Section B: Medical history. This section included details of the health status of 
respondents where 12 questions were asked including description of their own 
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health, pregnancy status and whether they suffered from hypertension, heart 
disease, hypercholesterolaemia, tuberculosis or other lung disease. The participants 
were asked to identify the type of diabetes they had, what their latest blood glucose 
measurement was, when it was taken and for how long had they been treated for 
diabetes. Respondents then had to identify who had diagnosed their diabetes and 
whether, at the time of diagnosis, patients were told about the importance of regular 
eye examinations. Finally in this section they were asked which other family 
members, if any, had diabetes. 
 
Section C: Eye care. Fourteen questions related to eye care and diabetes were 
included in this section. This section also dealt with access to eye and health care 
services. Questions included details of when the participants previous eye 
examination occurred, at which practice this took place and the distance they 
needed to travel for an eye test. Respondents were then asked the reason for 
attendance at the practice, whether it was for new spectacles, a diabetic eye 
examination or any other reason. The following questions related to their knowledge 
of where to go for their first diabetic eye examination, whether the costs of an 
examination made it difficult to attend for one and whether they could take time off 
work to have an eye examination. Patients were then asked whether they felt that 
they had received adequate information regarding the possible ocular complications 
of diabetes when they were first diagnosed and whether they found it expensive to 
test their blood glucose. Lastly questions about the type of additional information 
they would like to receive about diabetes, the format this information should take 
and from whom they would like to receive this information were asked. 
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Section D: Knowledge of diabetes. In this part of the questionnaire an attempt was 
made to determine the knowledge of diabetes of the participants. Seven questions 
regarding the types of diabetes, whether there is a heredity factor involved and 
whether pregnancy could cause diabetes were asked. The involvement of depression 
and anxiety in diabetes was explored as was some common blood tests used in the 
diagnosis and management of diabetes. 
 
Section E: General diabetes management. Participants were asked eleven questions 
in this section concerning the importance of a healthy diet and lifestyle and regular 
exercise. Thereafter, participants were asked about the importance of daily blood 
sugar testing, effective weight management and medication compliance. 
Respondents were questioned about their attendance to regular medical and eye 
examinations, the importance of smoking cessation and whether they, as patients, 
knew enough about diabetes to manage their own condition. Lastly, they were asked 
the rate the benefits of certain foodstuffs and supplements as part of a diabetic-
oriented diet plan and to indicate certain conditions that were associated with 
diabetes. 
 
Section F: Ocular complications of diabetes. This section questioned the 
participants‟ knowledge of ocular conditions associated with diabetes. Eleven 
questions regarding vision, colour vision, glaucoma and cataracts were asked. 
Wound healing and retinopathy, described as bleeding and damage inside the eye, 
were explored as was their opinion on the importance of an eye examination if they 
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could still see clearly or if their blood glucose was well controlled. Finally participants 
were asked whether they knew about laser treatment for diabetic eye disease. 
 
Section G: Management of diabetes. In the penultimate section patients were 
asked ten appropriate questions regarding their management of diabetes including 
whether they felt their diabetes was under control. Next they were asked whether 
they had a glucometer, how often they measured their blood glucose and what their 
usual blood glucose level was when tested. Respondents then answered questions 
on how their diabetes was being treated, whether they exercised and, if so, the 
frequency and quality of the exercise. Finally in this section patients were asked 
whether they had received lifestyle advice for the better control of diabetes and from 
whom this advice was obtained. 
 
Section H: General management of diabetes. In the final section of the 
questionnaire participants were asked seven questions relating to their diet, weight 
and whether they knew what their Body Mass Index (BMI) was. To conclude the 
questionnaire they were asked other questions regarding compliance and about the 
frequency and regularity of medical check-ups and annual eye examinations. 
3.3.4 The questionnaire procedure 
In order to ensure accuracy, reliability and validity, the questionnaires were 
administered by the researcher and also by appointed researchers who had been 
appropriately trained in order to ensure standardisation of results. Each participant 
was given an information sheet detailing the nature of the research, its title, the 
researcher and contact details of both the researcher and the supervisor as well as 
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the office of the UKZN Biomedical Research Ethics Committee (BREC). The 
information sheet al.so certified that the anonymity of the participants was 
guaranteed and that no-one would be identified in the final writing of the thesis and 
analysis of results. This form was signed by each participant prior to participating in 
the study indicating his or her understanding of the research and its implications. In 
order to prevent contamination of the results, the participants were left in private to 
complete the questionnaire with a research assistant available for any assistance if 
needed. 
3.4 PARTICIPANTS IN THE RESEARCH 
 
Random privately-funded or medically insured diabetic patients attending the 
designated optometric practices were examined. The designated optometric 




Diabetic patients who attended the practices were asked to voluntarily participate in 
the study. They were asked to sign a consent form in English, Afrikaans or isiXhosa. 
Once their permission had been obtained and after being informed about the nature 
of the study, the study questionnaire was completed. They were given instructions 
by the attending optometrist or trained research assistant and allowed as much time 
as needed to complete the questionnaire. This data was then captured using 




3.4.1 Sample selection  
3.4.1.1 Target population  
The target population included all privately-funded, self-funded or medically insured 
diabetic patients attending optometric practices in the designated areas of the 
Western Cape Province of South Africa. After an optometric examination the 
participating diabetic patients were given a questionnaire to complete by the 
researcher or by appointed researchers/research assistants who were trained in the 
methodology of the study in order to ensure standardisation of results.  
3.4.1.2 Survey population 
The survey population consisted of all privately-funded diabetic patients attending a 
private optometric practice in Milnerton and Malmesbury and who were prepared to 
participate in the research study after completion of the consent form. 
3.4.1.3 Sample size 
Sample size is normally arrived at by means of the estimated sampling error, where 
the sampling error is inversely proportional to the square root of the sample size, 
which means that the greater the sample size the smaller the sampling error (Polgar 
and Thomas 2000: 39). 
 
The sample size consisted of 120 patients who were privately-funded, self-funded or 
medically insured. In order to provide a statistically valid sample a minimum of 122 




To obtain a 95% confidence level at a confidence interval of 3, the minimum sample 
needed for all nine provinces of South Africa needed to be 1077 (Creative Research 
Systems, 2009) and, using the formula provided by Creative Research Systems 
(2009), for the same level in the Western Cape the minimum sample was 0.101 X 
1077 = 108. The final sample size for the study consisted of 122 [n sample = 122] 
patients seen in the selected private practices.  
  
Convenience sampling was employed in patient selection. Random selection was 
assured as all diabetic patients attending the designated optometric practices were 
invited to participate in the research. This would be considered to be statistically 
random as they attended the practice with an equal chance of being selected for 
participation in the study. Therefore no bias was evident in determining which 
patients presented at the practices for examination, provided that all participants 
met the inclusion criteria of being a previously diagnosed diabetic patient on health 
insurance or privately funded. 
3.4.1.4 Description of the sample 
The study population consisted of patients who during the case history section of a 
routine optometric examination were found to be diabetic and who privately funded 
their treatment or were medically insured. Patients making use of the Public Health 
Service for their diabetes treatment were excluded. The practices were located in 
Malmesbury, a town approximately 65 kilometres north of Cape Town, representing 
a rural population mix and Milnerton, a suburb of Cape Town representing the 
Atlantic seaboard. These designated practices reflected a mixture of urban and rural 




The population of the Swartland, the region of the Western Cape Province wherein 
Malmesbury is found, was 72099 in 2001 (Census 2001: Statistics South Africa). 
Figure 3.2 illustrates the population of the Swartland region by gender and 
population group. 
 
Figure 3.2:  The population of the Swartland (Statistics South Africa, 2001) 
 
 
The urban area in the research was Milnerton which falls within the City of Cape 
Town. In the 2001 Census this region had a population of 2 893 232 (Statistics 
South Africa, 2001). 
 
In both the urban and rural sectors of this study the majority of the population are 
from the coloured group, while in the rural area the white and black African numbers 
113 
 
are similar. The black African population proportion rises markedly in the urban area 
where it is second only to the coloured group and almost twice the size of the white 
population. Figure 3.3 illustrates the population of the City of Cape Town by gender 
and population group. 
 
Figure 3.3:  The population of the City of Cape Town (Statistics South Africa,  
  2001) 
 
 
3.5 THE PILOT STUDY 
 
The research study was preceded by a pilot study which van Teijlingen and Hundley 
(2001: 1) consider as crucial to a good study design and define them as mini 
versions of a full-scale study. The pilot study involved the use of a preliminary 
questionnaire that had been developed by the researcher and from this study the 
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final patient questionnaire evolved, which formed the basis of the quantitative data 
gathering process.  
 
The major advantage of a pilot study is that it might give advance warning about 
where the main research could fail or whether proposed instruments or methods are 
inappropriate or too complicated (Van Teijliningen and Hundley 2001: 1). Also of 
great importance is the fact that a successful pilot study can help convince other 
stakeholders that the main study is worth pursuing and supporting. Pilot studies do 
have their limitations, especially if they are based on relatively small numbers and as 
a consequence do not have any real statistical foundation. There is also the concern 
of contamination which, according to Van Teijliningen and Hundley (2001: 2), could 
arise in two ways namely where data from the pilot study could be included in the 
main results and where pilot participants are included in the main study but new 
data is collected from these people. The chief concern in this instance is that the 
participant has been exposed to an intervention and may therefore respond 
differently to one who has not previously experienced it. For this reason those 
involved in the pilot study were excluded from this research. 
 
3.6 DATA COLLECTION 
 
Data was collected from the study questionnaire.  This data was obtained during a 
routine optometric examination and involved the participant completing a 
questionnaire containing the variables to be utilised in the study. Once a study 
115 
 
questionnaire had been completed the data was captured using Microsoft Excel for 
statistical analysis. 
3.7 DATA ANALYSIS  
 
Data utilised for the statistical analysis of the results were derived from information 
obtained by the following procedures: 
1. Patient questionnaire completed by each participant with the assistance of 
trained research assistants or the researcher. 
2. The weight and height of the subjects in order to determine the body mass index 
(BMI) as an associated risk factor for diabetes. 
 
 
The data was analysed using the statistical analysis software of Microsoft Excel in 
Office 2007. The data analysis of the study elicited the central tendency, including 
the mean (average), median (midpoint) and mode (most common value). Dispersion 
factors measured where appropriate were the range (gap between largest and 
smallest values), and standard deviation.  
 
3.8 RELIABILITY, VALIDITY AND TRUSTWORTHINESS 
 
When establishing reliability in research, an instrument is considered reliable if it 
consistently gives the same results (Goddard and Melville, 2001). Babbie (1992: 132) 
remarks that the term refers to whether the study results adequately reflect the true 
meaning of the concept under consideration. Bowling (2002: 147) refers to the 
reproducibility and consistency of the instrument, where it is free from random error 
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and is homogenous. In order to facilitate the reliability of this study, a copy of the 
same questionnaire was used for each patient. The same procedures and 
instructions were utilised in each instance. 
 
In order for a study to have validity it needs to measure what it intends to measure 
(Bowling 2002: 147). To evaluate the validity of the instrument, a pilot study was 
undertaken by the researcher which reinforced the internal validity, especially in 
terms of the questions asked in the questionnaire.   
 
The major threat to the validity of the instrument is observer bias, whereby 
participant‟s answers could possibly be influenced by the researcher or research 
assistant. This was largely overcome by the use of the research instrument the 
results of which could be analysed or checked by an external observer. In addition, 
participants were left to privately complete the questionnaire with a research 
assistant available if necessary. The validity of the instrument, for concurrent validity 
(diagnosis), in respect of the questionnaire, is established by the nature of the 
questions which were unambiguous, referring to defined medical conditions and 
treatment modes. In addition, the questions were modified to be more applicable to 
the private optometric environment. 
 
All research, to be credible, is predicated on its trustworthiness. Lyon (2000) 
mentions the two elements of trustworthiness as being (a) the suitability of the 
research design or methodology used for the particular study and (b) the scientific 
rigour of the methodology. The latter statement infers that the data collected and 
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collated is true and not fabricated in any way. In this study the former is ensured by 
the appropriate questions to be asked in the patient questionnaire and the latter by 
use of the statistical analysis of the results so obtained and the role of the 
researcher or research assistants to ensure the questionnaire responses are not 
fabricated.  
 
Denzin (in Bowling 2002: 202) emphasises the use of triangulated research methods 
in order to elevate the researcher above the personal biases that occur with the use 
of single methods. His proposal was that the data is triangulated by being collected 
at different times and by different people and that the methodology also is 
triangulated by using multiple methods to collect the data. 
 
In order to triangulate results of this study a thorough literature review was 
conducted by the researcher, a pilot study was undertaken in consultation with 
experts in the field and the study questionnaire was drafted. Furthermore, diagnosis 
of diabetes had been previously made by a medical practitioner. The nature of the 
statistical analysis and wording of the questionnaire also aimed to ensure such 
triangulation.  
3.9 ETHICAL CONSIDERATIONS 
 
McKinney, in Babbie (1992: 470-71), is of the opinion that ethics in research is of 
paramount concern. In health research this is especially important as certain 
personal and often highly confidential issues are examined. Ethics in research is 
based on three major considerations according to McKinney (Babbie, 1992: 470-71). 
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These are informed consent, the right to privacy and protection from harm. Bowling 
(2002: 156) endorses this view stating that the ethical principle governing research 
is that respondents should not be harmed in any way. The South African Medical 
Research Council states that “research involving a human subject … is based on a 
moral commitment to advancing human welfare, knowledge and understanding.” 
(SA Health Info 2005: 1). Patients should also give their informed consent to 
participate in a study after they have been made fully aware of the nature of the 
study both verbally and in writing.  
 
Ethical approval for the research was obtained from the UKZN BREC. The Medical 
Research Council of South Africa (MRC) (Benatar et al. 2000: 8) mentions the four 
principles of biomedical ethics as being: 
 Autonomy – respect for the person and human dignity 
 Beneficence – benefit to the participant  
 Non-maleficence, meaning no harm must come to the participant and 
 Justice where the concept of equal distribution of risks and benefits between 
communities is recognised. 
 
In this study all respondents were informed of the nature of the research, their 
voluntary participation was emphasised and their anonymity and withdrawal at any 
time was assured. All patients in this study were given a fact sheet explaining the 
study and were all invited to sign a consent document. In this document their right 
to privacy and confidentiality of results was emphasised. They were also informed 
that there was no coercion involved in their participation and that it was entirely 
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voluntary. To this end all patients completed a consent form either in English, 
Afrikaans or isiXhosa. The questionnaire was also available in either 
English/Afrikaans format or English/isiXhosa format. 
 
All participants were assured that they could withdraw from the study at any time 
and that there would be no consequences for them should they so decide. All 
patients were attendees of an optometric practice in the designated areas, usually 
where they routinely received eyecare services. There was no discrimination on any 
basis other than that listed in the inclusion and exclusion criteria, i.e. diabetic 
patients under treatment outside of the public health system or non-diabetics. This 
study conforms to internationally accepted ethical norms and practices in research. 
 
All completed questionnaires were stored in the locked office of the researcher and 
were only accessible in his presence. Anonymity was ensured as there were no 
personal identifying details on the questionnaire and the consent forms were kept 
separately, ensuring that no match could be made between them and the completed 
questionnaire. All electronic data was anonymous and password protected. 
 
Benatar et al. (2000: 8 – 9), remark that ethics is the science of criteria, norms and 
values for human action and conduct. Ethics apply when one reflects on one‟s moral 
analysis of actions or decisions. The appropriateness of an action whether is it good 
or bad and how it possibly affects others is weighed by our ethical judgement and 
consideration. In terms of ethics for health research, these authors maintain that 
this kind of research should exist solely to benefit patients, to alleviate pain and to 
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prevent suffering. It is thus incumbent on researchers to recognise the boundaries of 
their professional expertise and not undertake research that they are not qualified to 
carry out. The researcher and the appointed research assistants were at all times 





In this chapter the theoretical basis for health research was described together with 
an overview of its relevance to the study. This involved the study of quantitative and 
qualitative phenomena, population based research as opposed to community-based 
research, questionnaires and the scientific method and why it is important. Secondly, 
the methodology and procedures of the research were described in detail. This 
included a description of the topics covered in the literature review, the study 
questionnaire as well as a concise description of the participants in the research. The 
latter included a description of the study area and of the target population. The pilot 
study was explained, the theoretical basis for pilot studies as well as the various 
research techniques that were employed. Finally the validity, reliability and 
trustworthiness of the study were highlighted as were the ethical considerations of 
research in general and of this study in particular. In the following chapter, Chapter 
4, the results of the study will be presented and the analysis thereof will be explored 







In this chapter the results of the study will be presented. Firstly the overall results 
are expounded, wherafter the results are separated into responses from the rural 
group, represented by those patients attending the Malmesbury practice (n=73) and 
the urban group, represented by those patients attending the Milnerton (n=49) 
practice. 
4.1.1 Biographical information 
 
Of the 122 respondents, 73 (60%) were from rural areas and 49 (40%) were from 
urban areas. Of the total sample, 121 indicated their ages which ranged from 33 to 
80 years with a mean of 58.6 and standard deviation (σ) of ± 11.24 years (mode = 
54 and median = 56.5 years) and included 66 (54%) males and 56 (46%) females. 
The overall ethnicity of the respondents included 62 (51%) Whites, 57 (49%) 




Figure 4.1: The ethnic distribution of respondents. 
 
Seventy-six (62%) respondents indicated that their language preference was 
Afrikaans and 44 (36%) preferred English while 1 (1%) preferred isiXhosa. The 
average number of successful years of study was 11.88 years, with a range of 5 to 
18 years (12 years being taken as successful matriculation). The mean weight of the 
respondents was 87.7 kg (σ = ± 20.6 kg) (range = 49 to 150 kg) and their mean 
height was 1.69 metres (σ = ± 0.106 metres) (range = 1.49 metres to 1.98 metres). 
From the measured heights and weight information, the Body Mass Index (BMI) of 
each participant/respondent was calculated. Their calculated BMI ranged from 20 







4.1.2 Medical history 
Seventy-three (60%) respondents rated their current health status as good, 46 
(38%) as average and three (2%) as poor. No respondents reported being 
pregnant. Seventy-six (62%) respondents reported that they had hypertension, 65 
(53%) had elevated cholesterol levels, none of the respondents reported having 
tuberculosis (TB), six (5%) had unspecified lung problems, one (1%) reported 




Figure 4.2: The overall percentage respondents regarding medical conditions. 
 
When asked to indicate what type of diabetes they had, 64 (53%) respondents 
indicated that they had Type 2 diabetes (T2DM), 5 (4%) had Type 1 diabetes 
(T2DM) and 53 (43%) reported that they did not know what type of diabetes they 
had. One hundred and fourteen (93%) respondents did not know or recall their 
latest blood glucose reading while eight (7%) respondents knew their blood glucose 
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level. Of those who knew their blood glucose level, the reported range was 2.7 
mmol/l to 19.2 mmol/l with a mean of 8.25 mmol/l ( σ = ± 3.25 mmol/l), and a 
mode of 7 mmol/l. Forty-nine (40%) respondents indicated that their blood glucose 
levels were measured on the same day, 17 (14%) indicated that it was done the 
previous day, 18 (15%) had their blood glucose levels measured within the same 
week, 20 (16%) in the previous month and 18 (15%) could not recall when they had 
last taken a blood glucose test. The duration of treatment ranged from 6 months to 
40 years, with a mean duration of 7.2 years (σ = ± 7.41), a median of 4.5 years and 
a mode of 1 year. Ninety three (75%) of respondents reported that their diabetes 
was diagnosed by a General Practitioner (GP), 19 (%) were diagnosed by a 
physician, 8 (%) by a nurse and 2 (%) reported other (cf. Figure 4.3). In Figure 4.3, 




Figure 4.3: The percentage distribution of diagnosing clinicians in total sample.  
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When asked whether they were told about the importance of regular eye 
examinations by the diagnosing clinician, 73 (60%) respondents indicated that they 
were informed and 49 (40%) reported that they were not. Forty (33%) of the 
respondents indicated that their mothers were diabetic, 32 (26%) indicated that 
their brothers were diabetic, 28 (23%) and 28 (23%) respectively indicated that 
their fathers and sisters were diabetic while 40 (33%) reported no family history of 
diabetes. 
4.1.3 Knowledge about eye care 
Of the respondents who answered this question, thirty-nine (32%) reported that 
their last eye examination was done one year ago, 36 (30%) two years ago, 24 
(20%) three years ago, nine (5%) four years ago and 13 (11%) respondents 




Figure 4.4: The overall percentage respondents showing the last time they had an 
  eye examination. 
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The majority, 64 (52%), of respondents had their previous eye examination in the 
same optometric practice where this study was conducted, 41 (34%) were examined 
at another practice and 16 (13%) had their last ophthalmic examination with an 
ophthalmologist. Seventy-two (59%) of the respondents reported that their main 
reason for the eye test was to obtain new glasses, 59 (48%) had their eye test 
because they were diabetic, 17 (14%) tested their eyes because they had optical 
benefits available on their medical aid, four (3%) were referred for an eye 
examination by their GP and eight (7%) reported that they had their eyes examined 
for no particular reason. Seventy-eight (64%) of the patients knew where to go for a 
diabetic eye examination and 44 (36%) did not know. Ninety-eight (80%) 
respondents reported that the cost of an eye test was not an important 
consideration to having their eyes examined but 24 (20%) indicated that it was. 
Similarly, 114 (93%) of respondents indicated that they had no problem taking time 
off work to have an eye examination while eight (7%) reported the contrary. 
Although 72 (59%) respondents felt that they had received adequate information 
regarding diabetic eye disease when they were first diagnosed with diabetes, the 







Figure 4.5: Percentage distribution of information required by respondents in the 
  sample.  
 
Eighty-four (71%) respondents indicated that checking their own blood glucose 
levels was not expensive, 33 (28%) said it was while five of the 122 respondents 
(4%) did not respond to this question. Sixty-seven (54%) respondents indicated that 






Figure 4.6: The overall percentage respondents regarding the medical professional 
  from whom they would like to receive information on diabetes.  
 
In response to how often they would like to receive information about diabetes, 82 
(67%) said on a continuous basis, 32 (26%) said once, while eight (7%) wanted to 
receive it twice. Eighty-one (66%) respondents preferred receiving information 
about diabetes from their GP and 53 (43%) preferred this information to be provided 
in pamphlet form. The preferred medical professional from whom respondents would 
like to obtain information on diabetes and the format in which they prefer the 





       
Figure 4.7: The preferred source of information of total sample. 
 
4.1.4 Overall patients’ knowledge of diabetes mellitus 
Seventy-five (61%) of the respondents knew that there are two main types of 
diabetes, 17 (14%) reported that there were more than two types and 15 (12%) 
reported either that there was only one type or did not know. Seventy-three (60%) 
of the respondents thought diabetes was a hereditary disease and 48 (40%) thought 
otherwise. Seventy-six (62%) felt that pregnancy could not cause diabetes while 46 
(38%) felt it could. One hundred and nineteen (98%) respondents agreed that the 
control of blood sugar levels reduces the complications of diabetes although three 
(2%) disagreed. Seventy-two (59%) respondents agreed that diabetes could cause 
depression and/or anxiety, 10 (8%) disagreed while 40 (33%) were unsure. As 
regards the converse question, fifty (41%) respondents agreed that depression 




When questioned about the importance of certain blood tests in the management of 
diabetes, 46 (38%) respondents considered the HbA1c glycolated haemoglobin test 
to be very important, two (2%) felt it was not important while the remainder 74 
(61%) were unsure. Sixty-six (54%) of respondents felt that the daily blood glucose 
test was very important, three (2%) felt it was of no importance while 52 (42%) 




Figure 4.8:  Ratings of the importance of different blood tests in diabetes  
  management.  
 
4.1.5 Overall knowledge about management of diabetes mellitus 
The maintenance of a healthy lifestyle and diet was considered to be very important 
by the majority 95 (78%) of respondents. Twenty-two (18%) respondents felt this 
aspect of diabetes management was important while five (4%) deemed this to be 
slightly important. Regular exercise was considered to be very important by 89 
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(73%) of patients while 27 (22%) respondents felt it was important and five (4%) 
as only slightly important. Of those respondents who completed this question, 
slightly more than half, 68 (56%), rated the daily testing of blood glucose as very 
important while 32 (24%) patients considered daily testing to be important and  22 
(18%) as slightly important. The effective weight management question was 
answered by 120 respondents and was considered to be very important by the vast 
majority, 86 (70%), while 28 (23%) of respondents found this element to be 
important and six (5%) only slightly important. There were no respondents who 
determined that taking their medication regularly and as directed was only slightly 
important and 112 (92%) considered this to be very important while ten (8%) 
patients thought this to be important. The majority 72 (59%) of respondents felt 
that regular medical checkups were very important, 42 (34%) regarded this as 
important while 14 (11%) thought this to be slightly important. A similar pattern 
emerged with regard to regular eye examinations where 72 (59%) of respondents 
determined this to be very important, 36 (30%) of respondents felt it was important 
while 14 (11%) thought regular eye examinations to be slightly important. In terms 
of cessation of smoking, 105 (86%) of respondents considered this to be very 
important, 12 (10%) felt this was important while a minority 5 (4%) regarded 
smoking cessation as slightly important. The ratings of relative importance of various 





Figure 4.9: The percentage ratings of factors that are involved in the management 
  of diabetes for total sample.  
 
Eighty-two (67%) respondents reported that they knew enough about diabetes to 
manage their own condition while 40 (33%) reported they did not. When asked to 
rate certain food, supplements or medication in terms of their beneficial effects on 
diabetes control, 83% rated chicken as very beneficial and, of the 114 respondents 
that answered regarding fish, 72% rated it very beneficial. Of the 95 respondents 
answering the question related to aspirin, Seventy-six (62%) respondents indicated 
that they were unsure of the benefits of aspirin in diabetes. Also, a significant 
proportion of the respondents were unsure of the beneficial effects of Omega 3 





Figure 4.10: Respondents‟ ratings regarding the benefits of various foodstuffs,  
   supplements and over the counter medication.  
 
Eighty-five (70%) of 121 respondents felt that obesity was commonly encountered 
in diabetes, 35 (30%) were not sure and 1 (1%) felt that it was not a common 
occurrence. Ninety (73%) respondents considered hypertension to be commonly 
associated with diabetes while 32 (26%) were unsure. In terms of cholesterol as a 
commonly encountered factor with diabetes, 71 (58%) of the respondents agreed 
that this was true. The responses to the questions on the association between 





Figure 4.11: Respondents‟ ratings of association between systemic conditions and 
  diabetes.  
 
4.1.6 Knowledge of ocular complications of diabetes  
One hundred and nineteen (98%) respondents agreed that diabetes could lead to 
visual problems, 1 (1%) did not agree and 2 (2%) were not sure. Many, (62%) 
respondents were also unsure that diabetes could cause squints or glaucoma (58%). 
Less than half of the respondents, 58 (48%) and 50 (41%) respectively agreed that 





Figure 4.12: Percentages of respondents‟ knowledge regarding the ocular  
   complications of diabetes.  
 
Eighty-eight (72%) respondents felt it was very important for diabetic patients to 
have an eye examination even if they could still see clearly. Twenty-four (20%) felt 
it was important while 10 (8%) said it was slightly important. Similarly, the majority 
91 (75%) of respondents reported that it was very important to have an eye 
examination even if their blood glucose levels were well controlled, 24 (20%) felt it 
was important while six (5%) felt it was slightly important. When asked if they knew 
about laser treatment for diabetic eye disease, 38 (31%) responded “yes” and 84 
(69%) reported “no”.      
4.1.7 Knowledge about management of diabetes 
 
The majority, 91 (75%), of respondents felt that their diabetes was under control 
and 31 (25%) felt it was not. Many, 100 (82%), respondents reported having a 
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glucometer to check their blood sugar/glucose levels while 22 (18%) reported not 
having one. In response to how often respondents checked their blood sugar levels, 
40 (33%) reported daily, 28 (23%) reported every second day, 35 (29%) less than 
weekly and 20 (16%) reported that they only checked their sugar/glucose levels 
when they visit their doctor. Almost half of respondents, 57 (47%), reported that 
their blood glucose levels were between 7 and 10 mmol/l when they last checked. 




Figure 4.13: Last tested blood glucose levels of respondents  
 
With regards to the treatment of diabetes, the majority 78 (62%) of the respondents 
used oral medication (pills/tablets), 33 (26%) used both pills and injection and eight 





Figure 4.14: Respondents‟ different modes of diabetes treatment    
 
When asked whether they exercised, 59% of respondents reported “yes” and 41% 
reported “no”. Of those who reported “yes”, 38% exercised daily while 20% 
respectively reported exercising 1-2 times per week and 3-4 times per week. Sixty-
two percent reported that they performed light exercise, 33% exercised moderately 
(light sweat) and 4% engaged in heavy exercise (out of breath).  
 
The majority 79 (65%) of respondents indicated that they had received lifestyle 
advice for their diabetic condition and 42 (35%) reported that they had not. Those 
who received this lifestyle modification advice reported getting it from their GP 
(35%), dietician (21%), articles (14%), nursing sister (8%), optometrist (6%), 
family or friend with diabetes (5%), ophthalmologist (4%) and the internet (4%). 
Eighty-six (70%) respondents indicated that they usually followed a healthy diet for 
the control of their diabetes, 15% reported either always following a healthy diet or 
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that they never followed a healthy diet. Sixty-two (51%) respondents felt that their 
weight was acceptable for good diabetes control and 60 (48%) felt that it was not. 
The majority, 100 (82%), of the respondents did not know their Body Mass Index 
(BMI) and 22 (18%) did. Many, 109 (90%), indicated that they took their medication 
regularly and as prescribed and 13 (10%) did not. Similarly, 100 (82%) respondents 
indicated that they went for regular medical check-ups and 22 (18%) did not. When 
asked whether the control of diabetes may help in preventing eye problems, 109 
(89%) participants agreed, one (1%) disagreed and 12 (10%) were unsure. Many, 
74 (61%), reported not having annual eye examinations and 48 (39%) respondents 
reported having them.        
4.2 RESULTS FROM RURAL RESPONDENTS 
4.2.1 Biographical information 
The rural sample comprised seventy-three subjects (n =73), of these 43 (61%) were 
males and 30 (42%) females.  The age range was 33 to 80 years with a mean of 57 
and a mode of 54 years with a median of 56.5 years. The majority 63 (86%) 
preferred Afrikaans, 9 (12%) preferred English and only one (1%) preferred 
isiXhosa. The majority of respondents, 43 (59%), were Coloured, 28 (38%) were 
White and 2 (3%) respondents indicated they were isiXhosa (cf. Figure 4.15).  
 
The average number of successful schooling was 11.99 years (range = 5 years to 12 
years), with the median and mode of 12 years. The average height of the rural 
participants was 1.71 metres (range = 1.5 to 1.98 metres) and their average weight 
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was 91.1 kilograms (range = 54 to 150 kg). The reported average BMI was 31 




Figure 4.15: The ethnic distribution of rural respondents. 
 
4.2.2 Medical history 
Most respondents, 46 (63%), reported to be in good health, 26 (35%) reported their 
health to be average and only one respondent reported poor general health. Forty-
eight (65%) respondents reported having hypertension, ten (13%) had heart 
disease, 41 (54%) cholesterol and two (4%) reported having lung problems. The 
percentage of respondents regarding the specific health conditions reported by the 







Figure 4.16: Rural respondents‟ associated medical conditions.  
 
Nearly half, 34 (46%), of the respondents reported that they had Type 2 diabetes, 
three (4%) reported having Type 1 diabetes and a significant proportion, 36 (49%), 
of respondents did not know what type of diabetes they had. The reported 
average/mean fasting blood glucose reading was 8.67 mmol/l, with the median of 
7.8 mmol/l, mode of 7 mmol/l and range = 2.7 mmol/l to 19.2 mmol/l ( σ = ± 
3.85mmol/l). Thirty-three respondents reported performing a daily blood glucose 
test while the majority 40 (55%) of rural participants did not. Of those respondents 
who performed blood glucose testing, 13% did it the day before, 12% within the 
week, 16% within the previous month and 12% could not remember. The average 
duration for rural subjects/patients was 6.64 years (σ = ± 6.85), with a median of 4 
years and a mode of 1 year. The GP far outnumbered other health professionals in 





Figure 4.17: Rural participants‟ diagnosing clinician. 
 
Many, 46 (63%), respondents from the rural area reported that they had been 
advised on the need for regular eye examinations and 27 (36%) reported that they 
did not receive such advice. Less than one quarter 25 (23%) of respondents 
reported that their mothers were diabetic, 22 (21%) reported that their brothers 
were diabetic, 20 (19%) had diabetic fathers, 19 (18%) reported having diabetic 
sisters and 20 (19%) had no diabetic family members. One quarter, 18 (25%), of 
respondents reported having their last eye examination a year previously and seven 
(10%) more than four years previously. Other responses to the question on the last 





Figure 4.18: Rural respondents‟ period since previous eye examination. 
 
The majority 40 (54%) of respondents had their previous/last eye examination at 
the practice where they completed the questionnaire, 23 (31%) at another practice 
and 10 (13%) at an ophthalmologist. Among the respondents who had their eyes 
tested, 49 (67%) and 38 (52%) respectively indicated it was because they needed 
new glasses or were diabetic, 10 (14%) reported that it was because their medical 
aid would pay, one (1%) indicated that they were either referred by their GP or 
there was no particular reason for undergoing an eye examination. Almost two-
thirds 47 (64%) reported that they knew where to go for an eye test/examination 
while 26 (36%) reported that they did not know. The cost of an eye 
test/examination was not a barrier for an eye examination for the majority, 57 
(72%), of the respondents from the rural area while 16 (22%) cited cost as a 
barrier. Similarly, 50 (68%) respondents reported that the cost of checking their 
blood sugar levels was not a barrier to doing so while 18 (32%) reported that it was. 
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Also, 68 (93%) respondents reported that taking time off work to go for an eye 
examination was not a problem for them while five (7%) indicated that this was a 
problem. The majority, 44 (60%), of participants felt that they were provided with 
adequate information about possible diabetic eye disease when they were diagnosed 
with their condition while 29 (40%) felt that this information was inadequate. With 
regards to the type of information they would like to receive, 49% of respondents 
reported that they would general information on diabetes and its effects on vision 
respectively. Smaller percentages reported that they would like information on 
special precautions to take as a diabetic (30%), exercise (32%) and the effects of 




Figure 4.19: Diabetic information rural respondents would like to receive. 
 
The majority, 50 (68%), preferred this information to be provided to them on a 
continuous basis, 17 (23%) preferred to be provided once and six (8%) preferred it 
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twice. Most, 54 (74%), respondents reported that they wanted information on 
diabetes to be given to them by their GP, 32 (44%) from their optometrist, 14 
(19%) from an ophthalmologist, 10 (14%) wanted their physicians to provide them 
with this information, eight (10%) from a pharmacist and five (7%) from a nursing 




Figure 4.20: The medical professional from whom rural respondents would like the 
information about diabetes.  
 
Regarding the source of information preferred, where respondents were invited to 
mark more than one possibility, 32 (44%), of the rural respondents reported 
pamphlets as the most convenient source, 22 (30%) preferred personal contact, 17 
(23%) wanted book-based information regarding diabetes, 14 (19%) and 13 (18%) 
of respondents preferred information from the internet or magazines respectively, 
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while six (8%) preferred SMS. Preferred sources of information from rural 




Figure 4.21: The source of diabetes information preferred by rural respondents.  
 
4.2.3 Rural respondents’ knowledge of diabetes 
The majority, 41 (56%), of rural respondents were aware that there are two main 
types of diabetes, 11 (15%) knew of one type only or did not know how many types 
of diabetes there were while10 (14%) reported that there were more than two types 
of diabetes. Many, 44 (61%) respondents knew that diabetes was a hereditary 
condition while 28 (39%) did not know. Most, 48 (65%), respondents reported that 
pregnancy was not a potential risk factor for the development of diabetes while the 
remainder, 25 (34%), reported that pregnancy was a risk factor. More than half, 44 
(60%), of respondents agreed that diabetes could lead to depression and/or anxiety, 
23 (32%) were unsure while six (8%) respondents disagreed. In response to 
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whether depression and/or anxiety could cause diabetes, 34 (47%) agreed, 30 
(41%) were unsure and nine (12%) disagreed. With regard to diabetic blood tests, 
the majority, 44 (60%), of rural respondents were unsure whether glycosylated 
haemoglobin (HbA1c) was important while 38 (53%) felt that daily blood glucose 




Figure 4.22: Rural respondents‟ opinion on the importance of blood tests for  
  diabetes  
4.2.4 Diabetes management of rural respondents 
The majority of rural respondents felt that maintaining a healthy diet and lifestyle 
(81%), regular exercises (79%), checking blood sugar daily (60%), weight 
management  (73%), regular medication (93%), regular medical check-ups (68%), 
regular eye examinations (63%) and smoking cessation (86%) were very important 





Figure 4.23: Rural respondents value of the various protocols in diabetes  
  management. 
 
The majority, 51 (70%), of rural respondents considered that they knew enough 
about diabetes to manage the condition themselves while 22 (30%) reported to the 
contrary. The majority (84%) of rural respondents felt that fish and chicken (77%) 
were very beneficial in the management of their condition although a significant 
proportion were unsure of the benefits of Omega 3 (53%), Aspirin (66%) and 






Figure 4.24: Rural respondents opinion of the benefits of foodstuffs and   
  supplements 
 
4.2.5 Rural respondents’ knowledge of associated health conditions 
Most, 56 (77%), of the respondents from the rural area identified hypertension as 
commonly associated with diabetes. Forty-seven (65%) recognised obesity, 43 
(59%) equally identified cholesterol, heart disease and stroke as significant co-
morbities. A significant proportion, 29 (40%), of the rural respondents were unsure 
or disagreed with the association between depression and diabetes, 27 (37%) were 
unsure of  stroke and diabetes association, 26 (36%) heart disease and diabetes and 





Figure 4.25: Knowledge of the association of various health conditions with  
  diabetes among the rural respondents.  
 
4.2.6 Rural respondents’ knowledge of ocular complications  
The majority, 71 (97%), of the respondents from the rural areas agreed that 
diabetes could affect vision while two (3%)  disagreed or were unsure that diabetes 
could affect their vision. Many, 69 (95%), respondents agreed that diabetes could 
affect wound healing after injury, 45 (62%) agreed that diabetes could cause 
bleeding within the eye, 40 (55%) that diabetes could cause cataracts and 38 (52%) 
agreed that colour vision could be affected. Significantly, a high proportion, 46 
(63%), of rural respondents reported that they were not sure that diabetes could 
cause glaucoma, 42 (57%) were unsure of diabetes related squints, 32 (44%) that 
diabetes could affect colour vision, 30 (41%) that diabetes could cause cataracts and 
27 (37%) of rural respondents were unsure whether diabetes could cause bleeding 





Figure 4.26: Rural respondents knowledge of the ocular complications of diabetes. 
 
When rural patients were asked how important it was to have an eye examination 
even if they could still see clearly, 53 (73%) felt it was very important, 13 (18%) 
said it was important and seven (9%) felt that it was slightly important. Similarly, 55 
(76%) rural respondents felt it was very important to to have an eye examination 
even if their diabetes was well controlled, 14 (19%) felt it was slightly important and 
three (4%) indicated that it was not important. The majority, 48 (66%) of rural 
respondents did not know about laser treatment for diabetic eye disease while 25 
(34%) reported that they did.      
 
4.2.7 Rural respondents’ knowledge of management of diabetes  
The majority, 56 (77%), of rural respondents felt that their diabetes was under 
control while 17 (23%) felt that their condition was not. However, more than half, 
39 (54%), of respondents reported blood sugar levels of 7 – 10 mmol/l, six (8%) 
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reported that their sugar levels were in excess of 10 mmol/l while 26 (36%) 
reported normal sugar levels of less than 7 mmol/l. One respondent (1%) did not 




Figure 4.27: Rural respondents usual blood glucose level.  
 
Most, 59 (82%), respondents from the rural area had a glucometer while 13 (18%) 
did not. More than one quarter of the rural respondents, 21 (29%), reported that 
they measured their blood sugar daily, 20 (27%) measured it every second day, 21 
(29%) less than weekly and 12 (16%) measured their glucose levels only when they 
went to the doctor. The majority, 44 (60%), of respondents reported that they were 
treating their condition by oral medication, 22 (30%) by insulin injection and pills 
while 4 (5%) respondents treated their diabetes either by insulin alone or by diet 





Figure 4.28: The diabetes treatment modality of rural respondents. 
 
Many respondents, 44 (61%), from the rural area admitted that they did not 
exercise regularly while 28 (39%) reported that they did. Of those who reported 
exercising regularly, 36% reported exercising daily, 25% exercised 3-4 times per 
week and 39% 1-2 times per week. The majority, (61%),  of these respondents 
admitted to doing light exercises, 32% moderate (light sweat) exercise and 7% 
reported did heavy exercise, defined as out of breath. Most, 44 (61%), rural diabetic 
patients had received lifestyle advice for their diabetic condition. The advice on 
lifestyle was received from their GP (82%), dietician (41%), articles (27%), 





4.2.8 Rural respondents’ general diabetes management  
The majority, 52 (71%), of rural respondents stated that they usully followed a 
healthy diet aimed at better controlling their diabetes, 12 (17%) reported always 
following a healthy diet while nine (12%) respondents reported never following a 
healthy diet. Half, 36 (50%), of the respondents felt that their weight was 
acceptable for good control of the disease while the other half (50%) felt it was not. 
A high proportion, 61 (84%),  of the respondents reported not knowing their Body 
Mass Index (BMI) with only 12 (16%) knowing what their BMI was. The majority, 64 
(89%), of rural respondents took their medication as prescribed while eight (11%) 
did not. Similarly, 59 (82%) reported going for regular medial check-ups and 13 
(18%) did not. Also, 63 (86%) of rural respondents agreed that controlling their 
blood glucose levels may help prevent eye problems, nine (12%) were unsure and 
only one (2%) disagreed. About one third 27 (37%) of rural respondents reported 
having annual eye examinations while 46 (63%) reported not having them. 
4.3 RESULTS FOR THE URBAN RESPONDENTS 
4.3.1 Biographical information 
Of the sample total of 122, 49 (40%) were urban respondents. Their ages ranged 
from 33 to 80 years with a mean and median of 60 years (σ = ± 27.29 years) and a 
mode of 63. Their gender distribution was 47% males and 53% females. There were 
71% Whites, 27% Coloureds and 2% isiXhosa in the sample (cf. Figure 4.29). There 





Figure 4.29: The ethnic distribution of urban respondents. 
 
The majority, 35 (71%), of the subjects stated that they were English-speaking 
followed by Afrikaans, 14 (29%). There were no other languages indicated in the 
sample. The highest level of education in the sample ranged from 8 to 17 years of 
successful schooling, with a mean of 11.7 years (σ = ± 5.41) and median and mode 
of 12 years. Their weight ranged from 49 to 130 kilograms, with a mean of 82.7 (σ 
= ± 39.4) and median and mode of 80 kilograms. The height of the urban 
respondents ranged from 1.49 to 1.87 metres, with a mean of 1.76 metres (σ = ± 
5.01) a median of 1.7 metres and a mode of 1.6 metres. The mean of their Body 
Mass Index (BMI) was 29.9 (σ = ± 13.0) and median 28 and mode 27.  
 
4.3.2 Medical history 
The majority, 27 (55%), of the respondents stated that their general health was 
good, 20 (41%) considered their health to be average and two (4%) felt that their 
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health was poor. A significant proportion, 28 (57%) and 24 (49%) respectively 
reported that they were treated for hypertension and cholesterol problems while four 
(8%) and three (6%) respectively were treated for  lung problems and heart disease 
(cf. Figure 4.30). 
 
 
Figure 4.30: Associated medical conditions of urban respondents. 
 
The majority, 30 (61%), of the urban respondents reported having Type 2 diabetes, 
two (4%) reported having Type 1 diabetes and 17 (35%) did not know what type of 
diabetes they had. The urban respondents‟ latest blood glucose levels ranged from 4 
mmol/l to 17.5 mmol/l, with a mean of 7.65 (σ = ± 5.21) a median of 6.5 mmol/l 
and a mode of  8 mmol/l. One third, 16 (33%), of the respondents reported that 
they had their blood sugar reading taken the same day they completed the survey, 
seven (14%) the previous day, nine (18%) within the previous week, eight (16%) 
within the previous month and nine (18%) indicated that they could not remember 
when they had last measured their blood glucose levels. The mean duration of 
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diabetes treatment in the urban respondents was 8.04 years, with a median of 5 
years and a mode of 4 years. The majority, 37 (74%), of patients were diagnosed 
with diabetes by their GP, eight (16%) by specialist physicians, three (6%) by nurses 
and one (2%) each by an optometrist and unspecified other (cf. Figure 4.31). 
 
 
Figure 4.31: Diagnosis of diabetes in urban respondents. 
 
More than half, 27 (55%), of respondents reported that they were told about the 
importance of regular eye examinations when they were diagnosed with diabetes 
while 22 ( 45%) reported that they were not told. A significant proportion, 20 
(41%), reported no immediate family members with diabetes, 15 (31%) had 
mothers with the disease, 10 (20%) brothers (20%), nine (18%) sisters and eight 




4.3.3 Eye care 
Less than half, 21 (43%), indicated that they had an annual eye examination, 11 
(23%) reported that they had it two years previously, 10 (20%) three years prior, 
one (2%) four years ago and six (12%) were last examined more than four years 
ago (cf. Figure 4.32). 
 
 
Figure 4.32: Urban respondents previous eye examination. 
 
Nealy half, 24 (49%), of the urban respondents indicated that they had their last eye 
examination at the same practice, 18 (37%) were examined at another practice and 
six (13%) indicated that they were last seen by an ophthalmologist. In response to 
why they came to have their eyes tested, 23 (47%) respondents  indicated that it 
was for new glasses, 21 (43%) said it was because they were diabetic, seven (14%) 
reported that it was because their medical aid would pay, three (6%) said it was 
because they were referred by their GP and seven (12%) came for no particular 
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reason. Of the urban respondents, 31 (63%) knew where to go for their diabetic eye 
examination and 18 (37%) reported that they did not know.  
 
An overwhelming majority, 41 (84%), of urban respondents reported that cost was 
not a barrier to having their eyes examined with only 8 (16%) citing cost as a 
barrier. Similarly, 46 (94%) urban respondents indicated that taking time off work in 
order to have an eye examination was not a problem with only three (6%) reporting 
difficulty. Furthermore, 34 (69%) respondents reported that the cost of blood sugar 
testing was not a barrier to doing it while 15 (31%) indicated that it was. Just above 
half, 28 (57%), of urban respondents indicated that they had received adequate 
information about how diabetes could affect their eyes while a significant proportion, 
21 (43%), reported not receiving such information.  
 
The majority (63%) of urban respondents were interested in receiving general 
information about diabetes, followed by the effects of diabetes on vision (35%), 
dietary control (33%), exercise (29%), special precautions (26%) and the effects of 






Figure 4.33: Urban respondents information requirements 
 
Almost two-thirds, 32 (65%), of urban respondents would prefer to be given 
information about diabetes on a continuous basis, 15 (31%) preferred to be given 
information once while two (4%) respondents chose twice. When asked from which 
medical professional they would prefer to receive diabetic information, 27 (55%) 
respondents  preferred the information on diabetes to be provided to them by their 
GP, 20 (41%) indicated the optometrist, 7 (14%) preferred their ophthalmologist 
and specialist physician and 10% each preferred a nurse or pharmacist. In some 






Figure 4.34: The medical professional from whom urban respondents preffered to 
  receive diabetes information 
 
A significant proportion, (43%), of the urban respondents indicated pamphlets as 
the best source of information about diabetes, (31%) indicated books, (26%) 







Figure 4.35: The source of diabetic information preferred by urban respondents. 
 
4.3.4 Knowledge of diabetes 
Many, 34 (69%), of the urban respondents indicated there were two main types of 
diabetes, four (8%) thought there was only one type, seven (14%) thought there 
were more than two types and four (8%) did not know how many types of diabetes 
there were. Twenty-nine (59%) respondents thought that the disease was 
hereditary while 20 (41%) thought it was not. More than one-third, 21 (43%), of 
respondents felt that pregnancy could cause diabetes while 28 (57%) thought 
otherwise. The majority, 28 (57%), of the urban respondents agreed that diabetes 
could cause depression and/or anxiety while 17 (35%) were unsure and four (8%) 
disagreed. However, only one-third, 16 (33%), agreed depression and/or anxiety 
could lead to diabetes, while 21 (43%) were unsure and 12 (24%) disagreed. The 
majority, 30 (61%), of respondents were unsure that HbA1c was a very important 
test for diabetes while 19 (39%) thought it was very important. Significantly, 28 
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(57%) reported that daily blood glucose was a very important test, 19 (39%) were 




Figure 4.36: Urban respondents value of diabetic blood tests. 
 
4.3.5 Knowledge of diabetes management 
The majority, 44 (90%), of urban respondents felt that taking their medication 
regularly and as prescribed was a very important factor in the management of their 
condition, 42 (86%) agreed cessation of smoking was important, 36 (73%) 
maintaining a healthy diet and lifestyle, 32 (65%) effective weight management, 31 
(63%) felt regular exercise was important, 26 (53%) regarded regular medical 
check-ups and eye examinations as important while half, 24 (50%) felt  checking 





Figure 4.37: Urban respondents‟ ratings of importance to the various management 
  protocols for diabetes.    
 
When asked whether they knew enough about their condition to manage it 
themselves, 31 (63%) of the urban respondents replied in the affirmative and 18 
(37%) said they did not know enough about diabetes to manage it properly. The 
majority (82%) of urban respondents agreed that fish was a very beneficial part of a 
diabetes-orientated diet, followed by chicken (76%), Omega 3 (67%). In terms of 
Aspirin use 28 (57%) were unsure of the benefits followed by Cinnamon where 25 





Figure 4.38: Urban respondents‟ opinion of the benefits of Omega 3, aspirin and 
  cinnamon. 
 
4.3.6 Associated health conditions 
Most, 37 (76%), of the urban respondents reported obesity as commonly associated 
with diabetes, 34 (69%) associated hypertension, 28 (57%) cholesterol and 27 
(55%) heart disease. Significantly, less than half, 23 (46%), of urban respondents 
felt that stroke was commonly associated with diabetes while 22 (45%) were unsure 
of the association. Many, 35 (71%), were unsure of the association between thyroid 
disease and diabetes. Also, 31 (63%) of urban respondents were unsure of the 






Figure 4.39: Urban respondents‟ knowledge regarding the association between  
  diabetes and other conditions. 
 
4.3.7 Ocular complications of diabetes 
Almost all, 48 (98%), urban respondents agreed that diabetes may affect vision and 
only one (2%) did not know. Many, 34 (71%) and 27 (55%) respectively, were 
unsure that diabetes may cause a squint and could affect colour vision. The 
majority, 43 (88%), agreed that diabetes may affect wound healing after injury and 
26 (53%) each agreed that it may cause cataracts and bleeding and damage inside 





Figure 4.40: Urban respondents‟ knowledge of the ocular complications of  
  diabetes. 
  
The majority, 35 (74%), of the urban respondents reported that it was important to 
have an eye test even if they could still see clearly, 11 (22%) felt it was slightly  
important while three (6%) felt it was not important. Similarly, 36 (73%) 
respondents reported that an eye examination was important even if their blood 
glucose levels were well controlled, 10 (20%) felt it was slightly important while 
three (6%) felt it was not important. Most, 36 (73%), urban respondents did not 
know about laser treatment for diabetic eye disease while 13 (27%) did.  
 
4.3.8 Management of diabetes  
Thirty-five (71%), of urban respondents reported that they felt their diabetes was 
under control while 14 (29%) reported that it was not. Most, 41 (84%), of the urban 
respondents had a glucometer while eight (16%) reported not having one to test 
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their own blood glucose levels. However, only 19 (39%) reported testing their blood 
sugar levels daily and 14 (16%) respondents tested less than once a week. Less 
than half, 21 (43%), reported having blood sugar levels of less than 7 mmol/l, 18 
(37%) reported between 7 to 10 mmol/l, nine (18%) reported more than 10 mmol/l 





Figure 4.41: Usual urban blood glucose levels.   
 
Of the 47 respondents who answered this question most, 34 (72%), urban 
respondents were being treated by oral medication,  11 (23%) by both oral 
medication and insulin injection and one (2%) each were being treated by insulin or 





Figure 4.42: Urban respondents diabetes treatment modalities. 
 
More than half, 27 (55%), of urban respondents reported not having regular 
exercise while 22 (45%) did. Of the 23 respondents who reported that they 
undertook some exercise, 26% exercised daily, 48% exercised 3-4 times per week 
and 26% reported exercising 1-2 times per week. The majority (64%) of those who 
exercised did light exercise while  36% did moderate exercise. None reported doing 
heavy exercise, defined as out of breath. Many, 35 (71%),  respondents had 
received lifestyle advice for diabetes control while 14 (29%) had not. Of those who 
reported receiving this advice, 69% received it from their GP, 51% from a dietician, 
37% from articles, 20% from nurses, 14% from family or friend, 11% from an 




4.3.9 General diabetes management 
Of the urban respondents, 34 (69%) reported usually following a diet specifically 
tailored for diabetes, six (12%) reported always managing to follow a diabetic-
oriented diet while nine (18%) never did. Slightly more than half, 26 (54%), of 
respondents felt that their weight was about right for optimum diabetic control with 
23 (46%) reporting their weight was not optimal. The majority, 39 (80%), admitted 
to not knowing their BMI as opposed to 10 (20%) reporting that they knew what it 
was. The overwhelming majority, 46 (94%), took their medication regularly and as 
prescribed while three (6%) reported not adhering to instructions. Similarly, 42 
(86%) of the urban respondents went for regular medical check-ups and seven 
(14%) did not. A vast majority 46 (94%) of urban participants agreed that 
controlling their blood glucose levels would help prevent eye problems while three 
(6%) were unsure. Less than half, 21 (43%), of urban respondents reported that 














DISCUSSION AND RECOMMENDATIONS 
5.1 INTRODUCTION 
Diabetes is characterised by hyperglycaemia and the main treatment objective is the 
reversal of hyperglycaemia to blood glucose levels found in non-diabetic individuals. 
Alwan (1994: 2) notes that the aim of this treatment is to reduce the possible 
complications of diabetes. How to maintain normal levels of blood glucose is often 
dependent on the knowledge that diabetic patients have about the disease. The lack 
of knowledge about the disease can lead to possible systemic and ocular 
complications and can influence the overall treatment goal (Please 2007: 90 and 
Joshi & Joshi 2008:29). In this chapter the results of the research study will be 
discussed. This includes trends derived from the qualitative and quantitative 
findings. Key comparisons will be made between those patients in the rural area 
represented by Malmesbury and those urban patients represented by the 
metropolitan areas of Milnerton and Claremont. These comparisons will provide an 
indication of the knowledge of diabetes, its ocular complications and the 
management protocols in these groups. The chapter will conclude with limitations of 
the study and recommendations. 
The primary objectives of the study have been met. These were to determine the 
level of knowledge of diabetes and its‟ ocular complications in private sector 
patients, their management and treatment protocols and whether there was a 
difference in rural and urban results. The majority of respondents correctly identified 
171 
 
regular eye examinations as necessary but only one third actually adhered to this 
regimen. Despite the majority of respondents stating that they felt they knew 
enough about diabetes to manage their own condition, the results appear to indicate 
the contrary. The majority of patients reported their fasting plasma glucose levels to 
be above the WHO recommendation of ≤7 mmol/l. Patients‟ knowledge of the 
management and treatment protocols appeared also to be sub-optimal. There were 
differences between rural and urban respondents‟ knowledge and management 
protocols. Examples of the difference are that significantly more rural patients than 
urban were aware of the risk of stroke with diabetes, whilst average BMI and 
average weight was slightly higher in rural respondents than urban. Rural 
respondents were also more likely to be treated for hypertension than their urban 
counterparts and less likely to attend an annual eye examination. 
5.1.1 Biographical comparisons 
The overall average schooling was 11.88 years. The mean schooling (11.7 years) of 
the urban cohort was almost similar to that of the rural cohort (11.88 years). In 
terms of weight, the urban group had an average weight of 82.7 kg and an average 
Body Mass Index (BMI) of 29.9 kg/m2. In comparison, the rural average weight was 
91.14 kg with an average BMI of 31.26 kg/m2 and overall the average weight was 
87.74 kg with an average BMI of 30.7 kg/m2. This contrasts with previous studies by 
Shaper et al. (1997: 1311) who recommended that the optimum BMI for British men 
be 22 kg/m2, while James et al. (2001: 228) advocated a limited range of healthy 
BMI to be between 18.5 and 22.9 kg/m2. The figures in the current study indicate 
that the BMI‟s of the diabetic patients were significantly above the recommended 
levels which raises concern for their overall health in both the short and medium 
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term. This strengthens conventional policy that raised BMI is indicative of obesity 
which is associated with diabetes. Medical professionals who diagnose patients with 
diabetes should inform and educate them about the significance of Body Mass Index 
and health care professionals managing diabetic patients should stress weight 
management as part of a continuous education programme for the patient. 
5.1.2 Medical history 
The overall percentage of those who reported having hypertension was 62%. Sixty- 
six per cent of rural respondents reported having hypertension compared to the 
57% of their urban counterparts. Patients were on treatment for high cholesterol in 
53% of the total respondents with rural respondents being higher with 56% and 
urban at 49%. One possible explanation for this resides in a study by Steyn et al. 
(1996: 479-484) who examined three founder-related LDL (Low Density Lipoprotein) 
cholesterol receptor gene mutations causing familial hypercholesterolaemia in 
Afrikaners. Since 86% of the rural sample indicated that Afrikaans was their 
preferred language the inference is that they could have higher cholesterol levels. 
Further research needs to be conducted to determine the reason for a higher 
prevalence of these conditions in rural areas than urban. Fifty three per cent of the 
total sample reported having Type 2 diabetes. Forty seven per cent of the rural 
respondents indicated that they had Type 2 diabetes while 61% of the urban group 
reported having Type 2 diabetes. Of concern is the significant amount (43%) of 
respondents who reported that they were uncertain of the type of diabetes they had. 
This was more evident in the rural group where many (49%) did not know the type 
of diabetes they had. While many of the urban group knew their type of diabetes 
(65%), a significant proportion (35%) was unsure which type of diabetes they had. 
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These results have serious implications for long term management of the condition 
which would be challenging if the diabetic patient did not know what type of 
diabetes they had. Similarly, one wonders how diabetic patients seek advice and 
information about their condition when they do not know exactly what their 
condition is. The Freemantle Study by Bruce et al. (2003: 82-89) observed that 
those diabetics who were better informed were most likely to visit dieticians and 
maintain self-monitoring programs. It is therefore recommended that once patients 
are diagnosed with diabetes, their condition should be explained to them in lay 
terms so that it is clearly understood. In doing so, health professionals need to take 
cognisance of cultural and language differences. During follow-up visits this 
information needs to be reinforced. 
The WHO criterion for the diagnosis of clinical diabetes is fasting plasma glucose of 
≥7.0 mmol/l (Alberti and Zimmert, 1998: 539). The majority (47%) of patients 
overall reported that their usual blood glucose measurement was between 7 and 10 
mmol/l which is higher than the WHO recommendations. A further 12% were higher 
than 10 mmol/l, resulting in a total of 59% of patients with less than optimally 
controlled blood glucose levels overall. Fifty-four per cent of the rural group 
measured between 7 and 10 mmol/l, with a further 8% above 10mmol/l indicating 
that 62% of patients had habitual measurements of greater than 7 mmol/l. Of the 
urban group, 37% had a habitual measurement between 7 and 10 mmol/l with an 
additional 9% measuring above 10mmol/l resulting in 46% being over the 7 mmol/l 
limit. The results of this study indicate that the urban group had a lower average 
blood glucose reading than their rural counterparts (7.65 mmol/l for the urban 
respondents versus 8.67 mmol/l for the rural respondents). Although the urban 
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cohort had lower average blood glucose levels than the rural cohort, both groups 
had levels above those recommended for optimum blood glucose control. It would 
thus appear that, notwithstanding the lower mode (7mmol/l) in rural participants, 
the rural patient was less than optimally compliant or managed in order to keep their 
blood glucose levels within the recommended levels. This implies that rural patients 
would be more at risk for long term complications of diabetes than their urban 
counterparts. A possible explanation for the disparity between the rural and urban 
average blood glucose levels is that the average weight of the rural participants was 
91 kilograms as opposed to the average weight of the urban respondents of 82 
kilograms. Furthermore, the difference in BMI (31.2 for rural and 29.9 for urban 
respondents) is an additional explanation for the disparity and may be indicative of a 
different diet philosophy between the two groups. The high averages could be linked 
to the frequency of blood glucose measurement, where an overall low proportion 
(33%) of patients tested their blood glucose on a daily basis. Twenty-nine per cent 
of rural patients tested their blood sugar daily as opposed to 38% of urban patients. 
Irregular or not testing can mask rises in blood sugar purely because the patient is 
unaware of their blood glucose levels, allowing the diabetic patient to continue with 
an unabated incorrect eating plan or lifestyle. This could possibly be due to apathy 
or ignorance as almost 82% of the respondents reported having a glucometer and 
69% did not think the cost of measuring blood glucose levels was a barrier to 
testing. It is therefore recommended that diabetic patients should be advised to visit 
their medical professionals on a more regular basis and that regular blood glucose 
monitoring should occur and results reviewed with the health care practitioner at 
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each visit. Reinforcement of the importance of regular blood sugar testing should be 
done at each visit to their medical professionals. 
The study demonstrated that seventy-five per cent of all diabetes diagnoses were 
done by their general practitioners (GP). The GP was also rated as the most 
preferred health care practitioner from whom diabetic information should be 
received. The GP therefore carries more responsibility with regard to the 
dissemination of information and continued management of the diabetic patient. 
Overall, 40% of patients reported that they were not informed about the need for 
regular eye examinations when they were first diagnosed with diabetes. Of these, 
many (45%) were urban respondents while 27% were rural respondents. A possible 
explanation for this is the anecdotal evidence that in busy urban medical practices 
most general practitioners see a patient every 15 minutes, a situation not unique to 
the South African medical fraternity (Ogden et al. 2004: 479-483). This affords the 
GP little time to carefully explain important concepts such as presenting for annual 
eye examinations. The pace of practice in the rural areas is possibly a little slower 
which allows for better patient communication. This concept becomes more 
important when patient knowledge about the ocular complications of diabetes is 
examined. The health care practitioner responsible for the diagnosis of diabetes 
should ensure that patients are advised about the need and reasons for regular eye 
examinations. The potential ocular complications should be explained to the patients 




Overall, only 32% of participants reported that they had an eye examination during 
the previous year. This figure was 24% for rural respondents and 43% for urban. 
This was despite 88% of participants indicating that regular eye examinations were 
either „very important‟ or „important‟ and 97% of patients reporting that diabetes 
could affect their vision. More significantly was that all the participants agreed that 
diabetes could affect their eyes and 89% of the total group agreed that controlling 
diabetes could help prevent eye problems. Although Brechner et al. (1993: 1714) 
recommends that all diabetic patients should have an annual dilated fundus 
examination, in the South African context the normal allowance/dispensation for 
those on medical insurance is one eye examination every two years. Considering 
that the study sample consisted of those who were on medical insurance or privately 
funded their medical treatment it was expected that the rate of eye examinations 
would be greatest after two years in order to be in line with health insurance 
guidelines. This, however, was not the case as fewer patients presented after two 
years than those that had annual eye examinations (30%). Of note was that 68% of 
patients had eye examinations at greater than annual intervals. The inference is that 
either apathy or ignorance, perhaps through a lack of diabetic counselling, is 
responsible for this phenomenon as 80% of respondents reported that cost was not 
a barrier to having an eye test. This is reasonable given that their health insurance 
would pay for an examination. The fact that 40% of the respondents were not 
informed about the need for regular eye examinations could have contributed to this 
result. Medical professionals and other health care practitioners should therefore 
emphasise the importance of annual eye examinations. Secondly, health insurance 
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companies should be advised to apportion appropriate funding to provide annual eye 
examinations specifically for diabetic members. This would benefit the medical 
insurance companies as ocular and systemic complications would be managed more 
cost effectively if identified and treated at an earlier stage. 
5.1.4  Knowledge of diabetes and its systemic complications 
The majority (61%) of respondents knew of only two types of diabetes. In this study 
there were no respondents who had gestational diabetes or were pregnant, which is 
a possible explanation for their lack of knowledge regarding this form of diabetes. 
More than 62% of participants felt that pregnancy was not associated with diabetes 
indicating that very few patients knew about gestational diabetes. The 
recommendation is that all pregnant patients should be counselled regarding the 
potential for gestational diabetes. Whilst a pregnant patient‟s weight is normally 
constantly monitored the reasons for this should be elucidated in prenatal 
consultations. Those who do contract gestational diabetes should be counselled 
further that they are at high risk for developing Type 2 diabetes and possibly at an 
earlier age than expected and that those at risk should be observant for signs and 
symptoms of the disease. This has long term dietary implications and BMI awareness 
is therefore essential. 
Overall, 60% of patients felt that diabetes was linked to heredity factors. This is 
important as those with diabetic family members need to be made aware of the 
potential for diabetes and manage their lifestyles accordingly. Health practitioners 
should council their diabetic patients about this important concept.  
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Studies have shown that diabetes has the potential to cause significant mental 
health problems, including depression (Ciechanowski, 2000: 3278 and Mezuk et al. 
2008: 2383). A recent study by Pan et al. (2010: 1884 – 1891) provides compelling 
evidence of the bidirectional association of diabetes and depression. Fifty-nine per 
cent of the overall respondents agreed that diabetes could cause depression and/or 
anxiety leaving a significant proportion (41%) that disagreed or were unsure. A 
general depressive state will leave diabetic patients unmotivated to maintain and 
closely follow treatment regimens as prescribed by their medical practitioners. 
Symptoms of depression include lethargy (Rodin and Voshart, 1986: 696 – 705) and 
consequently patients are reluctant to exercise and have sub-optimal self-care which 
includes eating and taking their medication (Lin et al. 2004: 2154 – 2160). All 
members of the health care team should be aware of the potential for depression 
associated with diabetes and close relatives should be counselled accordingly. Health 
care providers should be cautious with their patients on depression treatment and a 
careful ocular case-history should be taken. When examining patients already 
diagnosed with diabetes, health practitioners should be aware of the signs of 
depression and refer appropriately.  
The test for glycolated haemoglobin, also known as the HbA1c test, has become 
more significant in recent times (Sato et al. 2009: 644). Many clinicians have been 
using this test as a diagnostic tool for clinical diabetes as opposed to the random 
instant blood glucose test (Inoue et al. (2008: 1157). The majority of participants in 
this study were not familiar with the test and 62% were unsure of its importance. 
The implication of this finding is that diabetic patients are not informed as to the 
value of the HbA1c test as a measure of their disease progression and their blood 
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glucose control. This in turn has treatment implications where a delay in the 
utilisation of insulin as a means of tighter blood glucose control could result in 
diabetic eye disease, nephropathy or neuropathy. Heisler et al. (2005: 816 – 822) 
reported a marked improvement in self-management of diabetes when patients 
knew their HbA1c.  Forty-three per cent of the urban participants were either unsure 
of the importance of daily fasting blood glucose test or disagreed that it was 
important with urban candidates marginally more certain of the importance than 
their rural counterparts. Also, when patients were asked how important it was to 
check blood sugar on a daily basis, 54% thought it to be „very important‟. This, 
nevertheless, represents only slightly more than half of all participants. A possible 
explanation for this is that many patients are afraid to monitor their blood glucose 
readings for fear that they may be too high. This would then imply that their 
treatment should be intensified and that their condition had worsened. There is, 
furthermore, a possible psychological impact involved with the advent, or worsening 
of, depression (Mezuk et al. (2008: 2383). Notwithstanding the low numbers who 
tested daily, many respondents (82%) reported owning a glucometer. Diabetic 
patients should be encouraged to use their glucometers on a daily basis which will 
enable patients to monitor their blood glucose levels and to keep a diligent record of 
their readings. This is important in the management of their diabetic condition and 
should be emphasised by health care practitioners in their dealings with diabetic 
patients. Health insurance companies should be advised to provide glucometers and 
measuring sticks to their members as part of their health benefit package along with 
the necessary medication. Furthermore, all members should be encouraged to have 
a 3-monthly HbA1c blood test in order to properly monitor their glycolated 
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haemoglobin levels and endeavour to maintain this at ≤ 6.5%. This would improve 
the knowledge base of diabetic patients, 62% of whom in this study were unaware 
of the importance of the HbA1c test.  
The majority of participants in this study recognise the importance of regular 
exercise. More than 95% rated this factor as very important or important, however 
only 41% of the respondents reported that they exercised regularly. The benefits of 
exercise in terms of weight and BMI management as well as for the general 
circulation have been reported in several publications (Joshi and Joshi (2008: 22, 
Mozaffarian et al. (2009: 798).  Health care workers should be advised to make 
every effort to encourage their patients to exercise to the best of their abilities. For 
example, simple exercises such as brisk walking for 30 – 40 minutes three to four 
times a week should be advised as they do not have a cost factor compared to 
monthly gym subscriptions.   
5.1.5 Health management 
Despite their reported average blood glucose levels, 67% of all respondents felt that 
they knew enough about diabetes to manage their own condition. Abram (1972:659) 
has reported that regression, denial, and intellectualisation, (along with projection, 
displacement and introjection) are part of the coping mechanisms of chronic 
illnesses. These typically lead to depression which has strong links to diabetes 
(Ciechanowski, 2000: 3278 and Mezuk et al. (2008: 2383). The results of this study 
suggest that these patients may be incorrect in the assumption that they knew 
enough about diabetes in order to manage their own diabetic condition. Heath care 
practitioners should be aware of this and reinforce knowledge-empowerment 
181 
 
whereby patients are given facts in a way that they are comfortable with. In this 
manner existing knowledge can be used as a foundation for increasing knowledge 
through information. 
The benefits of Omega 3 fatty acids on general health have been reported in several 
studies (Hu et al. 2003: 1852). These benefits should be considered alongside the 
study by Glauber et al. (1988: 663 – 668) which cautioned that Omega 3 may give 
rise to hyperglycaemia. Two-thirds (67%) of those in the urban areas were aware of 
the benefits of Omega 3 fatty acids while approximately half (53%) of the rural 
patients were unsure. One possible explanation is that the majority of health 
magazines and articles are written in English. With the high proportion (86%) of the 
rural respondents being Afrikaans, fewer are likely to choose an English magazine to 
obtain health information.  Moreover, 76% of the overall respondents were unsure 
or indicated that there was no benefit of aspirin use in diabetes management. A 
possible explanation is that this may not have been discussed with them by their GP 
due to the limited time at his or her disposal. Many patients are therefore not 
exposed to the possible beneficial effects of regular aspirin use, especially in terms 
of coronary heart disease prevention. Hennekens et al. (2004: 2752) recommend 
that clinicians follow the guidelines of the American Diabetes Association to reduce 
the risks of cardiovascular disease in patients with diabetes by making use of low 
dose aspirin. With regard to nutritional supplementation, fifty-two per cent of all 
respondents were unaware of the benefits of cinnamon as a supplement in the 
diabetic diet. A possible explanation for this may be that many GP‟s and health care 
practitioners are possibly unaware of the benefits of cinnamon and/or are reluctant 
to advocate the use of so-called “natural” supplements. Furthermore, diabetic 
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patients may not have read about it in the various articles on the subject that appear 
in magazines or not have been to a dietician who could have advised them 
accordingly. Khan et al. (2003: 3215) demonstrated that the regular intake of 1 – 6 
grams of cinnamon each day reduced the risk factors associated with diabetes and 
cardiovascular diseases. More recently, Akilen et al. (2010: 1159) have shown that 
the daily intake of just 2 grams of cinnamon for 12 weeks significantly lowered 
HbA1c levels as well as reducing BMI and blood pressure. 
In terms of general health management issues in this study, the results suggest that 
there are areas where patients are lacking in knowledge to optimally manage their 
own condition. This is despite the fact that many patients reported that they are 
knowledgeable enough about their condition. This study therefore supports the 
recommendation that health care practitioners should recommend the use of 
supplements such as cinnamon and Omega 3 as part of a healthy diet and anti-
platelet medications such as aspirin where appropriate. These products have been 
reported to improve the cardiovascular prognosis of the diabetic patient (Akilen et al. 
2010: 1159; Hu et al. 2003: 1852 and Hennekens et al. 2004: 2752). 
5.1.6 Associated health conditions 
In general the participants in the study had adequate knowledge of obesity and 
hypertension associated with diabetes. The hypertension knowledge is reflected in 
the total number (62%) of respondents indicating that they were being treated for 
this condition. A possible explanation for knowledge of obesity association with 
diabetes can be found in the average weight and BMI of the respondents which was 
well above the optimum. This would have made the majority of respondents aware 
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of their adiposity and a weight loss programme may possibly have been suggested 
to them by their GP. With regard to thyroidopathy, the use of the drug metformin in 
Type 2 diabetes has been reported to result in a drop in thyroid stimulating hormone 
production. (Cappelli et al. 2009: 1589). Eighty-five per cent of participants in this 
study were either unsure or reported that thyroidopathy was uncommon in diabetes. 
Fifty-three per cent of urban respondents thought that stroke was uncommon in 
diabetes or were unsure while 59% of their rural counterparts thought it was a 
common occurrence. This is in conflict with studies by Barrett-Conner and Khaw 
(1988: 116) who reported that diabetes may confer excess risk of stroke 
independent of blood pressure. The results of this study indicate that many diabetic 
patients were unsure of the association between these systemic conditions and 
diabetes. This suggests a need for health care practitioners to be proactive and 
observant to ensure that appropriate clinical tests are carried out along with risk-
appropriate counselling to advise patients about the potential systemic health threats 
of diabetes. Furthermore, diabetic patients and their family members should be 
counselled to recognize the signs and symptoms of stroke in order to act 
immediately if these manifest. 
5.1.7 Knowledge of the ocular complications of diabetes 
With regard to the ocular complications of diabetes, three-quarters (75%) of 
patients regarded having an eye examination as very important even if they could 
still see clearly or their diabetes was well-controlled. However, only one third 
indicated that they had undergone an eye examination within the previous year. This 
could indicate that diabetic patients are not adhering to the recommendations for 
annual eye examinations even though they are aware of their importance, or 
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patients are not being adequately advised in this regard. This suggests that the 
diagnosing clinicians should advise their patients on the need for regular 
examination. It could also suggest that the GP‟s (who were the majority clinicians in 
terms of diagnosing diabetes) were not informing them about the ocular 
complications of diabetes and therefore the need for regular eye examinations. 
Almost all (97%) participants thought that diabetes could affect their eyes. An 
explanation for this could be that often diabetic patients hear non-specific references 
to the effect of diabetes on the eyes. This might be from their GP, an optometrist, a 
fellow diabetic or an article in a magazine. With regards to the exact effects of 
diabetes on the eyes, a large proportion of respondents were less certain of the 
specific effects. Lakowski et al. (1972: 145) demonstrated that colour vision testing 
was useful in predicting minor retinopathies in diabetic patients under 30 and over 
60 years of age. In 1987, Daley et al. (1987: 777) showed that there existed an 
early loss of blue-sensitive vision in Type 1 diabetes, due to nerve fibre layer 
degeneration specific to the blue-yellow colour sensitivity. Overall, 47% indicated 
that diabetes could affect colour vision, with 52% being from the rural group and 
41% from the urban group. A possible explanation for this is that, in this study, the 
optometrist in the rural area has a keen interest in the diabetic condition and 
conducts regular colour vision testing and explains the reason for this. The 
neurological effect of diabetes has ocular manifestations when cranial nerves III, IV 
and VI are affected, resulting in a strabismus-induced diplopia (Sukha and Rubin, 
2007: 120 and Records, 1970: 709). In terms of the effects of diabetes on extra-
ocular muscle innervation, eighty per cent of the overall respondents either 
disagreed or were unsure that diabetes could lead to a squint. Only one quarter 
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(25%) from the rural group and 10% of the urban group were of the opinion that 
diabetes could cause a squint, indicating further evidence of lack of knowledge of 
the ocular consequences of uncontrolled diabetes.  A possible explanation of this is 
that those diabetic patients presenting to an optometric practice are not generally 
seen by ophthalmologists until such time as they have been referred. In an 
ophthalmology practice, diabetic-induced strabismus would be more readily seen and 
consequently more patients would be aware of the occurrence.  
 
Just over half of the total sample (54%) agreed that diabetic patients were likely to 
develop cataracts although a significant proportion of patients were either unsure or 
disagreed. Cataracts are commonly encountered in diabetes and represent a 
significant cause of vision loss which is relatively easily corrected (Lang, 2000: 167). 
Sixty three per cent and 53% respectively, of the rural group and urban group were 
unsure of the possibility of diabetes-related glaucoma. One possible explanation for 
this is that an ophthalmology practice is more likely to see more diabetes-related 
glaucoma than an optometric practice and patients attending are therefore more 
likely to be aware of the relationship between diabetes and glaucoma. The Beaver 
Dam Study showed that the presence of open angle glaucoma is increased in older-
onset diabetes (Klein et al.: 1994: 1173 – 1177) however it is unlikely that lay 
persons would be aware of this unless specifically informed by a health care 
practitioner. Diabetic patients visiting an optometric practice should therefore be 
carefully screened for any signs of glaucoma and GP‟s should recommend that their 
diabetic patients be screened for the condition.  
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Diabetic retinopathy, described as „bleeding and damage inside the eyes‟ in the 
questionnaire, was understood to be a danger by many respondents. In total 58% 
agreed that diabetes could lead to retinopathy, with 62% of the urban cohort in 
agreement. Significantly, more than two-thirds (69 %) of the overall respondents did 
not know about laser treatment for diabetic eye disease, with 73% of the urban 
group reporting that they did not know. 
It is incumbent upon the health care practitioner that diabetic patients should be 
extensively informed about the ocular risks of diabetes and the importance of an 
annual eye examination. Furthermore, when presenting for an eye examination 
diabetic patients should be carefully monitored for colour vision defects, optic nerve 
head damage, intra-ocular pressure, retinopathy and oculomotor function. Fundus 
photography should be employed as it provides a permanent record to track 
progress and for interdisciplinary referral. It is also an invaluable teaching tool for 
diabetic patients.  
5.1.8 Management of diabetes 
The majority of respondents (75%) felt their diabetes was under control. This 
contradicts the results on the average blood glucose levels, where the average blood 
glucose of the total group was above 8 mmol/l. This is an indication that the 
knowledge of diabetes of the group is sub-optimal and contradicts the 67% of 
respondents who felt that they knew enough about their condition to manage it on 
their own. The results of this study show that 27% of the overall group were being 
treated by insulin injection and pill. A possible explanation for this is that oral 
medication alone was not sufficient to control their blood glucose levels. Nathan et 
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al. (2006: 1963 – 1972) report that when tight blood glucose control is lacking, 
insulin as an adjunct therapy is the most effective form of diabetes medication that 
lowers glycaemia. Initially in their disease, Type 2 diabetic patients compensate for 
increased insulin resistance by increasing pancreatic beta-cell insulin secretion. 
When this compensation is no longer adequate to overcome the insulin resistance, 
blood glucose escalates progressively. As the disease progresses, insulin levels 
slowly become reduced with the result that most patients with Type 2 diabetes are 
unable to achieve optimal glycaemic control with oral agents alone. This is a process 
taking, on average, up to 15 years (Mudaliar and Edelman, 2001: 1 – 2). Insulin can, 
when used in adequate doses, decrease any level of hyperglycaemia to, or close to, 
the therapeutic goal. This inexorable progression notwithstanding, tight initial 
glycaemic control and later insulin therapy contributes to fewer long-term side 
effects due to prolonged hyperglycaemia. 
The beneficial effects of exercise have been reported in studies conducted by, 
amongst others, Nadeau et al. (2009: 3687 – 3695) and Madden et al. (2009: 1531). 
Fifty-eight per cent of total respondents indicated that they did not exercise 
regularly. This figure rose to 61% in the rural group, whose average blood glucose 
and BMI were also greater, indicating an apparent correlation between exercise and 
blood glucose levels. Health care practitioners need to consider the effects of 
depression in diabetes and consider whether this may contribute to the lack of 
exercise due to lethargy, poor eating habits and feelings of inadequacy. Almost 75% 
of the respondents reported having had lifestyle advice for diabetes control, the 
majority of which advice was from their general practitioner and dietician. GP‟s were 
almost twice more likely, though, to be consulted for this advice than dieticians. 
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Given the constraints on the time of general practitioners, it is hardly likely that the 
dietary advice received from them would be at the same level as that from a 
dietician. Therefore, diabetic patients should be encouraged to seek lifestyle advice 
from as broad a field as possible and that this advice include dietary 
recommendations from a dietician. Dieticians should form a more significant part of 
the diabetes team and health insurance providers should take cognisance of their 
value in the management of the condition. 
When asked whether they followed a diet aimed at controlling their diabetes, the 
majority (70%) of the overall patients reported „usually‟. This is a positive aspect and 
implies that diabetic patients are taking the dietary advice from their GP and 
dietician seriously. However, almost half (49%) of the respondents felt their weight 
was not ideal for the effective control of diabetes. This appears to tie in with the 
82% of respondents that did not know their BMI. The importance of Body Mass 
Index (BMI) in diabetes control has been reported in several studies (Cole et al. 
1990:25 and National Obesity Observatory, 2009:5). The average BMI of all 
respondents in this study (30.7 kg/m2) is far higher than the recommended 22kg/m2 
(Shaper et al. 1997:1311) which correlates with the average fasting plasma glucose 
of the total group (8 mmol/l). GP‟s and other diabetes health care practitioners 
should inform their patients of the importance of BMI awareness and educate their 
patients about the value of observing their BMI status and using it as a valuable tool 
for monitoring their condition. Patients should be encouraged to know their weight 
and height and calculate their BMI by dividing their weight by the square of their 
height in metres. 
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Many of both the urban and rural patients agreed that controlling their diabetes 
would help to prevent eye problems. It raises the question, however, why only one-
third of participants presented for an annual eye examination? This could, perhaps, 
be due in part to the high proportion of patients who feel that their diabetes is under 
control and therefore did not go for regular eye examinations. Also, many felt that 
they knew enough about diabetes to manage their own condition. However, this 
could indicate that the patient is in the denial phase of the disease and that diabetic 
patients should move beyond this phase of the disease and make use of the advice 
given by their health care practitioner. This includes annual eye examinations and 
regular medical check-ups.  
It must be stressed that the role of the optometrist is particularly important in the 
management of the diabetic patient. Optometrists are ideally positioned to counsel 
diabetic patients and to educate them regarding the potential ocular damage 
resulting from diabetes. Optometric training institutions should provide further 
education in the form of continuous professional development programmes for 
existing practitioners to empower them with the knowledge about ocular 
complications of the disease. The United Kingdom has extensive programmes to 
facilitate the up-skilling of their optometric practitioners and one such programme is 
designed to enable the optometrist to be registered as a diabetes co-management 
practitioner. If implemented in South Africa, such a programme will enable 
optometrists to co-manage diabetic patients with other health care professionals on 
a more formal basis.  
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5.2 SUMMARY OF RECOMMENDATIONS 
The aim of this study was to determine the management regimens and level of 
knowledge of diabetes and its‟ ocular complications among private sector diabetic 
patients. The overall goal of the study was to enhance the role of the Primary Care 
Practitioner, including the optometrist, in performing a constructive supporting 
service in the overall management and care of the diabetic patient in private 
practice. From data derived from the study and in order to fully achieve these goals 
the following recommendations arose from the study: 
5.2.1  Health Care Practitioners 
The following recommendations pertain to the various health care practitioners 
involved in the management of the diabetic patient: 
 Medical practitioners, when diagnosing diabetes, should inform and educate 
their patients about the significance of Body Mass Index. When the diagnosis 
of diabetes is made, the condition needs to be explained to patients in 
simple/lay terms so that they can understand their condition better. Health 
care professionals need to take cognisance of cultural and language 
differences. During follow-up visits this information about diabetes needs to 
be reinforced.  
 The health care practitioner who diagnoses the diabetes needs to ensure the 
patient is informed of the need for regular eye examinations and, secondly, 
the reasons for this need. The potential ocular complications should be 
explained to the patient and reinforced at each subsequent visit. At diagnosis 
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patients should be extensively informed about the ocular risks of diabetes and 
that annual dilated eye examinations or fundus photography was essential.  
 Health care practitioners should be advised to recommend the use of 
supplements like cinnamon and Omega 3 as part of a healthy diet and, where 
appropriate, anti-platelet medications like aspirin to improve the 
cardiovascular prognosis of the patient. 
 All members of the health team should be aware of the potential for 
depression-linked diabetes and diabetes-linked depression. Health 
practitioners should be cautious with their patients on depression treatment 
and careful ocular case history should be taken. When examining those 
patients already diagnosed as diabetic, health practitioners should be aware 
of the signs of depression and refer appropriately.  
 Diabetic patients who have glucometers should be encouraged to use them. 
Those diabetic patients without glucometers should be advised to obtain one. 
Most pharmacies supply glucometers either free or at a low cost and the 
patient merely has to purchase the measuring sticks. Patients should be 
educated in the use of these instruments and the monitoring of the results. 
 Health care workers should make every effort to encourage their patients to 
exercise to the best of their individual ability, with brisk walking 3 – 4 times 
per week for 30 – 40 minutes the preferred mode.   
 Health practitioners should ensure that appropriate clinical tests are carried 
out along with appropriate counselling to advise patients about the potential 
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systemic health conditions associated with diabetes. Practitioners should 
utilise a process of knowledge-empowerment whereby patients are given 
enough information about their condition in a way that they understand and 
are comfortable with. 
 Diabetic patients should be encouraged to seek lifestyle advice from as broad 
a field as possible and that this advice include dietary recommendations from 
a dietician.  
 Diabetic patients should be encouraged to join support groups and mailing 
lists where information about diabetes can be shared in order to effectively 
manage their condition. In this regard, health care practitioners should 
emphasise the role of Diabetes SA, a non-governmental organisation, as a 
valuable information source. 
 When presenting for an eye examination patients should be carefully 
monitored for colour vision defects, optic nerve head damage, intra-ocular 
pressure, diabetic retinopathy and oculomotor function. Fundus photography 
should be employed by practitioners as it provides a permanent record and is 
an invaluable teaching tool for diabetic patients.  
 Optometrists are ideally placed to counsel diabetic patients and to educate 
them regarding the potential ocular damage resulting from diabetes. In this 
regard Optometric training institutions should provide further education for 
existing practitioners to become diabetes co-management practitioners. This 
could also form part of an on-going Continuing Professional Development 
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(CPD) programme, where accreditation is achieved, or as a post-graduate 
diploma. 
5.2.2 Institutional Bodies  
The following recommendations pertain to the institutional bodies involved in 
diabetes care and include Health Insurance companies and statutory bodies like the 
Health Professions Council of South Africa, the Board of Healthcare Funders and the 
South African Optometric Association: 
 Health insurance companies should recognise the importance and benefits of 
annual eye examinations and apportion appropriate funding to provide annual 
eye examinations for all diabetic members, based on sound cost-benefit 
analysis of the effects of diabetes. 
 Health insurance companies should be advised to provide glucometers and 
measuring sticks to their members as part of their health benefit package 
along with the necessary medication as Prescribed Minimum Benefits.  
 Health insurance companies should require of and reward members to 
undergo a 3-monthly HbA1c blood test in order to properly monitor glycolated 
haemoglobin levels and endeavour to maintain this at ≤ 6.5%. 
 Dieticians should play a more significant role in the diabetes team and that 
health insurance providers take cognisance of their value in the management 
of the condition. The cost-benefit to health insurance companies of diet-
compliant diabetic patients is something that the Professional Board for 
Dieticians should be highlighting. 
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 The Health Professions Council of South Africa (HPCSA) via the Professional 
Board for Optometry and Dispensing Opticians (PBODO) should invite 
optometric training institutions to offer advanced studies in diabetes co-
management in co-operation with ophthalmology and departments of internal 
medicine and the PBODO should compile minimum standard guidelines for 
optometric co-management of diabetic patients. 
 The Department of Health should utilise the positive role optometry could play 
in diabetes management and facilitate programmes in this regard. These 
programmes should be informative for the public at large. Secondly, the 
Department of Health should make funding available for the further training 
of optometrists to become diabetes co-management practitioners. 
 The South African Optometric Association (SAOA) needs to lobby at statutory 
level and act as liaison between the Ophthalmological Association of South 
Africa (OSSA) and the PBODO in order to facilitate progress on the role of 
optometrists in diabetes co-management. The SAOA should also launch a 
public awareness campaign to educate diabetic patients on the advantages of 
an annual eye examination. 
It is proposed that the recommendations of this study will be disseminated by means 
of journal articles, lectures and direct approaches to the PBODO, SAOA and Western 
Cape Department of Health. 
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5.3 LIMITATIONS OF THE STUDY 
The study is limited to two main areas in the Western Cape and it is acknowledged 
that this narrow band of sample selection renders the results ungeneralisable to the 
wider population. It does however indicate certain statistical trends which are 
important and worthy of further and deeper investigation. 
Many respondents appeared unfamiliar with certain phraseology in the 
questionnaire. While some terminology was deliberately used in order to test the 
knowledge of the respondent in respect of diabetes management and ocular 
complications of diabetes, certain concepts like Body Mass Index (BMI) were 
sometimes confused with Body Mass. 
Whilst this was essentially a quantitative study, certain qualitative measures may 
have been beneficial in order to obtain a wider perspective. These include interviews 
with GP‟s and other health care practitioners involved in the care of the diabetic 
patient.  
5.4 RECOMMENDATIONS FOR FUTURE STUDY 
A similar study to this involving a broader regional base and thereafter on a national 
scale will make findings more generalisable to the wider diabetic community. 
A qualitative study involving all members of the health care team involved in diabetic 
patient management would provide a valuable augmentation to this study. Such 
study would ideally involve input from, inter alia, GP‟s, dieticians, physicians, 
ophthalmologists and optometrists. 
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5.5  CONCLUSION 
This research commenced with a comprehensive literature review followed by 
development of the patient questionnaire and the analysis of the data. The aims and 
objectives of the study were subsequently realised and based on these 
recommendations have been made. In conclusion, the following can be highlighted: 
The results of this study indicate a clear trend where diabetic patients are not well-
informed or knowledgeable about the disease of diabetes as well as the possible 
consequences of the condition. This appears true for both the management of the 
disease as well as the ocular complications, despite many respondents feeling that 
they knew enough about their condition to self-manage. 
The literature provides clear evidence that increased, or enhanced, knowledge of 
diabetes facilitates greater compliance with management of the disease (Assal et al. 
(1985: 602). This results in potentially tighter blood glucose control with the 
associated long term benefits. Patient education and knowledge reinforcement is an 
essential part of diabetes care and management and, in the South African context, is 
particularly culturally sensitive. Furthermore, cognitive decline in the ageing 
population is exacerbated by uncontrolled plasma glucose levels. In this regard the 
importance of diet, exercise and the selective and judicious use of certain 
supplements are of vital importance. 
The importance of a team-oriented approach to diabetes management has become 
apparent during this study. The General Practitioner is clearly the health care 
provider who is most intimately involved with the private diabetic patient. It is 
evident that GP‟s are under severe time constraints and consultations are often 
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limited to 15 minutes. In such a limited time only the primary complaint can be 
adequately addressed, leaving little time for patient education and counselling. It is 
unreasonable to expect of a GP to be able to cater to all the needs of a diabetic 
patient in so short a time and use must be made of optometrists and dieticians as 
part of the health care team. Optometrists are ideally placed to add value to 
diabetes treatment in a co-management role, where microvascular abnormalities 
may be detected by fundoscopy and appropriate referrals can be made. Suitably 
trained optometrists are able to recommend certain lifestyle interventions, educate 
patients and obtain random blood glucose measurements. To facilitate this, the 
Professional Board for Optometry and Dispensing Opticians (PBODO) should provide 
guidelines for the management of diabetic patients in optometric practice. The 
PBODO should furthermore accredit education programs for optometrists to become 
diabetes co-management practitioners. The role of the South African Optometric 
Association should be to highlight the benefits of a comprehensive optometric 
examination for all diabetic patients and emphasise the role of the optometrist as a 
primary health care provider in this regard. 
It is clear from the literature that diabetes is a global concern and its prevalence is 
escalating to pandemic levels. There are vast socio-economic implications to this 
phenomenon and governments need to take cognisance of this as a matter of 
urgency. In South Africa, emphatic policy framework decisions must be taken and 
appropriate funding allocated in order to raise awareness amongst the population. 
Diabetes Mellitus is a major pandemic involving ever-greater numbers of the 
population. While the prognosis of well-managed diabetes is generally excellent, the 
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journey to optimal management is one that needs to be taken as a matter of 
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ANNEXURE A: Introduction letter and questionnaire  
                 Consent to participate in research 
 
Study title:  PATIENTS’ KNOWLEDGE OF DIABETES, ITS OCULAR 
COMPLICATIONS AND MANAGEMENT IN PRIVATE 
SECTOR POPULATION SAMPLE IN THE WESTERN CAPE, 
SOUTH AFRICA.  
I ……………………………………………… hereby confirm that I have been requested to 
participate in a research study on the knowledge of diabetes, its ocular complications 
and management. I have read the briefing document provided and the contents 
thereof.  
 
I confirm that I am voluntarily participating in the study and understand that all 
information will be kept confidential and that at no time will I be identified in the 
presentation of the results. Furthermore, I am aware that I have the right to refuse 
to participate or terminate my participation at any point. I am aware that should I 
have any queries, or if I have questions about my rights as a research participant, I 
may contact Mr K.C. Phillips at 022 4821900 (o/h), Mr K.P.Mashige at 031- 260 7352 
or the Research Ethics Committee at 031-260 3587. 
 
 
_________________               ______________ 
Signature of Participant                            Date 
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  Toestemming om deel te neem in die navorsing 
 
 
Studietitel: “PATIENTS’ KNOWLEDGE OF DIABETES, ITS OCULAR 
COMPLICATIONS AND MANAGEMENT IN PRIVATE 
SECTOR POPULATION SAMPLE IN THE WESTERN CAPE, 
SOUTH AFRICA.”  
Ek ……………………………………………….. bevestig hiermee dat ek gevra is om deel te 
neem in „n navorsingsstudie i.v.m. die kennis van diabetes, die okulêre komplikasies 
en die behandeling daarvan. Ek het die die verduidelikingsbrief gelees en verstaan 
die inhoud daarvan. 
 
Ek bevestig dat ek vrywillig in hierdie studie deelneem en verstaan dat alle inligting 
vertroulik is en dat ek op geen wyse geidentifiseerd in die voorlegging van die 
resultate sal wees nie. Ek is verder bewus dat ek te enige tyd die reg het om 
deelname aan hierdie studie te ontrek. Ek is ook bewus daarvan dat, sou ek enige 
navrae oor my regte as navorsingsdeelnemer het, ek die volgende kan kontak: Mnr 
KC Phillips by 022 4821900 (k/u), Mnr KP Mashige by 031- 260 7352 of die 
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   Isivumelwano sokuba yinxalenye yophando 
 
Isihloko: ULWAZI OLUPHANGALELEYO NGESIFO SESWEKILE NENDLELA 
 ESIBANGELA INGXAKI NGAYO NESINGALAWULEKA NGASO 
 EMEHLWENI KWISEBE ELIZIMELEYO LABEMI ABATHILE KWI 
 BANDLA LASENTSHONA KOLONI EMZANTSI AFRIKA 
Mna .................................................................. ndiyavuma ukuba yinxalenye 
ngokwesicelo kwizifundo eziphanda ngolwazi ngesifo seswekile futhi nangendlela 
esibangela ingxaki ngayo nesingalawuleka ngaso emehlweni. Ndiwafumene 
ndawafunda onke amaphepha acacisayo nanikeza ulwazi oluthe vetshe ngesisifo. 
 
Ndiyangqina ukuba ndizithandele ngokwam ukuba yinxalenye koluphando futhi 
ndiyaqonda ukuba lonke ulwazi oluqokelelweyo luyakugcinwa luyimfihlakalo negama 
lam alisayi kupapashwa kwiziphumo ezothi zivezwe. Ndiyazi ukuba ndinalo ilungelo 
lokwala okanye lokuzikhupha kwezizifundo zophando nangaliphi na ixesha 
endithanda ngalo. Ndiyazi ukuba nangaliphi na ixesha ndinemibuzo okanye 
ndinesikrokro ngamalungelo am okuba yinxalenye, ndingaqhakamshelana 
noMnumzana u K.C. Phillips ku 022 482 1900 (ngexesha lomsebenzi), Mnumzana 
K.P. Mashige ku 031 260 7325 okanye abe komiti ephanda ngokomgaqo ku 031-260 
3587.  
 
_________________               ______________ 
Ilungu elityikityayo                            Umhla 
